
<html lang="en"     class="pb-page"  data-request-id="0e93a78b-faed-4ef8-91f7-a5b9d2c2daa9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.8b01424;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2018.61.issue-24;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer" /></meta><meta name="dc.Creator" content="Xingsen  Wu" /></meta><meta name="dc.Creator" content="Xiang  Li" /></meta><meta name="dc.Creator" content="Zhihong  Li" /></meta><meta name="dc.Creator" content="Yancheng  Yu" /></meta><meta name="dc.Creator" content="Qidong  You" /></meta><meta name="dc.Creator" content="Xiaojin  Zhang" /></meta><meta name="dc.Description" content="The elevation of oxidative stress preferentially in cancer cells by efficient NQO1 substrates, which promote ROS generation through redox cycling, has emerged as an effective strategy for cancer th..." /></meta><meta name="Description" content="The elevation of oxidative stress preferentially in cancer cells by efficient NQO1 substrates, which promote ROS generation through redox cycling, has emerged as an effective strategy for cancer th..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 3, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01424" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01424" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01424" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01424" /></link>
        
    
    

<title>Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01424" /></meta><meta property="og:title" content="Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0022.jpeg" /></meta><meta property="og:description" content="The elevation of oxidative stress preferentially in cancer cells by efficient NQO1 substrates, which promote ROS generation through redox cycling, has emerged as an effective strategy for cancer therapy, even for treating drug-resistant cancers. Here, we described the identification and structural optimization studies of the hit compound 1, a new chemotype of nonquinone substrate for NQO1 as an efficient ROS generator. Further structure–activity relationship studies resulted in the most active compound 20k, a tricyclic 2,3-dicyano indenopyrazinone, which selectively inhibited the proliferation of NQO1-overexpressing A549 and A549/Taxol cancer cells. Furthermore, 20k dramatically elevated the intracellular ROS levels through NQO1-catalyzed redox cycling and induced PARP-1-mediated cell apoptosis in A549/Taxol cells. In addition, 20k significantly suppressed the growth of A549/Taxol xenograft tumors in mice with no apparent toxicity observed in vivo. Together, 20k acts as an efficient NQO1 substrate and may be a new option for the treatment of NQO1-overexpresssing drug-resistant NSCLC." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01424"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01424">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01424&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01424&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01424&amp;href=/doi/10.1021/acs.jmedchem.8b01424" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 11280-11297</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01411" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01430" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Xingsen Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xingsen Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China</div><div class="loa-info-affiliations-info">Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing, 211198, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xingsen++Wu">Xingsen Wu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiang Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiang Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China</div><div class="loa-info-affiliations-info">Department of Pharmaceutical Engineering, China Pharmaceutical University, Nanjing, 211198, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiang++Li">Xiang Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhihong Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhihong Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China</div><div class="loa-info-affiliations-info">Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing, 211198, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhihong++Li">Zhihong Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yancheng Yu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yancheng Yu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China</div><div class="loa-info-affiliations-info">Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing, 211198, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yancheng++Yu">Yancheng Yu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qidong You</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qidong You</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China</div></div><span class="conrtib-corresp"><strong>*</strong>Tel./Fax: +86-25-83271351. E-mail: <a href="/cdn-cgi/l/email-protection#2e57415b5f4a6e1f181d004d4143"><span class="__cf_email__" data-cfemail="f28b9d878396b2c3c4c1dc919d9f">[email protected]</span></a> (Q. You).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qidong++You">Qidong You</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8587-0122" title="Orcid link">http://orcid.org/0000-0002-8587-0122</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Xiaojin Zhang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaojin Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China</div><div class="loa-info-affiliations-info">Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing, 211198, China</div></div><span class="conrtib-corresp"><strong>*</strong>Tel.: +86-13913007140. E-mail: <a href="/cdn-cgi/l/email-protection#255f5d4f654655500b4041500b464b"><span class="__cf_email__" data-cfemail="e3999b89a3809396cd868796cd808d">[email protected]</span></a> (X. Zhang).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaojin++Zhang">Xiaojin Zhang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1898-3071" title="Orcid link">http://orcid.org/0000-0002-1898-3071</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01424&amp;href=/doi/10.1021%2Facs.jmedchem.8b01424" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 11280–11297</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 3, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 September 2018</li><li><span class="item_label"><b>Published</b> online</span>3 December 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 December 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01424" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01424</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D11280%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXingsen%2BWu%252C%2BXiang%2BLi%252C%2BZhihong%2BLi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D24%26contentID%3Dacs.jmedchem.8b01424%26title%3DDiscovery%2Bof%2BNonquinone%2BSubstrates%2Bfor%2BNAD%2528P%2529H%253A%2BQuinone%2BOxidoreductase%2B1%2B%2528NQO1%2529%2Bas%2BEffective%2BIntracellular%2BROS%2BGenerators%2Bfor%2Bthe%2BTreatment%2Bof%2BDrug-Resistant%2BNon-Small-Cell%2BLung%2BCancer%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D11297%26publicationDate%3DDecember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01424"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1978</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01424" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xingsen&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Xiang&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Zhihong&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yancheng&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Qidong&quot;,&quot;last_name&quot;:&quot;You&quot;},{&quot;first_name&quot;:&quot;Xiaojin&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;11280-11297&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01424&quot;},&quot;abstract&quot;:&quot;The elevation of oxidative stress preferentially in cancer cells by efficient NQO1 substrates, which promote ROS generation through redox cycling, has emerged as an effective strategy for cancer therapy, even for treating drug-resistant cancers. Here, we described the identification and structural optimization studies of the hit compound 1, a new chemotype of nonquinone substrate for NQO1 as an efficient ROS generator. Further structure–activity relationship studies resulted in the most active compound 20k, a tricyclic 2,3-dicyano indenopyrazinone, which selectively inhibited the proliferation of NQO1-overexpressing A549 and A549/Taxol cancer cells. Furthermore, 20k dramatically elevated the intracellular ROS levels through NQO1-catalyzed redox cycling and induced PARP-1-mediated cell apoptosis in A549/Taxol cells. In addition, 20k significantly suppressed the growth of A549/Taxol xenograft tumors in mice with no apparent toxicity observed in vivo. Together, 20k acts as an efficient NQO1 substrate and may be &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01424&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01424" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01424&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01424" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01424&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01424" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01424&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01424&amp;href=/doi/10.1021/acs.jmedchem.8b01424" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01424" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01424" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01424%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DWu%26date%3D2018%26atitle%3DDiscovery%2Bof%2BNonquinone%2BSubstrates%2Bfor%2BNAD%2528P%2529H%253A%2BQuinone%2BOxidoreductase%2B1%2B%2528NQO1%2529%2Bas%2BEffective%2BIntracellular%2BROS%2BGenerators%2Bfor%2Bthe%2BTreatment%2Bof%2BDrug-Resistant%2BNon-Small-Cell%2BLung%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D24%26spage%3D11280%26epage%3D11297%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291719" title="Redox reactions">Redox reactions</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/jmcmar.2018.61.issue-24/20181227/jmcmar.2018.61.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The elevation of oxidative stress preferentially in cancer cells by efficient NQO1 substrates, which promote ROS generation through redox cycling, has emerged as an effective strategy for cancer therapy, even for treating drug-resistant cancers. Here, we described the identification and structural optimization studies of the hit compound <b>1</b>, a new chemotype of nonquinone substrate for NQO1 as an efficient ROS generator. Further structure–activity relationship studies resulted in the most active compound <b>20k</b>, a tricyclic 2,3-dicyano indenopyrazinone, which selectively inhibited the proliferation of NQO1-overexpressing A549 and A549/Taxol cancer cells. Furthermore, <b>20k</b> dramatically elevated the intracellular ROS levels through NQO1-catalyzed redox cycling and induced PARP-1-mediated cell apoptosis in A549/Taxol cells. In addition, <b>20k</b> significantly suppressed the growth of A549/Taxol xenograft tumors in mice with no apparent toxicity observed in vivo. Together, <b>20k</b> acts as an efficient NQO1 substrate and may be a new option for the treatment of NQO1-overexpresssing drug-resistant NSCLC.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43457" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43457" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Non-small-cell lung cancer (NSCLC) is one of the common aggressive malignant tumors, accounting for ∼85% of human lung cancer, which is a disease that remains the leading cause of cancer-related mortality worldwide.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The overall 5-year survival rate for NSCLC (all stages combined) is roughly 17% and the 5-year survival rate in stage IV is only ∼2%.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Although the treatment of NSCLC has evolved over the past two decades, resulting in different therapeutic options, including chemotherapy,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> tyrosine kinase inhibitors,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> monoclonal antibodies,<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> and some combinations,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> great challenges still exist, because of the intrinsic or acquired drug resistance and genomic instability in cancers.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> For instance, taxol, which is a chemotherapy drug for the first-line treatment of NSCLC, almost universally fail for late-stage NSCLC patients, because of drug resistance.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Therefore, new drugs and new strategies for the effective treatment of drug-resistant NSCLC are urgent needs to develop.</div><div class="NLM_p">Modulation of the unique biochemical alterations in cancer cells provides a new approach for cancer therapy and probably prevents the development of drug resistance.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Reactive oxygen species (ROS) at low levels play important roles as second messengers in several cellular processes, such as proliferation, angiogenesis, and metastasis.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> However, when present at high levels, ROS irreversibly damage DNA, lipids, and proteins, and ultimately cause apoptosis of cancer cells.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> It is worth noting that cancer cells are usually exposed to a relatively high level of ROS, compared to that for normal cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Such biochemical differences make cancer cells more susceptible to induced oxidative stress, exceed the threshold that they can endure, and lead to ROS-mediated cell death.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> Therefore, pharmacological elevation of intracellular ROS level by small molecules has been regarded as an effective strategy for cancer therapy.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> Moreover, the efficacy of this ROS-generating method has been demonstrated in some drug-resistance cancers.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Co-treatment of the molecules that mediate their effects through an ROS-based mechanism with anticancer drugs has significantly sensitized the cells to drugs by overcoming the resistance.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Thus, the strategy to develop ROS-generating molecules could be promising in treating drug-resistance cancers.</div><div class="NLM_p">A crucial issue in developing ROS-generating strategy is how to elevate the levels of ROS specifically in cancer cells while simultaneously sparing normal cells. In this respect, NAD(P)H: quinone oxidoreductase (NQO1) and its redox substrates are gradually being paid close attention.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24−26)</a> NQO1 is such a cancer-specific cytosolic flavoenzyme that is highly elevated in multiple cancer cells, especially in NSCLC cells,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> where it is constitutively overexpressed more than 100-fold greater than that in correlative normal tissues.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> NQO1 uses the reduced pyridine nucleotide NADH or NADPH as a cofactor to catalyze the direct two-electron reduction of a wide variety of quinones to give hydroquinones (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> Many efficient NQO1 substrates have been reported to be potential antitumor drugs, and the three main mechanisms are described as follows: (1) a direct alkylation of DNA by the corresponding hydroquinones formed by NQO1 bioreduction (e.g., mitomycin C); (2) hydroquinones as potent Hsp90 inhibitors (e.g., geldamycin and its derivative 17-AAG); and (3) rapid generation of ROS through redox cycling between hydroquinones and its quinone substrates, such as β-lapachone (β-lap, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B) (an antitumor drug candidate in multiple clinical trials),<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> deoxynyboquinone (DNQ, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> streptonigrin (STN),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and their derivatives.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The last mode-of-action by redox cycling is the most substantiated NQO1-dependent mechanism for anticancer quinones. Upon bioreductive activation of certain quinones, the corresponding unstable hydroquinones rapidly react with physiological oxygen (O<sub>2</sub>) in cells to provide 2 equiv of superoxide (O<sub>2</sub><sup>•–</sup>), which is the main constituent of ROS, and regenerate the quinones (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Because of the fact that these redox substrates rapidly and catalytically generate a great amount of toxic ROS specifically in NQO1-overexpressing cells, they have considerable potential as efficient ROS generators for cancer treatment. However, what cannot be ignored is that all the present NQO1-mediated ROS generators via redox cycling, structurally, contain a quinone moiety (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B), which is often considered as a structural alert as applied in medicinal chemistry for the risk of idiosyncratic drug toxicity, because of its reactivity toward cellular nucleophiles through Michael addition.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Redox cycling of quinone substrates for NQO1, and the principle of NADPH-based NQO1 assay for screening new redox cycling NQO1 substrates; (B) representative NQO1-mediated redox cycling quinones as antitumor ROS generators; and (C) structure of hit compound <b>1</b> as nonquinone redox cycling substrate for NQO1 in this work.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Here, we report our efforts on the discovery of nonquinone substrates for NQO1 as effective intracellular ROS generators for the treatment of drug-resistant NSCLC. Through screening of an in-house collection of 7500 compounds by using an NADPH-based NQO1 assay, fortunately, compound <b>1</b> was identified as an efficient ROS generator through NQO1-catalyzed redox cycling with a tetracyclic nonquinone scaffold. It exerted significant antitumor activities in vitro toward both A549 and taxol-resistant A549/Taxol lung cancer cells, and showed considerable selectivity to NQO1-rich A549/Taxol cancer cells over NQO1-deficient L02 normal hepatic cells. Thus, tetracyclic compound <b>1</b> was selected as a starting point for optimization. Then, compound <b>20k</b> with a simplified tricyclic scaffold, which was more selective toward A549/Taxol cancer cells, was revealed from the structure–activity relationship (SAR) study by a step-by-step modification strategy. Pharmacological study demonstrated that <b>20k</b> dramatically elevated the intracellular ROS levels through NQO1-catalyzed redox cycling, and induced poly(ADP-ribose)polymerase-1 (PARP-1)-mediated cell apoptosis in an NQO1- and ROS-dependent manner in A549/Taxol cells. It also significally suppressed tumor growth in A549/Taxol cell-xenografted mouse model with no apparent toxicity observed in vivo. Therefore, we provide a new chemotype of nonquinone substrates for NQO1 as effective and selective intracellular ROS generators for developing promising new drugs for the treatment of NQO1-overexpresssing drug-resistant NSCLC.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03550" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03550" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  Hit Identification from an In-House Compound Collection Using an NADPH-Based NQO1 Assay</h3><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5">2.1.1.  Screening for Nonquinone Redox Cycling NQO1 Substrates as ROS Generators</h4><div class="NLM_p">With the aim to discover new chemical types of NQO1 substrates with redox cycling property, we screened experimentally an in-house compound collection containing 7500 compounds by using an NADPH-based NQO1 assay.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> As illustrated in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A, given that the tested compound acted as an NQO1 substrate and formed redox cycling, the amount of consumed NADPH would be much more than that of tested compound. <i>N</i> (cycles), which is defined as the number of equivalents of consumed NADPH divided by the number of equivalents of tested compound, was used as an index to the character of redox cycling. Compounds with N (cycles) > 10 (half of the N value of positive control quinone substrate β-lap) were selected as hit compounds. Fortunately, nonquinone compound <b>1</b> (Chemdiv ID: 000A-0055, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C) was revealed as an efficient redox cycling NQO1 substrate with an <i>N</i> (cycles) value of 23, which was comparable to that of well-known quinone substrate β-lap (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). Moreover, when compound <b>1</b> was tested in the absence of NQO1 or with the addition of an NQO1 inhibitor dicoumarol (DIC), no or little amount of NAPDH was consumed, indicating that the redox cycling of <b>1</b> relied on NQO1 bioreduction (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). Furthermore, by quantifying NADPH oxidation at 2 s intervals in the initial 5 min under different concentrations of <b>1</b>, the NQO1 reduction rates (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) and Michaelis–Menten curves (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C) were generated, and the apparent catalytic efficiencies were calculated. It was observed that compound <b>1</b> was a highly efficient substrate and redox cycler with a reduction rate of 1412 ± 64 μmol NADPH/min/μmol NQO1 at 10 μM, and a <i>k</i><sub>cat</sub>/<i>K</i><sub>M</sub> value of 5.8 ± 1.0 × 10<sup>6</sup> M<sup>–1</sup> s<sup>–1</sup>, which was processed much faster than β-lap (reduction rate = 1155 ± 44 μmol NADPH/min/μmol NQO1 at 10 μM, and <i>k</i><sub>cat</sub>/<i>K</i><sub>M</sub> = 4.4 ± 0.9 × 10<sup>6</sup> M<sup>–1</sup> s<sup>–1</sup>). Considering that the redox cycling could lead to ROS generation, we thus set out to identify the ability of <b>1</b> to generate ROS. The generation of superoxide (O<sub>2</sub><sup>• –</sup>) was measured by a spectrophotometric assay using cytochrome <i>c</i> as the terminal electron acceptor.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D, nonquinone compound <b>1</b> showed a rapid rate of ROS generation (ROS generation rate = 1092 ± 64 μmol cyt c/min/mg NQO1), being much more efficient than β-lap (ROS generation rate = 724 ± 7 μmol cyt c/min/mg NQO1). In addition. coincubation with DIC dramatically reduced the rate of ROS generation by <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D). These results indicated that the hit compound <b>1</b> could generate a high level of ROS via NQO1-directed redox cycling.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) <i>N</i> (cycles), representing the the number of equivalents of NADPH consumed, relative to the number of equivalents of substrates (10 μM) over the course of the NADPH-based NQO1 assay (in 5 min) monitored at 340 nm. (B) The initial reduction rates of nonquinone compound <b>1</b> and β-lap (10 μM) by NQO1. (C) Michaelis–Menten curves for <b>1</b> and β-lap with NQO1. (D) Rate of ROS production of <b>1</b> and β-lap in the presence and absence of the NQO1 inhibitor (DIC, 25 μM) with NQO1. (E) Cell death of NQO1-rich A549 cancer cells with <b>1</b> and β-lap for 72 h by MTT assay. (F) Cell death of NQO1-rich A549/Taxol drug-resistant cancer cells with <b>1</b> and β-lap for 72 h by MTT assay. (G) Cell death of NQO1-deficient L02 normal hepatic cells with <b>1</b> and β-lap for 72 h by MTT assay. (H) The selectivity ratio (SR) toward NQO1-rich A549/Taxol cancer cells over NQO1-deficient L02 normal hepatic cells; SR = IC<sub>50</sub> (L02)/IC<sub>50</sub> (A549/Taxol).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6">2.1.2.  Hit Compound <b>1</b> Exhibited Potent and Selective Cytotoxicity toward NQO1-Over-expressing Drug-Resistant NSCLC Cells in Vitro</h4><div class="NLM_p last">Cytotoxicity studies were performed on hit compound <b>1</b> with cell survival being determined by the 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay against the human NSCLC cells, A549 (NQO1-rich) and drug-resistant A549/Taxol (NQO1-rich), and L02 normal hepatic cells (NQO1-deficient) (<a class="ref internalNav" href="#notes1" aria-label="Figure S1">Figure S1</a> in the Supporting Information). β-Lap was used as a positive control. Compound <b>1</b> showed potent cytotoxicity against NQO1-overexpressing A549 and A549/Taxol cells with IC<sub>50</sub> values of 1.0 ± 0.2 μM (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>E) and 0.6 ± 0.1 μM (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>F), respectively, which was more active than β-lap. Whereas in the case of L02 cells, compound <b>1</b> was less sensitive with an IC<sub>50</sub> of 14.3 ± 1.6 μM (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>G). Of particular note was that nonquinone compound <b>1</b> showed considerable selectivity to drug-resistant NQO1-rich A549/Taxol cancer cells over NQO1-deficient L02 normal hepatic cells with a high selectivity ratio of 23.8, being much more selective than quinone compound β-lap (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>H). Thus, compound <b>1</b> could be a promising hit for further optimization.</div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.2.  SAR and Structural Modification of Compound <b>1</b> Utilizing a Step-by-Step Strategy</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8">2.2.1.  SAR Studies Focusing on Rings C and D of Tetracyclic Compound <b>1</b> Resulting in Tricyclic Compound <b>10</b></h4><div class="NLM_p">To further optimization of hit compound <b>1</b>, a detailed SAR study was performed based on their NQO1 reduction rates in vitro. The target compounds <b>2</b>–<b>10</b> focusing on Rings D and C of <b>1</b> were designed as illustrated in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. Their reduction rates and <i>N</i> (cycles) by NQO1 were determined at the concentration of 10 μM by using the aforementioned NADPH-based assay, and the results were shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. First, the oxadiazole ring D was converted to other aromatic rings, such as benzene (<b>2</b>–<b>4</b>) and thiophene (<b>5</b>), as well as aliphatic ring such as cyclohexane (<b>6</b>); however, their NQO1 activities were dramatically decreased, compared to <b>1</b>, with reduction rates in the range of 254–362 μmol NADPH/min/μmol NQO1. The removal of ring D as in compound <b>7</b> was also detrimental for its reduction activity by NQO1 (356 ± 41 μmol NADPH/min/μmol NQO1). These results suggested that ring D of <b>1</b> was of great importance for its NQO1 reduction activity. Then, the pyrazine ring C of <b>7</b> was converted to 1,2,4-trazine as in compound <b>8</b>; no increased activity was observed. Moreover, the replacement of pyrazine ring C with benzene ring as in compound <b>9</b> led to a complete loss in activity, indicating that the N atoms in C ring were responsible for NQO1 reduction. Furthermore, considering that the oxadiazole aromatic ring D of <b>1</b> probably acted as a delocalization moiety in the process of NQO1 reduction, we designed compound <b>10</b> with two cyano substitution directly linked to ring C by a ring opening strategy (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The <i>sp</i>-hybridized atoms in cyano group were expected to act similar function to the oxadiazole ring D for electron delocalization during NQO1 reduction. Encouragingly, compound <b>10</b> exerted considerable activity to <b>1</b> as expected, with a reduction rate of 1362 ± 38 μmol NADPH/min/μmol NQO1, which was slightly more active than β-lap (1155 ± 44 μmol NADPH/min/μmol NQO1). Compound <b>10</b> was also an efficient redox cycler, showing 20 redox cycles in the presence of NQO1 in 5 min. It must be emphasized that compound <b>10</b> with a simplified indenopyrazinone tricylic scaffold, structurally, was more beneficial for further optimization than the tetracylic hit compound <b>1</b>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design of the target compounds <b>2</b>–<b>10</b>, focusing on the rings C and D of <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Reduction Rates of the Target Compounds <b>1</b>–<b>10</b> Catalyzed by NQO1</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compound</th><th class="colsep0 rowsep0" align="center" char="±">reduction rate by NQO1 (μmol NADPH/min/μmol NQO1)</th><th class="colsep0 rowsep0" align="center" char="."><i>N</i><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (cycles)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">1412 ± 64</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">362 ± 30</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>3</b></td><td class="colsep0 rowsep0" align="char" char="±">300 ± 22</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>4</b></td><td class="colsep0 rowsep0" align="char" char="±">320 ± 35</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>5</b></td><td class="colsep0 rowsep0" align="char" char="±">316 ± 21</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>6</b></td><td class="colsep0 rowsep0" align="char" char="±">254 ± 34</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>7</b></td><td class="colsep0 rowsep0" align="char" char="±">356 ± 41</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>8</b></td><td class="colsep0 rowsep0" align="char" char="±">347 ± 65</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>9</b></td><td class="colsep0 rowsep0" align="center" char="±">NA<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center" char=".">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>10</b></td><td class="colsep0 rowsep0" align="char" char="±">1362 ± 38</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center" char=".">β-lap</td><td class="colsep0 rowsep0" align="char" char="±">1155 ± 44</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The equiv of NADPH utilized relative to the number of equivalents of substrates over the course of the assay (in 5 min).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">No activity.</p></div></div></div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">2.2.2.  SAR Studies Focusing on Rings B and C of Tricyclic Compound <b>10</b></h4><div class="NLM_p">Next, for further exploring the SAR, the target compounds <b>11</b>–<b>19</b> focusing on Rings B and C of <b>10</b> were designed as illustrated in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. Their reduction rates and <i>N</i> (cycles) by NQO1 were determined, and the results are shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. Removal of the carbonyl group in B ring as in <b>11</b> led to a complete loss in activity, suggesting that the carbonyl group was crucial for NQO1 reduction. Compounds <b>12</b>–<b>16</b> were designed by replacing the cyano group at C3 with groups containing lone pair electrons, such as oxygen-containing compounds <b>12</b> and <b>13</b>, nitrogen-containing compounds <b>14</b> and <b>15</b>, and halogen-containing compound <b>16</b>. However, compounds <b>12</b>–<b>16</b> showed extremely low reduction rates, in the range of 117–260 μmol NADPH/min/μmol NQO1 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Furthermore, the target compounds <b>17</b>–<b>19</b> were generated by changing the linear cyano group into similarly linear alkynyl groups with <i>sp</i>-hybridized carbon atoms. Nevertheless, they all exerted significantly decreased activity, compared to <b>10</b>. In addition, compound <b>19</b> with bulky benzyl substitution to the end of alkynyl moiety could hardly be reduced by NQO1. The results demonstrated that the cyano groups substituted at ring C played a crucial role for NQO1 reduction activity, and these sites were not suitable for further modification.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design of the target compounds <b>11</b>–<b>19</b> focusing on the rings B and C of <b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Reduction Rates of the Target Compounds <b>11</b>–<b>19</b> Catalyzed by NQO1</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compound</th><th class="colsep0 rowsep0" align="center" char="±">reduction rate by NQO1 (μmol NADPH/min/μmol NQO1)</th><th class="colsep0 rowsep0" align="center" char="."><i>N</i><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (cycles)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>11</b></td><td class="colsep0 rowsep0" align="center" char="±">NA<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center" char=".">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>12</b></td><td class="colsep0 rowsep0" align="char" char="±">151 ± 33</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>13</b></td><td class="colsep0 rowsep0" align="char" char="±">183 ± 42</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>14</b></td><td class="colsep0 rowsep0" align="char" char="±">149 ± 34</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>15</b></td><td class="colsep0 rowsep0" align="char" char="±">260 ± 45</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>16</b></td><td class="colsep0 rowsep0" align="char" char="±">117 ± 30</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>17</b></td><td class="colsep0 rowsep0" align="char" char="±">332 ± 63</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>18</b></td><td class="colsep0 rowsep0" align="char" char="±">363 ± 92</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>19</b></td><td class="colsep0 rowsep0" align="center" char="±">NA<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center" char=".">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>10</b></td><td class="colsep0 rowsep0" align="char" char="±">1362 ± 38</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center" char=".">β-lap</td><td class="colsep0 rowsep0" align="char" char="±">1155 ± 44</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The number of equivalents of NADPH utilized, relative to the number of equivalents of substrates over the course of the assay (in 5 min).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">No activity.</p></div></div></div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">2.2.3.  SAR Studies Focusing on Ring A of Tricyclic Compound <b>10</b></h4><div class="NLM_p">According to the SAR information above, the following moieties including the carbonyl group in ring B, the nitrogen-containing pyrazine ring C, and the cyano groups substituted on C, were revealed to be important pharmacorphoric features responsible for <b>10</b> by NQO1 reduction. Thus, we retained these features in the subsequent modification and focused on ring A of <b>10</b>. The target compounds <b>20a</b>–<b>20m</b> were designed by introducing different groups, mainly concerning the electronic effects, such as weak electron-donating group (−CH<sub>3</sub>), strong electron-donating groups (−OCH<sub>3</sub> and −OH), and electron-withdrawing groups (F, Cl, and −CF<sub>3</sub>) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). As shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, monosubstituted compounds <b>20a</b>–<b>20g</b> were all efficient NQO1 substrates and redox cyclers, possessing reduction rates in the range of 1104–1376 μmol NADPH/min/μmol NQO1 that were comparable to <b>10</b>. Interestingly, monosubstitutions with electron-withdrawing groups (−F and −CF<sub>3</sub>) as in <b>20f</b> and <b>20g</b> were found to be more beneficial for improving NQO1 reduction activity, compared to monosubstitutions with electron-donating groups such as −CH<sub>3</sub>, −OCH<sub>3</sub>, and −OH as in compounds <b>20a</b>–<b>20e</b>. Furthermore, introducing disubstitutions with electron-donating −CH<sub>3</sub> (<b>20h</b>) and −OCH<sub>3</sub> (<b>20i</b> and <b>20j</b>) significantly led to a decrease in reduction rates by NQO1 (656–902 μmol NADPH/min/μmol NQO1), when compared to <b>10</b>. Notably, among this series of target compounds, <b>20k</b> with difluoro substitution at C6 and C7 sites of ring A revealed to be the most-efficient NQO1 substrate, with a reduction rate of 1471 ± 42 μmol NADPH/min/μmol NQO1, as well as the most efficient redox cycler, showing 25 redox cycles in the presence of NQO1 in 5 min (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), which was much more efficient than <b>10</b> and β-lap. Changing the positions of difluoro groups in <b>20k</b> to C5 and C8 as in <b>20l</b>, and replacing the difluoro with dichloro groups as in <b>20m</b> both resulted in decreased activity, when compared with <b>20k</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Target Compounds <b>20a</b>–<b>20m</b> Focusing on Ring A of <b>10</b>, and Their Reduction Rates Catalyzed by NQO1</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0021.gif" alt="" id="GRAPHIC-d7e1223-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compound</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center" char="±">reduction rate by NQO1 (μmol NADPH/min/μmol NQO1)</th><th class="colsep0 rowsep0" align="center" char="."><i>N</i><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (cycles)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1197 ± 44</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20b</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1298 ± 58</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1104 ± 43</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1118 ± 36</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1141 ± 39</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1376 ± 65</td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1365 ± 53</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20h</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">902 ± 43</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20i</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">656 ± 88</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20j</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">768 ± 78</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20k</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1471 ± 42</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20l</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">1302 ± 69</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20m</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1180 ± 72</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>10</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1362 ± 38</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center" char=".">β-lap</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">1155 ± 44</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The number of equivalents of NADPH utilized, relative to the number of equivalents of substrates over the course of the assay (in 5 min).</p></div></div></div><div class="NLM_p">In addition, representative compounds <b>1</b>, <b>10</b>, <b>20i</b>, and <b>20k</b> were selected to calculate their catalytic efficiency. The reduction rates by NQO1 at various concentrations (3.1–70 μM) were determined and the corresponding Michaelis–Menten curves were subsequently generated (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). It was observed that compound <b>20k</b> was the most efficient substrate (<i>k</i><sub>cat</sub>/<i>K</i><sub>M</sub> = 6.2 ± 1.1 × 10<sup>6</sup> M<sup>–1</sup> s<sup>–1</sup>), possessing much better kinetic parameters than <b>10</b> (<i>k</i><sub>cat</sub>/<i>K</i><sub>M</sub> = 5.1 ± 0.9 × 10<sup>6</sup> M<sup>–1</sup> s<sup>–1</sup>) and β-lap (<i>k</i><sub>cat</sub>/<i>K</i><sub>M</sub> = 4.4 ± 0.9 × 10<sup>6</sup> M<sup>–1</sup> s<sup>–1</sup>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Michaelis–Menten curves for <b>1</b>, <b>10</b>, <b>20i</b>, <b>20k</b>, and β-lap with NQO1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">2.2.4.  Synthesis of the Target Compounds</h4><div class="NLM_p">The target compounds <b>2</b>–<b>8</b> and <b>10</b> were synthesized using the routes summarized in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Briefly, diverse diamine materials (<b>22a</b>–<b>22c</b>, <b>23</b>–<b>27</b>) reacted with ninhydrin hydrate (<b>21</b>) in the presence of acetic acid, using ethanol as a solvent to give efficiently the target compounds <b>2</b>–<b>8</b> and <b>10</b> in one step. Target compound <b>9</b> was commercially available and was purchased directly. The rest target compounds <b>11</b>–<b>19</b> and <b>20a</b>–<b>20m</b> were synthesized using the routes summarized in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Similarly, indanedione <b>28</b> reacted with 2,3-diaminomaleonitrile (<b>27</b>) in isopropanol at room temperature gave <b>11</b> in one step with a yield of 82%. Treatment of <b>10</b> with corresponding nucleophiles such as sodium alkoxides and amines gave <b>12</b>–<b>15</b> in moderate yields of 37%–87%. Compound <b>16</b> was synthesized by heating <b>14</b> in acetonitrile in the presence of <i>tert</i>-butyl nitrite and CuCl<sub>2</sub> in 58%. Subsequent treatment of <b>16</b> with corresponding alkynes through Sonogashira coupling reaction gave <b>17</b>–<b>19</b> in acetonitrile in 24%–36%. Compounds <b>20a</b>–<b>20m</b> were obtained by cyclization of different substituted indanediones (<b>29a</b>–<b>29m</b>) with 2,3-diaminomaleonitrile (<b>27</b>) in ethanol, followed by oxidation using potassium bichromate in a solvent mixture of acetic acid and water in 42%–66% over two steps.</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes for the Target Compounds <b>2</b>–<b>8</b>, and <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) AcOH, EtOH, rt, 2 h, 73%–86%; (b) AcOH, EtOH, 40 °C, 4 h, 28%–30%; and (c) AcOH, EtOH, 70 °C, 4 h, 66%.</p></p></figure><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes for the Target Compounds <b>11</b>–<b>19</b>, and <b>20a</b>–<b>20m</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>27</b> (1 equiv), isopropanol, rt, 2 h, 82%; (b) corresponding sodium alkoxides (1 equiv) or amines (1–3 equiv), THF, rt, 2 h, 37%–87%; (c) <i>tert</i>-butyl nitrite (5 equiv), CuCl<sub>2</sub> (5 equiv), CH<sub>3</sub>CN, 65 °C, 4 h, 58%; (d) corresponding alkynes (1.5 equiv), Pd(dppf)<sub>2</sub>Cl<sub>2</sub> (0.1 equiv), CuI (0.1 equiv), Et<sub>3</sub>N (1.1 equiv), CH<sub>3</sub>CN, 80 °C, 3 h, 24%–36%; (e) <b>27</b> (1 equiv), EtOH, rt, 6 h; (f) K<sub>2</sub>Cr<sub>2</sub>O<sub>7</sub> (0.6 equiv), AcOH, H<sub>2</sub>O, 100 °C, 1 h, 42%–66% over two steps. The detailed R groups for <b>20a</b>–<b>20m</b> are shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</p></p></figure></div><div id="sec2_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">2.2.5.  SAR Analysis by Electrochemical Property</h4><div class="NLM_p">Electrochemistry is the standard method for studying chemical redox reactions, and electrochemical techniques has been considerably applied to biology.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> We have investigated and reported on the electrochemical behavior of <i>ortho</i>-quinones.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> As for redox cycling substrates for NQO1, undoubtedly, the electrochemical parameters were always correlated with their biological activities. In this work, the electrochemical studies were consequently performed to investigate the electrochemical behavior of the nonquinone redox cycler and to further explain their SAR.</div><div class="NLM_p">Representative compounds (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) were selected to contain each of the structural classes. The <i>E</i><sub>redox</sub> values, with reference to ferrocene (F<sub>c</sub><sup>0/+</sup>), were determined and shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and the cyclic voltammograms (CV) of the representative compounds are shown in <a class="ref internalNav" href="#notes1" aria-label="Figure S2">Figure S2</a> in the Supporting Information.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <i>E</i><sub>redox</sub> values and NQO1 rates for representative target compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As illustrated in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, these investigated nonquinone compounds possessed <i>E</i><sub>redox</sub> values ranging from −0.918 V to −1.500 V. It has been suggested that the <i>E</i><sub>redox</sub> values of successful NQO1 quinone substrates should range from −0.70 V to −1.20 V, and the compounds were hard to be bioreduced by NQO1 if the E<sub>redox</sub> values were beyond the range.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The nonquinone compounds with an indenopyrazinone scaffold in this work were also found to meet the requirement of the rule. Compounds (<b>20k</b>, <b>1</b>, and <b>10</b>) with rapid NQO1 reduction rates (>1300 μmol NADPH/min/μmol NQO1) showed higher <i>E</i><sub>redox</sub> values (greater than −0.1 V), ranging from −0.918 V to −0.994 V, while compounds (<b>12</b>, <b>7</b>, <b>17</b>, and <b>2</b>) with very slow NQO1 reduction rates exhibited much lower <i>E</i><sub>redox</sub> values (less than −1.2 V). These results could well explain why the replacement by a benzene ring (as in <b>2</b>) or removal of ring D (as in <b>7</b>) of compound <b>1</b>, and changing of the cyano group of compound <b>10</b> (as in <b>12</b> and <b>17</b>) were all detrimental for reduction by NQO1. Furthermore, compound <b>20k</b>, which was derived by introducing additional electron-withdrawing difluoro substituents to <b>10</b>, exerted a slightly increased <i>E</i><sub>redox</sub> value, resulting in improvement of NQO1 reduction rate when compared to <b>10</b>. Similarly, in the case of <b>20i</b>, possessing additional electron-donating methoxy groups led to a decrease in <i>E</i><sub>redox</sub> value and a significant decline in NQO1 reduction activity. In summary, as for the nonquinones with an indenopyrazinone scaffold in this work, the electrochemical reduction potentials could correlate well with their reduction rates by NQO1, and the preferable <i>E</i><sub>redox</sub> values fell between −0.70 V and −1.0 V. These findings provided us a complementary method to further design and optimize this new chemotype of redox cycling substrates by NQO1 for developing novel ROS generating antitumor agents.</div></div><div id="sec2_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">2.2.6.  Binding Mode and Catalytic Analysis by Molecular Modeling</h4><div class="NLM_p">Utilizing the crystal structure of NQO1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H69">1H69</a>),<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> molecular modeling was performed using GOLD 5.1 software<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and depicted using PyMOL to elucidate the possible binding mode of NQO1 with tetracyclic hit compound <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A) and the most active, representative tricyclic compound <b>20k</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B), and the other compounds used in electrochemistry study (<a class="ref internalNav" href="#notes1" aria-label="Figure S3">Figure S3</a> in the Supporting Information). It was shown that they reside deep in the catalytic sites of NQO1 protein and was oriented above the isoalloxazine ring of bound cofactor FAD by π-stacking interaction. This was similar to the reported quinone substrates.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The carbonyl group and N1 atom of <b>1</b> and <b>20k</b> could interact with the Tyr126 and Tyr128 residues by hydrogen bonding, respectively (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>B). The residues including Trp105, Phe106, and Phe178 formed a hydrophobic pocket of sufficient size to allow only small substituents to interact favorably. Besides of matching for the catalytic binding site of NQO1, the substrates to be bioreduced by NQO1 required an appropriate hydride donor–acceptor distance between the acceptor site in substrate and the FAD cofactor (atom N5, which transfer the hydride) in NQO1.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Thus, the distance between the carbon atom of C(9)═O in <b>20k</b> and the nitrogen atom of N(5)H in FAD was calculated as 3.425 Å, which was within a reasonable distance (<4 Å) for hydride transfer, the key process for initiating NQO1 bioreduction. Based on this, the catalytic process for the reduction of the new chemotype of nonquinone substrates by NQO1, as exemplified by <b>20k</b>, was proposed as illustrated in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C. The C(9)═O moiety acted as a electrophilic site for accepting hydride (H<sup>–</sup>) from the reduced FAD (FADH<sub>2</sub>), which is similar to that of quinone substrate β-lap (<a class="ref internalNav" href="#notes1" aria-label="Figure S4">Figure S4</a> in the Supporting Information). The two hydrogen bonding interaction of C(9)═O···Tyr126 and N(1)···Tyr128 were suggested to reduce the electron density of the C9 hydride acceptor, thus facilitating hydride (H<sup>–</sup>) transfer from FADH<sub>2</sub>. Meanwhile, the Tyr126 and Tyr128 residues were also responsible for promoting substrate <b>20k</b> (oxidized form) to accept another proton (H<sup>+</sup>), thus completing the reduction process to give <b>20k-H2</b> (reduced form). Notably, it is the N(1) atom that plays as the proton acceptor in nonquinone substrate <b>20k</b>, while it is the C═O moiety in quinone substrate β-lap (<a class="ref internalNav" href="#notes1" aria-label="Figure S4">Figure S4</a>). These computational findings were also in accordance with the aforementioned key pharmacophoric features. In addition, the efficient recovery of substrate <b>20k</b> after NQO1-mediated redox cycling has also been observed experimentally in an HPLC-based assay (<a class="ref internalNav" href="#notes1" aria-label="Figure S5">Figure S5</a> in the Supporting Information).</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Docked poses of (A) compound <b>1</b> and (B) compound <b>20k</b> into the catalytic sites of NQO1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H69">1H69</a>). (C) Proposed redox cycling process for <b>20k</b> by NQO1 reduction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">2.3.  In Vitro Antitumor Evaluation</h3><div class="NLM_p">On the basis of the enzymatic assays and electrochemical studies, compounds (<b>1</b>, <b>10</b>, and <b>20a</b>–<b>20m</b>) that possessed good NQO1 reduction rates and preferable redox cycling properties, were selected for cellular assays to investigate their potency against NQO1-rich NSCLC cells (A549 cells and Taxol-resistant A549/Taxol cells) and NQO1-deficient normal hepatic cells (L02) by the MTT assay. β-Lap and Taxol were used as comparison controls. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, all the target compounds were sensitive to NQO1-rich and Taxol-resistant A549/Taxol cancer cells with IC<sub>50</sub> values, ranging from 0.6 μM to 6.8 μM, which were much more potent than Taxol (IC<sub>50</sub> = 27.0 μM). These compounds were also active to NQO1-rich A549 cancer cells with IC<sub>50</sub> values ranging from 0.8 μM to 5.9 μM. Whereas in the case of NQO1-deficient normal L02 cells, the compounds were much less sensitive, exerting IC<sub>50</sub> values ranging from 14.3 μM to 35.9 μM, showing a desirable selectivity between cancer and normal cells. Notably, all of the tricyclic target compounds (<b>10</b> and <b>20a</b>–<b>20m</b>) were less toxic to normal L02 cell when compared to the tetracyclic hit <b>1</b>. Relative high selectivity ratios in compounds <b>20f</b> and <b>20k</b>–<b>20m</b> were observed, being much greater than hit <b>1</b> and positive control β-lap. Interestingly, these compounds with high selectivity were found to be substituted with fluoro or chloro in ring A. Among all the compounds tested, <b>20k</b>, which is the most excellent redox cycling substrate for NQO1, turned out to be the most active and selective tricyclic nonquinone compound to drug-resistant A549/Taxol cancer cells with an IC<sub>50</sub> value of 0.6 μM and a selectivity ratio of 50.3. Besides, as shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, <b>20k</b> was also found to be active toward other NQO1-overexpressing human cancers (<a class="ref internalNav" href="#notes1" aria-label="Figure S1">Figure S1</a>), such as multidrug-resistant A549/VCR lung cancer cells, MCF-7 breast cancer cells, and MIA PaCa-2 pancreatic cancer cells. As for NQO1-deficient human lung cancer H596 cells, <b>20k</b> was much less sensitive (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Cytotoxicity of Representative Nonquinone Compounds toward NQO1-Rich A549 and A549/Taxol Cancer Cells, and NQO1-Deficient L02 Normal Cells</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">cytotoxicity, IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compound</th><th class="colsep0 rowsep0" align="center" char="±">A549/Taxol (NQO1-rich)</th><th class="colsep0 rowsep0" align="center" char="±">A549 (NQO1-rich)</th><th class="colsep0 rowsep0" align="center" char="±">L02 (NQO1-deficient)</th><th class="colsep0 rowsep0" align="center" char=".">selectivity ratio, IC<sub>50</sub> (L02)/IC<sub>50</sub> (A549/Taxol)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">0.6 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">14.3 ± 1.6</td><td class="colsep0 rowsep0" align="char" char=".">23.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>10</b></td><td class="colsep0 rowsep0" align="char" char="±">2.9 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.4 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">21.3 ± 1.8</td><td class="colsep0 rowsep0" align="char" char=".">7.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20a</b></td><td class="colsep0 rowsep0" align="char" char="±">2.7 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">26.0 ± 1.5</td><td class="colsep0 rowsep0" align="char" char=".">9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20b</b></td><td class="colsep0 rowsep0" align="char" char="±">2.4 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">22.6 ± 1.6</td><td class="colsep0 rowsep0" align="char" char=".">9.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20c</b></td><td class="colsep0 rowsep0" align="char" char="±">4.9 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">2.3 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">21.6 ± 1.3</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20d</b></td><td class="colsep0 rowsep0" align="char" char="±">2.2 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">2.1 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">22.0 ± 2.4</td><td class="colsep0 rowsep0" align="char" char=".">10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20e</b></td><td class="colsep0 rowsep0" align="char" char="±">6.7 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">3.5 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">25.0 ± 1.4</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20f</b></td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">1.4 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">26.1 ± 0.8</td><td class="colsep0 rowsep0" align="char" char=".">32.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20g</b></td><td class="colsep0 rowsep0" align="char" char="±">4.1 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">5.2 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">28.8 ± 2.3</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20h</b></td><td class="colsep0 rowsep0" align="char" char="±">6.3 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">4.4 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">30.9 ± 1.4</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20i</b></td><td class="colsep0 rowsep0" align="char" char="±">5.1 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">4.5 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">28.1 ± 0.8</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20j</b></td><td class="colsep0 rowsep0" align="char" char="±">6.8 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">5.9 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">35.9 ± 0.9</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20k</b></td><td class="colsep0 rowsep0" align="char" char="±">0.6 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">30.2 ± 1.3</td><td class="colsep0 rowsep0" align="char" char=".">50.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20l</b></td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">23.0 ± 1.2</td><td class="colsep0 rowsep0" align="char" char=".">25.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20m</b></td><td class="colsep0 rowsep0" align="char" char="±">1.3 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">2.7 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">35.8 ± 2.3</td><td class="colsep0 rowsep0" align="char" char=".">27.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center" char=".">Taxol</td><td class="colsep0 rowsep0" align="char" char="±">27.0 ± 1.6</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">5.6 ± 2.1</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center" char=".">β-lap</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">3.1 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">11.9 ± 1.4</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td></tr></tbody></table></div></div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Cytotoxicity of <b>20k</b> toward NQO1-rich A549/Taxol, A549/VCR, MCF-7, and MIA PaCa-2 cancer cells and NQO1-deficient H596 lung cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, when the A549/Taxol cells were pretreated with either 50 μM dicoumarol (DIC) as a NQO1 inhibitor or 10 mM <i>N</i>-acetylcysteine (NAC) as an antioxidant prior to treatment with <b>20k</b>, compound <b>20k</b> exhibited a 42–55-fold less antiproliferative activity against A549/Taxol cells (A549 + DIC and A549 + NAC, IC<sub>50</sub> = 25.6 μM and 33.2 μM, respectively) (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). The results indicated that <b>20k</b> exhibited antitumor activity and overcame drug resistance through NQO1-dependent and ROS-mediated pathways.</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Cytotoxicity of <b>20k</b> toward A549/Taxol cancer cells in the presence and absence of the NQO1 inhibitor (DIC, 50 μM) and ROS Scavenger (NAC, 10 mM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">2.4.  Determination of ROS Generation in Cell-Free and Cell-Based Assays</h3><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">2.4.1.  Determination of ROS Generation in a Cell-Free Assay</h4><div class="NLM_p">Considering that the redox cycling could lead to rapid ROS generation, we thus selected representative compounds (<b>1</b>, <b>10</b>, and <b>20k</b>) with efficient NQO1 reduction rates to further identify their abilities to generate ROS. Compound <b>20k</b> co-incubated with NQO1 inhibitor DIC, and compounds <b>9</b> and <b>11</b> with no NQO1 reduction activity were selected as negative controls. β-Lap was chosen as a positive control. The production of superoxide anion, the main constitute of ROS, was measured by a cell-free spectrophotometric assay using cytochrome <i>c</i> as the terminal electron acceptor. As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>, the nonquinones <b>1</b>, <b>10</b>, and <b>20k</b> showed rapid rates of ROS generation, being much more efficient than β-lap. Compound <b>20k</b> with the highest metabolic rate by NQO1 (1471 ± 42 μmol NADPH/min/μmol NQO1) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) also exhibited the highest rate of ROS production (1208 ± 45 μmol cyt <i>c</i>/min/mg NQO1) (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>). Furthermore, co-incubation with DIC dramatically reduced the rate of ROS production by <b>20k</b>. In addition, compounds <b>9</b> and <b>11</b> without NQO1 reduction activity also failed to generate ROS by NQO1. The results indicated that these nonquinone substrates could rapidly generate a high level of ROS through NQO1-dependent redox cycling.</div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Rate of ROS production of representative compounds (<b>1</b>, <b>10</b>, and <b>20k</b>), <b>20k</b> + NQO1 inhibitor DIC (25 μM), <b>9</b>, and <b>11</b> were used as negative controls. β-Lap was used as a positive control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">2.4.2.  Determination of ROS Generation Induced by <b>20k</b> in A549/Taxol Cells</h4><div class="NLM_p">It was supposed that <b>20k</b> exerted its antitumor activity by generating ROS through futile redox cycles catalyzed by intracellular NQO1. We then monitored intracellular ROS level using a ROS-sensitive fluorogenic dye (2′,7′-dichlorodihydrofluorescein diacetate, DCFH-DA) after treating the A549/Taxol cells with compounds <b>20k</b> and β-lap at 1 and 10 μM for 3 h. As shown in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A, <b>20k</b> strongly generated excessive ROS in A549/Taxol cells and the ROS levels were even higher than the control β-lap in A549/Taxol cells. Considering that DCFH-DA detects a broad range of ROS, including hydrogen peroxide, hydroxyl radical, and peroxy radicals, we subsequently employed two other ROS sensors that probe more specific ROS in cells. APF (3′-(p-aminophenyl) fluorescein) mainly senses hydroxyl radicals, whereas dihydroethidium (DHE) selectively detects superoxide anions in cells.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> Fluorescence imaging with the three different ROS probes showed <b>20k</b> generated excessive ROS that mainly included superoxide anion rather than hydroxyl radical (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B). Notably, the level of ROS generated by <b>20k</b> outcompeted that induced by β-lap. When we pretreated the A549/Taxol cells with either 50 μM DIC as a NQO1 inhibitor or 10 mM NAC as an antioxidant prior to treatment with compound <b>20k</b> (10 μM), ROS generation was greatly attenuated. The results indicated that <b>20k</b> induced ROS generation in an NQO1-dependent manner in A549/Taxol cells.</div><figure id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) Compound <b>20k</b> generated high levels of ROS in A549/Taxol cancer cells. Fluorescence was detected using a fluorescence microscope. (B) Similar experiments were done in A549 cells using three different ROS probes (DCFH-DA, DHE, APF) with pretreatment with 50 μM DIC or 10 mM NAC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24">2.5.  Pharmacological Studies on Compound <b>20k</b> in A549/Taxol Cells</h3><div id="sec2_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">2.5.1.  Induction of DNA Damage in A549/Taxol Cells by <b>20k</b></h4><div class="NLM_p">Dramatic ROS induction by <b>20k</b> suggested that <b>20k</b> exposure may cause damage and breaks in DNA. DNA damage, measured by comet tail formation, was detected in A549/Taxol cells after the treatment with <b>20k</b> (10 μM, 2 h) (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>B), which was comparable to the positive control H<sub>2</sub>O<sub>2</sub> (2 mM). Furthermore, DNA damage was greatly attenuated in DIC and NAC pretreated A549/Taxol cells. Thus, the results demonstrated that NQO1-mediated ROS formation by <b>20k</b> led to significant DNA breaks.</div><figure id="fig12" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Compound <b>20k</b> induced DNA damage in A549/Taxol cells in a NQO1, ROS-dependent manner. Cells were also exposed to 2 mM H<sub>2</sub>O<sub>2</sub> for 2 h as positive controls. Comet tail lengths of A549/Taxol cells were measured by using ImageJ software (a.u., arbitrary unit).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">2.5.2.  Effect of <b>20k</b> on Nucleotides Depletion by PARP-1 Hyperactivation</h4><div class="NLM_p">Excessive ROS production and significant DNA breaks were observed after the treatment with <b>20k</b> in A549/Taxol cells. Poly(ADP-ribose)polymerase-1 (PARP-1), which is a critical DNA repair enzyme, is immediately activated after genotoxic stress and catalyze the formation of short-lived negatively charged poly(ADP-ribose) (PAR) polymers. We examined the role of this repair protein in <b>20k</b>-induced lethality. PAR accumulation, which is an indicator of PARP-1 hyperactivation, was detected in the A549/Taxol cells in 10 min of the treatment of <b>20k</b>, then reduced rapidly in a time-dependent manner and disappeared after 60 min of the treatment (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>A). Furthermore, PAR accumulation was suppressed in DIC and NAC pretreated A549/Taxol cells (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>A).</div><figure id="fig13" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Compound <b>20k</b> induced PARP-1 hyperactivation causing NQO1-dependent nucleotide depletion. Cells were exposed to 10 μM <b>20k</b>, with or without 50 μM DIC and 10 mM NAC, and harvested at the indicated times. (A) Western blot analyses of PAR formation in A549/Taxol cells exposed to compound <b>20k</b> (10 μM) (left) with or without 50 μM DIC and 10 mM NAC (right) and harvested at the indicated times. (B) Changes of intracellular ATP level (left) and NAD<sup>+</sup> level (right) in the presence and absence of the NQO1 inhibitor (DIC, 50 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, rapid PAR formation correlated well with the loss of essential metabolic nucleotides (i.e., ATP and NAD<sup>+</sup>) in the A549/Taxol cells (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a> and <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>). Addition of DIC and NAC prevented <b>20k</b>-induced PAR formation (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>A) as well as nucleotide loss (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>B). Inhibition of PARP-1 activity using 3-aminobenzamide (3-AB), an NAD<sup>+</sup> analogue, spared A549/Taxol cells from <b>20k</b>-induced dose-dependent PAR formation (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>A) and attenuated nucleotide depletion (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>B). Thus, PARP-1 inhibition protected cells from <b>20k</b>-induced PARP-1 hyperactivation. These results indicated that <b>20k</b> induced PARP-1 hyperactivation and depletion of essential nucleotides in an NQO1- and ROS- dependent manner.</div><figure id="fig14" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Inhibition of PARP-1 hyperactivation delays NQO1-dependent nucleotide pool depletion in A549/Taxol cells after <b>20k</b> treatment. (A) Western blot analyses of PAR formation in A549/Taxol cells exposed to compound <b>20k</b> (10 μM) (left) with or without 25 mM 3-AB and harvested at the indicated times. (B) Changes of intracellular ATP level (left) and NAD<sup>+</sup> level (right) in the presence and absence of the PARP-1 inhibitor (3-AB, 25 mM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27">2.5.3.  Induction of A549/Taxol Cell Apoptosis by <b>20k</b></h4><div class="NLM_p">To determine whether the inhibitory effects of <b>20k</b> on drug-resistant lung cancer cellular proliferation are accompanied by enhanced cancer cell apoptosis, Annexin V-FITC and propidium iodide (PI) staining were performed and the percentages of apoptotic cells were tested using flow cytometry assay. A549/Taxol cells were incubated with different concentrations of <b>20k</b> (1, 5, and 10 μM) for 24 h. We observed that treatment with <b>20k</b> induced apoptosis in the A549/Taxol cells in a dose-dependent manner, which was significantly attenuated in DIC and NAC pretreated A549/Taxol cells (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>B). The results indicated that <b>20k</b> induced apoptosis through NQO1-dependent and ROS-mediated pathways.</div><figure id="fig15" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Compound <b>20k</b> induced NQO1-dependent apoptosis in A549/Taxol cells. Cells were exposed to 10 μM compound <b>20k</b>, with or without 50 μM DIC and 10 mM NAC, and harvested at the indicated times. (A) FACS analysis showed apoptosis in A549/Taxol cells after treatment of <b>20k</b> for 24 h. (B) Percentage of apoptosis cells after treatment with indicated concentration of <b>20k</b>. (C) <b>20k</b> blocked the generation of PARP cleavage and p53 in A549/Taxol cells in an NQO1- and ROS-dependent manner. The arrows indicate cleaved PARP and P53, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Furthermore, Western blot analysis showed that <b>20k</b> increased the levels of apoptotic markers,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> including cleaved PARP and p53, in a dose-dependent manner. Likewise, pretreatment with 50 μM DIC and 10 mM NAC attenuated the escalation of cleaved PARP and p53 (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>C), indicating that <b>20k</b> induced apoptosis through NQO1-mediated ROS generation.</div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">2.6.  In Vivo Pharmacological Studies on Compound <b>20k</b></h3><div id="sec2_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29">2.6.1.  Antitumor Efficacy of <b>20k</b> in Inhibiting the Growth of A549/Taxol Xenograft Tumors in Mice</h4><div class="NLM_p">Compound <b>20k</b> was investigated for its in vivo antitumor efficacy against A549/Taxol xenografts. In the study, compound <b>20k</b> was administered through tail intravenous injection at 15 mg/kg and 30 mg/kg every other day for 3 weeks. Taxol (2 mg/kg) was chosen as the reference. As shown in <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>, compound <b>20k</b> significantly inhibited the growth of A549/Taxol tumor. The T/C values of the 15 and 30 mg/kg doses were 62.1% and 25.9%, respectively (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>A). Meanwhile, the tumor weights of mice treated with <b>20k</b> at 30 mg/kg (0.50 ± 0.07 g) were reduced by 64.9%, compared with the control (1.43 ± 0.15 g) (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>B). In addition, compound <b>20k</b> was well-tolerated, no significant body weight loss was observed in <b>20k</b>-treated mice during the treatment period (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>C). Furthermore, remarkable tumor destruction induced by <b>20k</b> was observed by Hematoxylin-eosin (H&E) staining (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>D). As shown by H&E staining, large areas of necrosis (regions with homogeneous pink staining) and karyorrhexis were watched after treatment of <b>20k</b>, while Taxol show less tumor destruction, indicating the excellent tumoricidal efficacy of <b>20k</b>. These results suggested that <b>20k</b> had potential antitumor efficacy against the growth of implanted drug-resistant human NSCLC cells in mice.</div><figure id="fig16" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Compound <b>20k</b> suppressed the tumor growth in vivo in A549/Taxol tumor xenografts nude model. A549/Taxol tumor-bearing mice were treated with vehicle and <b>20k</b> (15 mg/kg and 30 mg/kg). Taxol (2 mg/kg) was selected as the reference. (A) Changes in tumor volume of A549/Taxol tumor-bearing mice after treatment for 3 weeks. (B) Tumor weight after treatment. (C) Mice body weight of the treated mice. (D) H&E stained tissue sections from A549/Taxol tumor-bearing mice after treatment. Scale bars = 400 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30">2.7.  In Vivo Preliminary Toxicity Studies on Compound <b>20k</b></h3><div class="NLM_p">We further examined the acute toxicity of <b>20k</b> on the A549/Taxol tumor-bearing nude mice through histopathology and blood biochemistry analysis. After 3 weeks of injection, mice were euthanized, H&E staining of major organs were conducted. The blood was collected for blood biochemistry analysis. As shown in <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>A, the heart, liver, spleen, lungs, and kidneys showed no obvious damage after treatment of <b>20k</b>, indicating that compound <b>20k</b> has no apparent toxicity on mice. In addition, blood biochemistry tests revealed that compound <b>20k</b> has less hepatotoxicity, nephrotoxicity, and cardiotoxicity in tumor-bearing nude mice, compared to Taxol (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>B), as reflected by the liver function indicators (TP, total protein; ALB, albumin; GLB, globulin, and AST, aspartate aminotransferase), kidney function indicators (BUN, blood urea nitrogen) and myocardial enzyme indicator (LDH, lactate dehydrogenase). These results indicated that compound <b>20k</b> had good drug safety with little toxicity to normal tissues and can be applied in new cancer therapeutics.</div><figure id="fig17" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Evaluation of <b>20k</b>-induced systemic toxicities in vivo. (A) H&E staining of major organs from nude mice after treatment of saline, <b>20k</b> (15 mg/kg and 30 mg/kg) and Taxol (2 mg/kg). (B) Blood biochemistry analysis of the indicators of TP, ALB, GLB, AST, BUN, and LDH in mice. Scale bars = 400 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31">2.8.  Determination of ROS Generation and GSH Depletion in Vivo</h3><div class="NLM_p">It has been proven that <b>20k</b> exerted its antitumor activity by generating ROS through intracellular NQO1 in A549/Taxol cells. We further evaluated the abilities of compound <b>20k</b> to induce ROS generation and its effect on the antioxidant system in vivo by examining tumor tissues isolated from A549/Taxol tumor-bearing mice. It is shown that compound <b>20k</b> increased the ROS level and reduced the level of GSH (glutathione), which plays a crucial role in maintaining biological redox homeostasis and is an important part of the antioxidant system (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>). In conclusion, compound <b>20k</b> could induce ROS generation and deplete GSH levels simultaneously, so that it can maximally exploit the ROS-mediated cancer cell death.</div><figure id="fig18" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Measurement of ROS and GSH levels in tumor tissues isolated from A549/Taxol tumor-bearing mice: (A) ROS generation and (B) GSH depletion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">3.  Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38748" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38748" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this study, we initially identified that compound <b>1</b> was an excellent NQO1 substrate with a tetracyclic nonquinone scaffold through screening of an in-house database. Then compound <b>1</b> was selected as a hit compound for further SAR study by a step-by-step modification strategy, which led to compound <b>10</b> with a simplified indenopyrazinone tricylic scaffold. Concerning both the structure features for NQO1 binding and the electrochemical redox potentials for NQO1 bioreduction, a series of 2,3-dicyano indenopyrazinones were designed, synthesized, and biologically evaluated. It was found that the most efficient NQO1 substrate <b>20k</b> displayed potent and selective antiproliferative activity against NQO1-overexpressing A549 cells and drug-resistance A549/Taxol cells. Furthermore, pharmacological study demonstrated that <b>20k</b> dramatically elevated the intracellular ROS levels through NQO1-catalyzed redox cycling, and induced PARP-1-mediated cell apoptosis in an NQO1- and ROS-dependent manner in A549/Taxol cells. In addition, <b>20k</b> significantly suppressed the growth of A549/Taxol xenograft tumors in mice with no apparent toxicity observed in vivo. In conclusion, we discover a new chemotype of nonquinone substrates for NQO1 as effective and selective intracellular ROS generators for developing promising new drugs for the treatment of NQO1-overexpresssing drug-resistant NSCLC.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">4.  Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34775" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34775" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34">4.1.  General Chemistry</h3><div class="NLM_p last">All reagents were purchased from commercial sources. Organic solutions were concentrated in a rotary evaporator (BüchiRotavapor) below 55 °C under reduced pressure. Reactions were monitored by thin-layer chromatography (TLC) on 0.25 mm silica gel plates (GF254) and visualized under UV light. Melting points were determined with a Melt-Temp II apparatus. The <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were measured on a Bruker AV-300 instrument using deuterated solvents with tetramethylsilane (TMS) as internal standard. EI-MS was collected on Shimadzu Model GCMS-2010 instruments. ESI-mass and high resolution mass spectra (HRMS) were recorded on a Water Q-Tof micro mass spectrometer. Analytical results are within 0.40% of the theoretical values. The purity (≥95%) of the target compounds is verified by the high-performance liquid chromatography (HPLC) study performed on an Agilent C18 (4.6 mm × 150 mm, 3.5 μm) column using a mixture of solvent methanol/water and acetonitrile/water at a flow rate of 0.5 mL/min and peak detection at 254 nm under UV.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35">4.2.  Synthesis</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">4.2.1.  General Procedure for the Synthesis of <b>2</b>–<b>5</b></h4><div class="NLM_p">To a solution of 1,2,3-indantrione monohydrate (<b>21</b>) (356 mg, 2 mmol) in EtOH (10 mL) was added <b>22a</b>–<b>22c</b> or <b>23</b> (2 mmol) and AcOH (1 mL), the mixture was stirred at room temperature for 2 h. The precipitate was filtered, washed with EtOH, and dried under vacuum to afford the target compounds <b>2</b>–<b>5</b> (28%–86%).</div><div id="sec4_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37">4.2.1.1.  11<i>H</i>-indeno[1,2-<i>b</i>]quinoxalin-11-one (<b>2</b>)</h5><div class="NLM_p last">Yield: 86%. Yellow solid. mp 225–226 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.24 (d, <i>J</i> = 7.5 Hz, 1H), 8.12 (d, <i>J</i> = 7.5 Hz, 2H), 7.93 (d, <i>J</i> = 6.0 Hz, 1H), 7.85–7.73 (m, 3H), 7.61 (t, <i>J</i> = 7.5 Hz, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ: 189.2, 155.9, 148.6, 142.4, 142.0, 140.9, 136.2, 136.0, 131.9, 131.8, 131.0, 129.7, 129.1, 124.1, 121.9. ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>15</sub>H<sub>9</sub>N<sub>2</sub>O: 233.0709, found: 247.0708. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 5.989 min, 97.5%.</div></div><div id="sec4_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38">4.2.1.2.  7,8-Dimethyl-11<i>H</i>-indeno[1,2-<i>b</i>]quinoxalin-11-one (<b>3</b>)</h5><div class="NLM_p last">Yield: 82%. Yellow solid. mp 257–258 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.00 (d, <i>J</i> = 6.0 Hz, 1H), 7.90 (s, 1H), 7.86 (d, <i>J</i> = 9.0 Hz, 1H), 7.78 (s, 1H), 7.71 (t, <i>J</i> = 7.5 Hz, 1H), 7.54 (t, <i>J</i> = 7.5 Hz, 1H), 2.47 (s, 3H), 2.46 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ: 189.5, 155.4, 147.6, 142.9, 141.3, 141.1, 140.8, 140.2, 135.9, 135.8, 131.4, 130.1, 128.5, 123.9, 121.6, 20.0, 19.7. ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>17</sub>H<sub>13</sub>N<sub>2</sub>O: 261.1022, found: 261.1030. HPLC (70% methanol in water): <i>t</i><sub>R</sub> = 7.532 min, 96.2%. HPLC (90% methanol in water): <i>t</i><sub>R</sub> = 7.015 min, 98.0%.</div></div><div id="sec4_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39">4.2.1.3.  7,8-Difluoro-11<i>H</i>-indeno[1,2-<i>b</i>]quinoxalin-11-one (<b>4</b>)</h5><div class="NLM_p last">Yield: 85%. Yellow solid. mp 255–256 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.10 (d, <i>J</i> = 9.0 Hz, 1H), 8.03–7.86 (m, 3H), 7.80 (t, <i>J</i> = 7.5 Hz, 1H), 7.65 (t, <i>J</i> = 7.5 Hz, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ: 188.7, 156.4, 155.1, 154.9, 153.5, 153.0, 151.6, 151.4, 150.1, 149.9, 148.8, 140.6, 140.3, 140.2, 139.4, 139.2, 136.4, 135.9, 132.4, 124.4, 122.1, 116.9, 116.7, 115.4, 115.1. ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>15</sub>H<sub>6</sub>F<sub>2</sub>N<sub>2</sub>NaO: 291.0340, found: 291.0346. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 5.149 min, 98.6%.</div></div><div id="sec4_2_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40">4.2.1.4.  9<i>H</i>-indeno[1,2-<i>b</i>]thieno[3,4-<i>e</i>]pyrazin-9-one (<b>5</b>)</h5><div class="NLM_p last">Yield: 73%. Yellow solid. mp 210–212 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.24 (d, <i>J</i> = 3.0 Hz, 1H), 8.12 (d, <i>J</i> = 6.0 Hz, 1H), 7.98–7.95 (m, 2H), 7.81 (t, <i>J</i> = 7.5 Hz, 1H), 7.65 (t, <i>J</i> = 7.5 Hz, 1H). ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>13</sub>H<sub>7</sub>N<sub>2</sub>OS: 239.0274, found: 239.0275. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 6.134 min, 98.5%.</div></div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41">4.2.2.  General Procedure for the Synthesis of <b>6</b> and <b>7</b></h4><div class="NLM_p">To a solution of 1,2,3-indantrione monohydrate (<b>21</b>) (356 mg, 2 mmol) in EtOH (10 mL) was added <b>24</b> and <b>25</b> (2 mmol) and AcOH (0.5 mL), the mixture was stirred at 60 °C for 4 h in the air. After cooling to room temperature, the solvent was removed under reduced pressure and residue was purified using silica gel column chromatography (eluent: petroleum ether/EtOAc 20:1) to afford solids <b>6</b> and <b>7</b> (28%–30%).</div><div id="sec4_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42">4.2.2.1.  6,7,8,9-Tetrahydro-11<i>H</i>-indeno[1,2-<i>b</i>]quinoxalin-11-one (<b>6</b>)</h5><div class="NLM_p last">Yield: 28%. Yellow solid. mp 176–178 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.81 (d, <i>J</i> = 7.5 Hz, 1H), 7.76 (d, <i>J</i> = 7.5 Hz, 1H), 7.62 (t, <i>J</i> = 7.5 Hz, 1H), 7.46 (t, <i>J</i> = 7.5 Hz, 1H), 3.06 (m, <i>J</i> = 3.0 Hz, 4H), 1.97 (m, <i>J</i> = 3.0 Hz, 4H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ: 190.5, 157.2, 156.0, 153.0, 144.6, 140.5, 135.3, 133.3, 130.7, 123.9, 120.6, 32.4, 31.6, 21.9, 21.8. ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>15</sub>H<sub>13</sub>N<sub>2</sub>O: 237.1022, found: 237.1026. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 5.735 min, 98.9%.</div></div><div id="sec4_2_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43">4.2.2.2.  9<i>H</i>-indeno[1,2-<i>b</i>]pyrazin-9-one (<b>7</b>)</h5><div class="NLM_p last">Yield: 30%. Yellow solid. mp 151–153 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.56 (d, <i>J</i> = 3.0 Hz, 1H), 8.50 (d, <i>J</i> = 3.0 Hz, 1H), 7.90 (d, <i>J</i> = 7.5 Hz, 1H), 7.83 (d, <i>J</i> = 7.5 Hz, 1H), 7.70 (t, <i>J</i> = 7.5 Hz, 1H), 7.54 (t, <i>J</i> = 7.5 Hz, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ: 189.8, 160.0, 147.6, 146.1, 144.0, 140.1, 135.8, 133.2, 131.5, 124.2, 121.3. ESI-HRMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calculated for C<sub>11</sub>H<sub>6</sub>N<sub>2</sub>NaO: 205.0372, found: 205.0377. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.677 min, 99.3%.</div></div><div id="sec4_2_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44">4.2.2.3.  3-Amino-9<i>H</i>-indeno[1,2-<i>e</i>][1,2,4]triazin-9-one (<b>8</b>)</h5><div class="NLM_p last">Aminoguanidinium nitrate (274 mg, 2 mmoL) and AcOH (1 mL) was added to a solution of 1,2,3-indantrione monohydrate (<b>21</b>) (356 mg, 2 mmol) in EtOH (10 mL), and the mixture was stirred at 70 °C for 3 h. The precipitate was filtered, washed with EtOH, and dried under vacuum to afford <b>8</b> (262 mg, 66%) as a yellow solid. mp 193–196 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 8.47 (s, 1H), 8.25 (s, 1H), 7.88 (d, <i>J</i> = 7.5 Hz, 1H), 7.83 (d, <i>J</i> = 7.5 Hz, 1H), 7.80–7.75 (m, 2H). <sup>13</sup>C NMR (75 MHz, DMSO) δ: 186.6, 164.6, 162.3, 143.8, 137.0, 136.0, 135.7, 134.2, 123.8, 122.8. ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>10</sub>H<sub>7</sub>N<sub>4</sub>O: 199.0614, found: 199.0618. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.326 min, 98.2%.</div></div><div id="sec4_2_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45">4.2.2.4.  9-Oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>10</b>)</h5><div class="NLM_p last">2,3-Diaminomaleonitrile (216 mg, 2 mmol) and AcOH (1 mL) was added to a solution of 1,2,3-indantrione monohydrate (<b>21</b>) (356 mg, 2 mmol) in EtOH (10 mL), and the mixture was stirred at room temperature for 2 h. The precipitate was filtered, washed with EtOH, and dried under vacuum to afford <b>10</b> (381 mg, 82%) as a yellow solid. mp 268–269 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 8.11 (d, <i>J</i> = 7.5 Hz, 1H), 7.98–7.90 (m, 2H), 7.82 (t, <i>J</i> = 7.5 Hz, 1H). <sup>13</sup>C NMR (75 MHz, DMSO) δ: 186.5, 160.8, 150.8, 138.6, 137.8, 136.3, 135.3, 134.6, 132.5, 125.5, 124.1, 114.8, 114.6. ESI-HRMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calculated for C<sub>13</sub>H<sub>4</sub>N<sub>4</sub>NaO: 255.0277, found: 255.0273. HPLC (90% methanol in water): <i>t</i><sub>R</sub> = 7.532 min, 96.2%.</div></div><div id="sec4_2_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46">4.2.2.5.  9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>11</b>)</h5><div class="NLM_p last">To a suspension of 1,2-indanone (<b>20</b>) (146 mg, 1 mmol) in isopropanol (10 mL) was added 2,3-diaminomaleonitrile (<b>27</b>) (108 mg, 1 mmol) and the mixture was stirred at room temperature for 4 h. The precipitate was filtered, washed with EtOH, and dried under vacuum to afford <b>11</b> (159 mg, 73%). mp 176–178 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 7.81–7.76 (m, 2H), 7.64 (d, <i>J</i> = 3.0 Hz, 1H), 7.62–7.48 (m, 1H), 3.59 (s, 2H). <sup>13</sup>C NMR (75 MHz, DMSO) δ: 158.7, 147.6, 137.8, 136.7, 136.6, 135.9, 135.6, 132.7, 127.9, 127.2, 114.6, 113.7, 31.1. ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>13</sub>H<sub>7</sub>N<sub>4</sub>: 219.0665, found: 219.0667. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 3.551 min, 99.0%.</div></div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">4.2.3.  General Procedure for the Synthesis of <b>12</b>–<b>15</b></h4><div class="NLM_p">A solution of corresponding sodium alkoxides (2 mmol) or amines (2–6 mmol) was added to a suspension of <b>10</b> (464 mg, 2 mmol) in MeOH (10 mL), and the mixture was stirred at room temperature for 4 h. The precipitate was filtered, washed with EtOH, and dried under vacuum to afford solids <b>12</b>–<b>15</b> (37%–87%).</div><div id="sec4_2_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48">4.2.3.1.  3-Methoxy-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2-carbonitrile (<b>12</b>)</h5><div class="NLM_p last">Yield: 87%. Yellow solid. mp 260–262 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 8.11 (d, <i>J</i> = 9.0 Hz, 1H), 7.85–7.81 (m, 2H), 7.71 (t, <i>J</i> = 7.5 Hz, 1H), 4.24 (s, 3H). ESI-HRMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calculated for C<sub>13</sub>H<sub>7</sub>N<sub>3</sub>NaO<sub>2</sub>: 260.0430, found: 260.0436. HPLC (90% methanol in water): <i>t</i><sub>R</sub> = 7.472 min, 99.0%.</div></div><div id="sec4_2_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49">4.2.3.2.  3-Ethoxy-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2-carbonitrile (<b>13</b>)</h5><div class="NLM_p last">Yield: 82%. Yellow solid. mp 232–234 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 7.90–7.79 (m, 3H), 7.70 (t, <i>J</i> = 7.5 Hz, 1H), 4.70 (q, <i>J</i> = 6.0 Hz, 2H), 1.47 (t, <i>J</i> = 7.5 Hz, 3H). <sup>13</sup>C NMR (75 MHz, DMSO) δ: 186.9, 163.5, 162.0, 140.0, 138.1, 136.3, 135.1, 133.7, 124.2, 122.5, 116.4, 114.7, 65.2, 14.0. ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>14</sub>H<sub>10</sub>N<sub>3</sub>O<sub>2</sub>: 252.0768, found: 252.0766. HPLC (90% methanol in water): <i>t</i><sub>R</sub> = 10.776 min, 99.4%.</div></div><div id="sec4_2_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50">4.2.3.3.  3-Amino-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2-carbonitrile (<b>14</b>)</h5><div class="NLM_p last">Yield: 37%. Yellow-green solid. mp 287–289 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 8.46 (s, 2H), 7.76–7.72 (m, 3H), 7.68–7.63 (m, 1H). <sup>13</sup>C NMR (75 MHz, DMSO) δ: 186.7, 163.0, 158.1, 138.2, 135.9, 135.8, 135.5, 133.1, 123.5, 121.9, 115.9, 110.0. ESI-HRMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calculated for C<sub>12</sub>H<sub>6</sub>N<sub>4</sub>NaO: 245.0434, found: 245.0443. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.686 min, 98.8%.</div></div><div id="sec4_2_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51">4.2.3.4.  3-(Dimethylamino)-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2-carbonitrile (<b>15</b>)</h5><div class="NLM_p last">Yield: 74%. Yellow solid. mp 267–269 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 7.85 (d, <i>J</i> = 6.0 Hz, 1H), 7.80–7.74 (m, 2H), 7.67 (t, <i>J</i> = 7.5 Hz, 1H), 3.47 (s, 6H). ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>14</sub>H<sub>11</sub>N<sub>4</sub>O: 251.0927, found: 251.0929. HPLC (90% methanol in water): <i>t</i><sub>R</sub> = 8.381 min, 97.6%.</div></div><div id="sec4_2_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52">4.2.3.5.  3-Chloro-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2-carbonitrile (<b>16</b>)</h5><div class="NLM_p last">A mixture of <i>tert</i>-butyl nitrite (0.54 mL, 5 mmol), CuCl<sub>2</sub> (0.20 g, 1.5 mmol) and <b>14</b> (222 mg, 1 mmol) in anhydrous MeCN (10 mL) was stirred at 65 °C for 4 h. The precipitate was filtered out and filtrate was concentrated under reduced pressure. The residue was further purified via silica gel column chromatography, using 5%–10% petroleum ether to ethyl acetate gradient solvent system to afford <b>16</b> (140 mg, 58%) as a yellow solid. mp 229–231 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 8.03 (d, <i>J</i> = 9.0 Hz, 1H), 7.93–7.86 (m, 2H), 7.78 (t, <i>J</i> = 7.5 Hz, 1H). <sup>13</sup>C NMR (75 MHz, DMSO) δ: 186.5, 161.6, 153.3, 146.8, 137.0, 135.5, 135.1, 134.4, 127.0, 124.8, 123.3, 114.7. ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>12</sub>H<sub>5</sub>ClN<sub>3</sub>O: 242.0116, found: 242.0111. HPLC (90% methanol in water): <i>t</i><sub>R</sub> = 8.424 min, 96.2%.</div></div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53">4.2.4.  General Procedure for the Synthesis of <b>17</b> and <b>18</b></h4><div class="NLM_p">To a solution of <b>16</b> (242 mg, 1 mmol) in anhydrous MeCN (10 mL) was added corresponding alkynes (1.5 mmol), triethylamine (0.16 mL, 1.1 mmol), Pd(dppf)<sub>2</sub>Cl<sub>2</sub> (69 mg, 0.1 mmol), CuI (17 mg, 0.1 mmol) under a nitrogen atmosphere. The mixture was stirred at 80 °C for 3 h under a nitrogen atmosphere. After cooling to room temperature, the precipitate was filtered out and filtrate was concentrated under reduced pressure. The mixture was further purified using silica gel column chromatography (eluent: petroleum ether/EtOAc 40:1) to afford solids <b>17</b>–<b>19</b> (24%–36%).</div><div id="sec4_2_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54">4.2.4.1.  9-Oxo-3-(prop-1-yn-1-yl)-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2-carbonitrile (<b>17</b>)</h5><div class="NLM_p last">Yield: 36%. Yellow solid. mp 226–228 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.01 (d, <i>J</i> = 6.0 Hz, 1H), 7.90 (d, <i>J</i> = 9.0 Hz, 1H), 7.78 (t, <i>J</i> = 7.5 Hz, 1H), 7.66 (t, <i>J</i> = 7.5 Hz, 1H), 2.33 (s, 3H). ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>15</sub>H<sub>8</sub>N<sub>3</sub>O: 246.0662, found: 246.0664. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.471 min, 98.9%.</div></div><div id="sec4_2_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55">4.2.4.2.  3-(Cyclopropylethynyl)-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2-carbonitrile (<b>18</b>)</h5><div class="NLM_p last">Yield: 28%. Yellow solid. mp 231–233 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.00 (d, <i>J</i> = 9.0 Hz, 1H), 7.89 (d, <i>J</i> = 7.5 Hz, 1H), 7.76 (t, <i>J</i> = 7.5 Hz, 1H), 1.70 (m, <i>J</i> = 6.0 Hz, 1H), 1.16–1.13 (m, 4H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ: 186.7, 160.2, 144.8, 144.3, 138.5, 136.3, 134.8, 133.3, 130.8, 124.7, 122.7, 114.5, 110.4, 72.0, 10.0, 0.6. ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>17</sub>H<sub>10</sub>N<sub>3</sub>O: 272.0818, found: 272.0818. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.805 min, 99.1%.</div></div><div id="sec4_2_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56">4.2.4.3.  9-Oxo-3-(phenylethynyl)-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2-carbonitrile (<b>19</b>)</h5><div class="NLM_p last">Yield: 24%. Yellow solid. mp 235–237 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.96 (d, <i>J</i> = 6.0 Hz, 1H), 7.83 (d, <i>J</i> = 6.0 Hz, 1H), 7.73–7.67 (m, 3H), 7.59 (t, <i>J</i> = 7.5 Hz, 1H), 7.46–7.35 (m, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ: 186.6, 160.3, 144.8, 144.5, 138.5, 136.4, 134.9, 133.4, 132.5, 131.1, 130.7, 128.3, 124.7, 122.8, 119.6, 114.5, 102.8, 84.5. ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>20</sub>H<sub>10</sub>N<sub>3</sub>O: 308.0818, found: 308.0820. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.952 min, 96.4%.</div></div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57">4.2.5.  General Procedure for the Synthesis of <b>20a</b>–<b>20m</b></h4><div class="NLM_p">2,3-Diaminomaleonitrile (<b>27</b>) (324 mg, 3 mmol) was added to a suspension of substituted 1,2-indanone (<b>29a</b>–<b>29m</b>) (3 mmol) in isopropanol (20 mL). The mixture was stirred at room temperature for 6 h, The precipitate was filtered, washed with EtOH, and dried under vacuum. The crude product was used without further purification. To a suspension of compound <b>30a</b>–<b>30m</b> (1 mmol) in AcOH (5 mL) was added K<sub>2</sub>Cr<sub>2</sub>O<sub>7</sub> (542 mg, 1.8 mmol), and the mixture was heated to 100 °C for 1 h. After cooling to room temperature, the solvent was evaporated under reduced pressure, and the mixture was further purified using silica gel column chromatography to afford the solid <b>20a</b>–<b>20m</b> (42%–66%).</div><div id="sec4_2_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58">4.2.5.1.  6-Methyl-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>20a</b>)</h5><div class="NLM_p last">Yield: 50%. Yellow solid. mp 231–233 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 7.96 (s, 1H), 7.87 (d, <i>J</i> = 6.0 Hz, 1H), 7.64 (d, <i>J</i> = 9.0 Hz, 1H), 2.53 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO) δ: 185.6, 160.3, 150.8, 149.1, 138.4, 135.2, 134.0, 133.6, 131.9, 125.1, 124.0, 114.3, 114.1, 21.8. ESI-HRMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calculated for C<sub>14</sub>H<sub>6</sub>N<sub>4</sub>NaO: 269.0434, found: 269.0425. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.277 min, 98.7%.</div></div><div id="sec4_2_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59">4.2.5.2.  8-Methoxy-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>20b</b>)</h5><div class="NLM_p last">Yield: 42%. Yellow solid. mp 229–231 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 7.90 (t, <i>J</i> = 9.0 Hz, 1H), 7.65–7.59 (m, 1H), 7.48 (d, <i>J</i> = 9.0 Hz, 1H), 4.02 (s, 3H). ESI-HRMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calculated for C<sub>14</sub>H<sub>6</sub>N<sub>4</sub>NaO<sub>2</sub>: 285.0383, found: 285.0380. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.341 min, 97.2%.</div></div><div id="sec4_2_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60">4.2.5.3.  7-Methoxy-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>20c</b>)</h5><div class="NLM_p last">Yield: 50%. Yellow solid. mp 221–223 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 7.96 (d, <i>J</i> = 6.0 Hz, 1H), 7.62 (s, 1H), 7.32 (d, <i>J</i> = 9.0 Hz, 1H), 4.03 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO) δ: 184.1, 166.7, 159.7, 151.3, 141.1, 133.9, 132.2, 129.0, 127.6, 120.6, 114.3, 114.1, 108.2, 56.8. ESI-HRMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calculated for C<sub>14</sub>H<sub>6</sub>N<sub>4</sub>NaO<sub>2</sub>: 285.0383, found: 285.0385. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.188 min, 99.0%.</div></div><div id="sec4_2_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61">4.2.5.4.  6-Methoxy-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>20d</b>)</h5><div class="NLM_p last">Yield: 66%. Yellow solid. mp 224–226 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 7.94 (d, <i>J</i> = 6.0 Hz, 1H), 7.62 (s, 1H), 7.31 (d, <i>J</i> = 7.5 Hz, 1H), 4.01 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO) δ: 184.2, 166.6, 159.7, 151.3, 141.1, 133.9, 132.2, 129.0, 127.6, 120.6, 114.3, 114.0, 108.2, 56.8. ESI-HRMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calculated for C<sub>14</sub>H<sub>6</sub>N<sub>4</sub>NaO<sub>2</sub>: 285.0383, found: 285.0383. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.164 min, 96.1%.</div></div><div id="sec4_2_5_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62">4.2.5.5.  6-Hydroxy-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>20e</b>)</h5><div class="NLM_p last">Yield: 44%. Orange solid. mp 243–246 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 9.77 (s, 1H), 7.36 (d, <i>J</i> = 9.0 Hz, 1H), 7.09 (dd, <i>J</i> = 9.0 Hz, <i>J</i> = 3.0 Hz, 1H), 6.92 (d, <i>J</i> = 3.0 Hz, 1H). ESI-HRMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calculated for C<sub>13</sub>H<sub>4</sub>N<sub>4</sub>NaO<sub>2</sub>: 271.0226, found: 271.0218. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 3.968 min, 98.0%.</div></div><div id="sec4_2_5_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63">4.2.5.6.  6-Fluoro-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>20f</b>)</h5><div class="NLM_p last">Yield: 60%. Yellow solid. mp 220–222 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 8.08–8.04 (m, 2H), 7.69–7.62 (m, 1H). ESI-HRMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calculated for C<sub>13</sub>H<sub>3</sub>FN<sub>4</sub>NaO: 273.0183, found: 273.0180. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.152 min, 98.9%.</div></div><div id="sec4_2_5_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64">4.2.5.7.  6-Trifluoromethyl-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>20g</b>)</h5><div class="NLM_p last">Yield: 47%. Yellow solid. mp 248–250 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 8.22 (s, 1H), 7.98 (d, <i>J</i> = 9.0 Hz, 1H), 7.87 (d, <i>J</i> = 7.5 Hz, 1H). ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>14</sub>H<sub>4</sub>F<sub>3</sub>N<sub>4</sub>O: 301.0332, found: 301.0331. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.343 min, 99.3%.</div></div><div id="sec4_2_5_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65">4.2.5.8.  6,7-Dimethyl-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>20h</b>)</h5><div class="NLM_p last">Yield: 60%. Yellow solid. mp 233–235 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.82 (s, 1H), 7.74 (s, 1H), 2.49 (s, 3H), 2.46 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO) δ: 185.8, 160.6, 150.9, 148.0, 144.8, 136.2, 134.0, 133.9, 131.4, 125.8, 124.3, 114.4, 114.1, 20.3, 20.0. ESI-HRMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calculated for C<sub>15</sub>H<sub>8</sub>N<sub>4</sub>NaO: 283.0590, found: 283.0583. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.403 min, 96.0%.</div></div><div id="sec4_2_5_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66">4.2.5.9.  6,7-Dimethoxy-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>20i</b>)</h5><div class="NLM_p last">Yield: 62%. Red solid. mp 278–280 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 7.56 (s, 1H), 7.48 (s, 1H), 4.03 (s, 3H), 3.95 (s, 3H). ESI-HRMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calculated for C<sub>15</sub>H<sub>8</sub>N<sub>4</sub>NaO<sub>3</sub>: 315.0489, found: 315.0495. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.482 min, 98.1%.</div></div><div id="sec4_2_5_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67">4.2.5.10.  5,8-Dimethoxy-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>20j</b>)</h5><div class="NLM_p last">Yield: 48%. Red solid. mp 270–272 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 7.62 (d, <i>J</i> = 9.0 Hz, 1H), 7.50 (d, <i>J</i> = 9.0 Hz, 1H), 4.00 (s, 3H), 3.97 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO) δ: 184.6, 160.9, 156.6, 154.0, 151.6, 133.7, 133.4, 130.5, 130.4, 114.4, 114.1, 107.1, 105.6, 56.9, 56.5. ESI-HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>15</sub>H<sub>9</sub>N<sub>4</sub>O<sub>3</sub>: 293.0669, found: 293.0676. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.487 min, 98.8%.</div></div><div id="sec4_2_5_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68">4.2.5.11.  6,7-Difluoro-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>20k</b>)</h5><div class="NLM_p last">Yield: 55%. Yellow solid. mp 204–206 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.93–7.88 (m, 1H), 7.85–7.80 (m, 1H). <sup>13</sup>C NMR (75 MHz, DMSO) δ: 184.2, 159.2, 156.5, 156.4, 155.0, 154.9, 154.4, 154.3, 153.0, 152.9, 150.7, 136.4, 134.6, 133.9, 132.5, 115.8, 115.7, 114.6, 114.4, 114.3, 114.2. ESI-HRMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calculated for C<sub>13</sub>H<sub>2</sub>F<sub>2</sub>N<sub>4</sub>NaO: 291.0089, found: 291.0092. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.185 min, 98.8%.</div></div><div id="sec4_2_5_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69">4.2.5.12.  5,8-Difluoro-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>20l</b>)</h5><div class="NLM_p last">Yield: 44%. Orange solid. mp 210–212 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 7.59–7.49 (m, 1H), 7.47–7.17 (m, 1H). ESI-HRMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calculated for C<sub>13</sub>H<sub>2</sub>F<sub>2</sub>N<sub>4</sub>NaO: 291.0089, found: 291.0086. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.165 min, 98.3%.</div></div><div id="sec4_2_5_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70">4.2.5.13.  6,7-Dichloro-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile (<b>20m</b>)</h5><div class="NLM_p last">Yield: 48%. Yellow solid. mp 236–238 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 8.48 (s, 1H), 8.30 (s, 1H). ESI-HRMS <i>m</i>/<i>z</i> [M]<sup>−</sup> calculated for C<sub>13</sub>H<sub>2</sub>Cl<sub>2</sub>N<sub>4</sub>O: 299.9606, found: 299.9600. HPLC (90% acetonitrile in water): <i>t</i><sub>R</sub> = 4.319 min, 97.6%.</div></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71">4.3.  Molecular Modeling</h3><div class="NLM_p last">A docking study was performed using the crystal structure of the human NQO1 complex with ARH019 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H69">1H69</a> and resolution = 1.86 Å). Compounds were imported to Discovery Studio 4.0, and the 3D conformation was generated by the “Prepare Ligands” protocol at pH 7.0. Then, compounds were energy-minimized in CHARMm force field for docking. The molecular docking was performed using GOLD 5.1 software in combination with ChemScore scoring function. The protein was prepared, and the active site was defined as being any volume within 8 Å of the original ligand ARH019 in <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H69">1H69</a>. The number of genetic algorithms (GAs) run was set to 10, then each GOLD run was saved and docking was terminated when the top 10 solutions attained root-mean-square deviation (RMSD) values within 1.5 Å. The best output poses of ligands generated were analyzed based on hydrogen bonds and van der Waals interactions to the enzyme. The best poses were visualized with PyMol.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72">4.4.  Electrochemistry</h3><div class="NLM_p last">Cyclic voltammetry (CV) for the selected compounds was conducted using a Model CS120 electrochemical analyzer (CH Instruments) that was equipped with a conventional three-electrode system. The system consisted of a glassy carbon electrode (GCE) as the working electrode, a Pt wire as the counter electrode, and an Ag/AgCl, Cl<sup>–</sup> (saturated) as the reference electrode. All electrodes were contained in a one-compartment electrochemical cell with a volumetric capacity of 10 mL. The reference electrode and the salt bridge were calibrated by voltammetry relative to <i>E</i><sub>redox</sub> for ferrocene (0/+) couple in DMF/Bu<sub>4</sub>NPF<sub>6</sub>, to allow the measured <i>E</i><sub>redox</sub> values for the nonquinones to be quoted relative to ferrocene (0/+). Electrochemical reduction was performed in aprotic media (DMF + Bu<sub>4</sub>NPF<sub>6</sub> 0.1 M) at room temperature (22–25 °C). Each compound (1 mM) was added to the supporting electrolyte, and the solution was deoxygenated with nitrogen and kept under a continuous flow of nitrogen during the experiment. All data were recorded at a potential range between 0.00 and −2.00 V and at potential sweep rates of 50 mV/s.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73">4.5.  Pharmacology: In Vitro NQO1 Reduction Assay</h3><div class="NLM_p">All of the synthesized compounds were monitored as NQO1 substrates using an NADPH recycling assay and recombinant NQO1 (DT-diaphorase, EC 1.6.5.5, human recombinant, Sigma), in which NADPH oxidation to NADP<sup>+</sup> was monitored by absorbance (<i>A</i><sub>340</sub>) on a Varioskan Flash (Thermo, Waltham, MA). Compounds in DMSO stock (2 μL of 10× stock per well) were added a 96-well plate. NADPH (400 μM) and NQO1 (1.4 μg/mL) in 50 mM potassium phosphate buffer (pH 7.4) were added to each well (198 μL). Once the 96-well plate was filled with the assay solution except the NADPH solution, it was placed into the incubator at 37 °C and left to sit for 3 min before the measurement. The reaction was initiated by the addition of NADPH solution into the wells, and the absorbance change at 340 nm was measured at 2 s intervals for 5 min at room temperature (22–25 °C). The linear portion of the absorbance versus time graphs (the first 20 s to 1 min) were fitted and the slopes were calculated (velocity). Initial velocities were calculated and results expressed as μmol NADPH oxidized/min/μmol protein. In addition, initial velocities were calculated for a variety of concentrations and Michaelis–Menten curves were generated using Graphpad Prism 6.</div><div class="NLM_p">As for screening of the in-house compound collection, the tested compound at the concentration of 10 μM was coincubated with NQO1 (1.4 μg/mL) and NADPH (400 μM), and NADPH oxidation to NADP<sup>+</sup> in 5 min was monitored by absorbance at 340 nm. N (cycles), defined as the equiv of consumed NADPH divided by the equiv of tested compound, was calculated.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74">4.5.1.  Cell Culture</h4><div class="NLM_p last">The multidrug resistant human lung cancer A549/Taxol, A549/VCR (ATCC), human lung cancer A549 (ATCC), human breast cancer MCF-7 (ATCC), and human pancreatic cancer MIA PaCa-2 (ATCC) cell lines were cultured in a humidified, 5% CO<sub>2</sub> atmosphere at 37 °C in Roswell Park Memorial Institute medium (RPMI) 1640 (Gibco) or Dulbecco’s modified Eagle’s medium (DMEM) (Gibco) supplemented with 10% fetal bovine serum (FBS, heated-inactivated, Fisher Scientific) and 1% penicillin/streptomycin. All cell lines were subcultured every 2–3 days.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75">4.5.2.  Cell Viability Assay</h4><div class="NLM_p last">Cells were seeded in 96-well plates at a density of 1 × 10<sup>4</sup> cells/mL and allowed to attach overnight. Each compound was added to the wells at concentrations ranging from 1 to 100 μM for 4 h, Plates were then removed and replaced with fresh medium. Plates were incubated at 37 °C in a 5% CO<sub>2</sub> atmosphere for 72 h. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) solution (5 mg/mL) was added and the cells were incubated for another 4 h. The solutions were removed carefully by extraction, the formazan was dissolved in 150 μL of DMSO. The absorbance (OD) was read on a plate at 560 nm. The concentration causing 50% inhibition of cell growth (IC<sub>50</sub>) was determined. All toxicity experiments were repeated on at least three technical replicates. The data were analyzed using Graphpad Prism 6.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76">4.5.3.  Superoxide Anion Generation in Cell-Free Assay</h4><div class="NLM_p last">The superoxide anion generation was monitored using a spectrophotometric assay and cytochrome <i>c</i> as the terminal electron acceptor, in which the reduction rate of cytochrome <i>c</i> was measured by absorbance (<i>A</i><sub>550</sub>) on a Varioskan Flash (Thermo, Waltham, MA). Nonquinone compounds (25 μM), cytochrome <i>c</i> (30 μM), NADPH (200 μM), and recombinant NQO1 (0.1–3.0 1.4 μg/mL) (DT-diaphorase, EC 1.6.5.5, human recombinant, Sigma) were mixed in a final volume of 1 mL of 25 mM Tris-HCl solution (pH 7.4) containing bovine serum albumin (0.7 mg/mL) and 0.1% Tween 20. The reactions were initiated by the addition of NADPH solution into the wells, and the absorbance change at 550 nm was measured at 2 s intervals for 5 min at room temperature (22–25 °C). Reduction rates were calculated from the linear part of the absorbance vs time graphs (the first 0 to 30 s), and results were expressed as μmol cytochrome <i>c</i> reduced/min/mg protein by using a molar extinction coefficient of 21.1 mM<sup>–1</sup>cm<sup>–1</sup> for cytochrome <i>c</i>. The data were analyzed using Graphpad Prism 6.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77">4.5.4.  Measurement of Intracellular ROS Levels</h4><div class="NLM_p last">The fluorescent imaging of ROS production was performed on A549/Taxol cells. Cells were seeded at 1 × 10<sup>6</sup> cells/well in a 6-well plate and were incubated at 37 °C under a 5% CO<sub>2</sub> atmosphere for 24 h. Cells were then treated with compounds at the indicated time and dosages, incubated with 10 μM DCFH-DA (Beyotime), DHE (Beyotime), APF (Sigma) for 30 min at 37 °C, and fixed with 4% formaldehyde for 20 min. The cells were washed twice with PBS, and fluorescence was observed under a laser scanning confocal microscope (Olympus Fluoview FV1000, Japan).</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78">4.5.5.  Western Blot Analysis</h4><div class="NLM_p last">Biomarker modulation was determined by Western blot. A549/Taxol cells in Petri dishes were treated with compounds at the indicated ways. The cells were harvested, washed with cold PBS, and trypsinized, then the cell lysates were prepared and centrifuged at 12 000 rpm for 20 min at 4 °C. The supernatants were collected and the protein concentration was determined by a bicinchoninic acid (BCA) assay (Thermo, Waltham, MA). Protein samples were separated by SDS-PAGE and then transferred onto PVDF membranes (PerkinElmer, Norwalk, CT, USA). After blocking with 1% bovine serum albumin for 1 h, membranes were incubated at 37 °C for 1 h and then at 4 °C overnight with primary antibodies. Finally, the membranes were treated with a DyLight 800 labeled secondary antibody at 37 °C for 1 h and scanned through the Odyssey infrared imaging System (LO–COR, Lincoln, NE, USA).</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79">4.5.6.  Alkaline Comet Assay</h4><div class="NLM_p last">DNA damage was assessed by evaluating DNA “comet” tail area and migration distance. A549/Taxol cells were exposed to 10 μM compound <b>20k</b> with or without the pretreatment of 50 μM DIC or 10 mM NAC, and incubated for 2 h at 37 °C. The cell suspensions (3 × 10<sup>5</sup> cells/mL in PBS) were mixed with 1% low melting temperature agarose at 37 °C and transferred onto a CometSlide (KeyGEN). After solidifying for 30 min at 4 °C, slides were submerged in prechilled lysis buffer (2.5 M NaCl, 100 mM EDTA pH 10, 10 mM Tris Base, 1% sodium lauryl sarcosinate, and 1% Triton X-100) at 4 °C for 1 h, then the slides were incubated in alkaline unwinding solution (300 mM NaOH, and 1 mM EDTA) for 30 min at room temperature and washed twice in 1× TBE (89.2 mM Tris Base, 89 mM boric acid, and 2.5 mM EDTA disodium salt). Damaged and undamaged DNA was then separated by electrophoresis in 1× TBE for 20 min at 1 V/cm, fixed in 70% ethanol, and stained using propidium iodide (KeyGEN). Comets were visualized using a laser scanning confocal microscope (Olympus IX51, Japan), and images were analyzed by using ImageJ software.</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80">4.5.7.  Determination of NAD<sup>+</sup> and ATP Levels</h4><div class="NLM_p">Intracellular NAD<sup>+</sup> levels were measured by a previous assay.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> In brief, the A549/Taxol cells were seeded at 1 × 10<sup>6</sup> cells/well in a 6-well plate and allowed to attach overnight. Cells were exposed to 10 μM compound <b>20k</b> with or without the pretreatment of 50 μM DIC or 25 mM 3-AB, and harvested at the indicated time. Cell extracts were prepared in 0.5 M perchloric acid, neutralized (1 M KOH, 0.33 M KH<sub>2</sub>PO<sub>4</sub>/K<sub>2</sub>HPO<sub>4</sub>, pH 7.5), and centrifuged to remove KClO<sub>4</sub> precipitates. Supernatants or NAD<sup>+</sup> standards were incubated for 20 min at 37 °C with NAD<sup>+</sup> reaction mixture as described. The absorbance of the extracts was measured at 570 nm and the results were analyzed using Graphpad Prism 6.</div><div class="NLM_p last">Intercellular ATP levels were analyzed using the ATP Assay Kit (Beyotime, China). Briefly, the A549/Taxol cells were seeded at 1 × 10<sup>6</sup> cells/well in a 6-well plate and allowed to attach overnight. Cells were exposed to 10 μM compound <b>20k</b> with or without the pretreatment of 50 μM DIC or 25 mM 3-AB, and harvested at the indicated time. The cells were then lysed and centrifuged at 12 000 rpm for 10 min to isolate total protein. Next, the supernatant was added to ATP detection solution and luminescence was immediately detected using Thermo LUMINOSKAN ASCENT. Data then were analyzed using Graphpad Prism 6.</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81">4.5.8.  Apoptosis Analysis</h4><div class="NLM_p last">Cell apoptosis was analyzed using the Annexin V-FITC-PI (FACS) assay. The A549/Taxol cells were seeded at 1 × 10<sup>6</sup> cells/well in a 6-well plate and allowed to attach overnight. Cells were exposed to compound <b>20k</b> at indicated concentrations with or without the pretreatment of 50 μM DIC or 10 mM NAC for 24 h. The cells then were harvested and centrifuged at 1000 g for 5 min, washed with PBS, and resuspended. The cells were stained with Annexin V (1:300) for 30 min, followed by PI (1:400) staining for 5 min. Fluorescence intensity was analyzed using a flow cytometer (FACSCalibur, BD Biosciences, USA).</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82">4.5.9.  In Vivo Antitumor Activity</h4><div class="NLM_p last">Animal experiments were conducted according to protocols approved by Institutional Animal Care and Use Committee of China Pharmaceutical University. Approximately 5 × 10<sup>6</sup> A549/Taxol cells suspended in PBS (50 μL) was injected into the flanks of athymic nude mice (7–8 weeks). After the tumors grew to 100–150 mm<sup>3</sup>, all the mice were randomized into four groups (five mice for each group) and treated with vehicle, Taxol (2 mg/kg) and compound <b>20k</b> (15 mg/kg or 30 mg/kg). Compound <b>20k</b> was dissolved in 20% HPβCD and normal saline. Taxol, manufactured by Bristol-Myers Squibb, was diluted to the appropriate concentration with normal saline. All agents were administered every other day for 3 weeks by tail vein injection, and tumor growth was monitored and measured every day. After 3 weeks, mice were euthanized and the average tumor weights were calculated.</div></div><div id="sec4_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83">4.5.10.  Pathology Analysis</h4><div class="NLM_p last">A549/Taxol xenograft tumor mice were treated with saline, <b>20k</b> (15 mg/kg and 30 mg/kg) and Taxol (2 mg/kg) through tail intravenous injection every other day for 3 weeks. Nude mice were executed and dissected surgically for evaluation of possible pathological changes. Heart, liver, spleen, lungs, kidneys, and tumors were fixed in 10% buffered formalin, dehydrated in ethanol, embedded in paraffin, and then stained with hematoxylin and eosin (H&E). The pathological changes were captured with a Nikon 80i optical microscope.</div></div><div id="sec4_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84">4.5.11.  Blood Biochemistry Analysis</h4><div class="NLM_p last">After treatment with saline, <b>20k</b> (15 mg/kg and 30 mg/kg) and Taxol (2 mg/kg), the blood from A549/Taxol xenograft tumor mice was collected and subjected to blood biochemistry test. Blood samples from normal healthy mice were also needed as a contrast. The blood samples were centrifuged and diluted with acidified isopropanol (containing 0.75 M HCl solution). The supernatant was subjected to blood biochemistry test after being centrifuged. Functional indicators including total protein (TP), albumin (ALB), globulin (GLB), aspartate aminotransferase (AST), blood urea nitrogen (BUN), and lactate dehydrogenase (LDH) were determined.</div></div><div id="sec4_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85">4.5.12.  Determination of ROS and GSH in Vivo</h4><div class="NLM_p last">The ROS levels were measured by using DCFH-DA probe mentioned above. The tumor tissues were weighed and put into homogenizer to grind into homogenates, then homogenates were washed with PBS and centrifugation at low speed, the cell suspension was prepared and incubated with 10 μM DCFH-DA for 30 min at 37 °C, washed twice with PBS and analyzed using a flow cytometer (FACSCalibur, BD Biosciences, USA). The GSH levels were measured using a GSH and GSSG Assay Kit (Beyotime). Briefly, tumor tissues (10 mg) were homogenized in protein removal reagent M solution (100 μL), then being centrifuged at 1000 g for 10 min at 4 °C. The supernatant was measured for total GSH levels using a Varioskan Flash (Thermo, Waltham, MA).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">()</a></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01424" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61300" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61300" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01424" class="ext-link">10.1021/acs.jmedchem.8b01424</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Determination of the NQO1 activity in corresponding cancer cells, and normal hepatic L02 cells, cyclic voltammograms of the representive compounds, β-lap, and the control Ferrocene, doking poses for the representive compounds, possible reduction process for quinone substrate β-lap by NQO1, HPLC spectra for compound recovery after NQO1 assay, <sup>1</sup>H NMR and HRMS spectra for all of the target compounds, and <sup>13</sup>C NMR spectra for representative target compounds, HPLC assessment of purity for target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01424/suppl_file/jm8b01424_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01424/suppl_file/jm8b01424_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01424/suppl_file/jm8b01424_si_001.pdf">jm8b01424_si_001.pdf (6.53 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01424/suppl_file/jm8b01424_si_002.csv">jm8b01424_si_002.csv (1.74 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01424" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54712" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54712" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qidong You</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing, 210009, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8587-0122" title="Orcid link">http://orcid.org/0000-0002-8587-0122</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#770e18020613374641445914181a"><span class="__cf_email__" data-cfemail="96eff9e3e7f2d6a7a0a5b8f5f9fb">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaojin Zhang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing, 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, School of Science, China Pharmaceutical
University, Nanjing, 211198, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1898-3071" title="Orcid link">http://orcid.org/0000-0002-1898-3071</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8cf6f4e6cceffcf9a2e9e8f9a2efe2"><span class="__cf_email__" data-cfemail="265c5e4c6645565308434253084548">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xingsen Wu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing, 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, School of Science, China Pharmaceutical
University, Nanjing, 211198, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiang Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing, 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Engineering, China Pharmaceutical
University, Nanjing, 211198, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhihong Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing, 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, School of Science, China Pharmaceutical
University, Nanjing, 211198, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yancheng Yu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing, 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, School of Science, China Pharmaceutical
University, Nanjing, 211198, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants from the National Natural Science Foundation of China (Nos. 81773571 and 81603025), Jiangsu Province Funds for Excellent Young Scientists (No. BK20170088), the Fundamental Research Funds for the Central Universities (No. 2632017ZD03), and the Jiangsu Qing Lan Project and 333 Project. Part of the work was supported by the National Major Science and Technology Project of China (Nos. 2015ZX09101032 and 2017ZX09302003).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS</td></tr><tr><td class="NLM_term">NQO1</td><td class="NLM_def"><p class="first last">NAD(P)H:quinone oxidoreductase-1</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">β-lap</td><td class="NLM_def"><p class="first last">β-lapachone</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">CV</td><td class="NLM_def"><p class="first last">cyclic voltammogram</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Databank</p></td></tr><tr><td class="NLM_term">equiv</td><td class="NLM_def"><p class="first last">equivalent</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">nonsmall cell lung cancer</p></td></tr><tr><td class="NLM_term">DCFH-DA</td><td class="NLM_def"><p class="first last">2′,7′-dichlorodihydrofluorescein diacetate</p></td></tr><tr><td class="NLM_term">DHE</td><td class="NLM_def"><p class="first last">dihydroethidium</p></td></tr><tr><td class="NLM_term">APF</td><td class="NLM_def"><p class="first last">3′-(<i>p</i>-aminophenyl) fluorescein</p></td></tr><tr><td class="NLM_term">PAR</td><td class="NLM_def"><p class="first last">poly(ADP-ribose) modified protein</p></td></tr><tr><td class="NLM_term">PARP-1</td><td class="NLM_def"><p class="first last">poly(ADP-ribose)polymerase-1</p></td></tr><tr><td class="NLM_term">DIC</td><td class="NLM_def"><p class="first last">dicoumarol</p></td></tr><tr><td class="NLM_term">NAC</td><td class="NLM_def"><p class="first last"><i>N</i>-acetylcysteine</p></td></tr><tr><td class="NLM_term">3-AB</td><td class="NLM_def"><p class="first last">3-aminobenzamide</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86126" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86126" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 49 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oser, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederst, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sequist, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span> <span> </span><span class="NLM_article-title">Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">e165</span>– <span class="NLM_lpage">e172</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(14)71180-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2FS1470-2045%2814%2971180-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=25846096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1Gntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=e165-e172&issue=4&author=M.+G.+Oserauthor=M.+J.+Niederstauthor=L.+V.+Sequistauthor=J.+A.+Engelman&title=Transformation+from+non-small-cell+lung+cancer+to+small-cell+lung+cancer%3A+molecular+drivers+and+cells+of+origin&doi=10.1016%2FS1470-2045%2814%2971180-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin</span></div><div class="casAuthors">Oser, Matthew G.; Niederst, Matthew J.; Sequist, Lecia V.; Engelman, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e165-e172</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Lung cancer is the most common cause of cancer deaths worldwide.  The two broad histol. subtypes of lung cancer are small-cell lung cancer (SCLC), which is the cause of 15% of cases, and non-small-cell lung cancer (NSCLC), which accounts for 85% of cases and includes adenocarcinoma, squamous-cell carcinoma, and large-cell carcinoma.  Although NSCLC and SCLC are commonly thought to be different diseases owing to their distinct biol. and genomic abnormalities, the idea that these malignant disorders might share common cells of origin has been gaining support.  This idea has been supported by the unexpected findings that a subset of NSCLCs with mutated EGFR return as SCLC when resistance to EGFR tyrosine kinase inhibitors develops.  Addnl., other case reports have described the coexistence of NSCLC and SCLC, further challenging the commonly accepted view of their distinct lineages.  Here, we summarize the published clin. observations and biol. underlying tumors with combined SCLC and NSCLC histol. and cancers that transform from adenocarcinoma to SCLC.  We also discuss pre-clin. studies pointing to common potential cells of origin, and speculate how the distinct paths of differentiation are detd. by the genomics of each disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxTYO7xdPsabVg90H21EOLACvtfcHk0ljVALORlxccvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1Gntbw%253D&md5=9b28f389a12e304fda76a53730136783</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2814%2971180-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252814%252971180-5%26sid%3Dliteratum%253Aachs%26aulast%3DOser%26aufirst%3DM.%2BG.%26aulast%3DNiederst%26aufirst%3DM.%2BJ.%26aulast%3DSequist%26aufirst%3DL.%2BV.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26atitle%3DTransformation%2520from%2520non-small-cell%2520lung%2520cancer%2520to%2520small-cell%2520lung%2520cancer%253A%2520molecular%2520drivers%2520and%2520cells%2520of%2520origin%26jtitle%3DLancet%2520Oncol.%26date%3D2015%26volume%3D16%26issue%3D4%26spage%3De165%26epage%3De172%26doi%3D10.1016%2FS1470-2045%2814%2971180-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span> <span> </span><span class="NLM_article-title">miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">756</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-12-2651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1158%2F0008-5472.CAN-12-2651" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=756-766&issue=2&author=J.+Caiauthor=J.+Wuauthor=H.+Zhangauthor=L.+Fangauthor=Y.+Huangauthor=Y.+Yangauthor=X.+Zhuauthor=R.+Liauthor=M.+Li&title=miR-186+downregulation+correlates+with+poor+survival+in+lung+adenocarcinoma%2C+where+it+interferes+with+cell-cycle+regulation&doi=10.1158%2F0008-5472.CAN-12-2651"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-2651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-2651%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DM.%26atitle%3DmiR-186%2520downregulation%2520correlates%2520with%2520poor%2520survival%2520in%2520lung%2520adenocarcinoma%252C%2520where%2520it%2520interferes%2520with%2520cell-cycle%2520regulation%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26issue%3D2%26spage%3D756%26epage%3D766%26doi%3D10.1158%2F0008-5472.CAN-12-2651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shum, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Soler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span> <span> </span><span class="NLM_article-title">Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">701</span>– <span class="NLM_lpage">716</span>, <span class="refDoi"> DOI: 10.1080/14656566.2017.1316374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1080%2F14656566.2017.1316374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=28388240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtlOgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=701-716&issue=7&author=C.+Hardinauthor=E.+Shumauthor=A.+P.+Singhauthor=R.+Perez-Solerauthor=H.+Cheng&title=Emerging+treatment+using+tubulin+inhibitors+in+advanced+non-small+cell+lung+cancer&doi=10.1080%2F14656566.2017.1316374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer</span></div><div class="casAuthors">Hardin, C.; Shum, E.; Singh, A. P.; Perez-Soler, R.; Cheng, H.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">701-716</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Tubulin inhibitors including taxanes and vinca alkaloids are important components of chemotherapy regimens used in advanced non-small cell lung cancer (NSCLC).  Despite a treatment paradigm shift due to molecularly-targeted therapies and immunotherapy, a majority of patients will receive chemotherapy during their treatment course.  Either used alone or in combination, tubulin inhibitors have demonstrated clin. benefits in different settings of lung cancer management.  This review first discusses FDA-approved tubulin inhibitors for NSCLC, such as paclitaxel, docetaxel, vinorelbine, and nab-paclitaxel.  The article then provides a summary of novel tubulin inhibitors, including cabazitaxel, eribulin, ixabepilone, patupilone, plinabulin, new colchicine analogs and others.  It also discusses new tubulin inhibitor combinations with immunotherapy (PD-1/PD-L1 inhibitors) and molecularly-targeted therapies (e.g. anti-angiogenic agents, mTOR inhibitors, heat shock protein 90 inhibitors, MEK inhibitors, and anti-HER3 agents).  Lastly, emerging data on potential resistance mechanisms and predictive biomarkers for tubulin inhibitors are explored.  Tubulin inhibitors will likely continue to play important roles in NSCLC management due to the advent of novel agents and combinations.  Through further understanding of tumor biol., investigation of drug resistance, and development of predictive biomarkers, we will be better positioned to incorporate microtubule inhibition into patient specific treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK-YrHuRCjlbVg90H21EOLACvtfcHk0ljVALORlxccvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtlOgs7g%253D&md5=93b5c6a7083682bb9efd8c274490a8ff</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F14656566.2017.1316374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14656566.2017.1316374%26sid%3Dliteratum%253Aachs%26aulast%3DHardin%26aufirst%3DC.%26aulast%3DShum%26aufirst%3DE.%26aulast%3DSingh%26aufirst%3DA.%2BP.%26aulast%3DPerez-Soler%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DH.%26atitle%3DEmerging%2520treatment%2520using%2520tubulin%2520inhibitors%2520in%2520advanced%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2017%26volume%3D18%26issue%3D7%26spage%3D701%26epage%3D716%26doi%3D10.1080%2F14656566.2017.1316374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gridelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sgambato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casaluce, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adjei, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciardiello, F.</span></span> <span> </span><span class="NLM_article-title">ALK inhibitors in the treatment of advanced NSCLC</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2013.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.ctrv.2013.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=23931927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1elu7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2014&pages=300-306&issue=2&author=C.+Gridelliauthor=S.+Petersauthor=A.+Sgambatoauthor=F.+Casaluceauthor=A.+A.+Adjeiauthor=F.+Ciardiello&title=ALK+inhibitors+in+the+treatment+of+advanced+NSCLC&doi=10.1016%2Fj.ctrv.2013.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">ALK inhibitors in the treatment of advanced NSCLC</span></div><div class="casAuthors">Gridelli, Cesare; Peters, Solange; Sgambato, Assunta; Casaluce, Francesca; Adjei, Alex A.; Ciardiello, Fortunato</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-306</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Pharmacol. agents that target protein products of oncogenes in tumors are playing an increasing clin. role in the treatment of cancer.  Currently, the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) represent the std. of care for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring activating EGFR mutations.  Subsequently other genetic abnormalities with "driver" characteristics - implying transforming and tumor maintenance capabilities have been extensively reported in several small distinct subsets of NSCLC.  Among these rare genetic changes, anaplastic lymphoma kinase (ALK) gene rearrangements, most often consisting in a chromosome 2 inversion leading to a fusion with the echinoderm microtubule-assocd. protein like 4 (EML4) gene, results in the abnormal expression and activation of this tyrosine kinase in the cytoplasm of cancer cells.  This rearrangement occurs in 2-5% of NSCLC, predominantly in young (50 years or younger), never- or former-smokers with adenocarcinoma.  This aberration most commonly occurs a independently of EGFR and KRAS gene mutations.  A fluorescent in situ hybridization assay was approved by the US Food and Drug Administration (FDA) as the std. method for the detection of ALK gene rearrangement in clin. practice and is considered the gold std.  Crizotinib, a first-in-class dual ALK and c-MET inhibitor, has been shown to be particularly effective against ALK pos. NSCLC, showing dramatic and prolonged responses with low toxicity, predominantly restricted to the gastro-intestinal and visual systems, and generally self-limiting or easily managed.  However, resistance to crizotinib inevitably emerges.  The mol. mechanisms of resistance are currently under investigation, as are therapeutic approaches including crizotinib-based combination therapy and novel agents such as Hsp90 inhibitors.  This review aims to present the current knowledge on this fusion gene, the clinic-pathol. profile of ALK rearranged NSCLC, and to review the existing literature on ALK inhibitors, focusing on their role in the treatment of NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdYKLtYrF29bVg90H21EOLACvtfcHk0lhIJu38AswQwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1elu7zF&md5=25ac98f22906223641088f231c3e5702</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2013.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2013.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DGridelli%26aufirst%3DC.%26aulast%3DPeters%26aufirst%3DS.%26aulast%3DSgambato%26aufirst%3DA.%26aulast%3DCasaluce%26aufirst%3DF.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26aulast%3DCiardiello%26aufirst%3DF.%26atitle%3DALK%2520inhibitors%2520in%2520the%2520treatment%2520of%2520advanced%2520NSCLC%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2014%26volume%3D40%26issue%3D2%26spage%3D300%26epage%3D306%26doi%3D10.1016%2Fj.ctrv.2013.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forde, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ettinger, D. S.</span></span> <span> </span><span class="NLM_article-title">Targeted therapy for non-small-cell lung cancer: past, present and future</span>. <i>Expert Rev. Anticancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">758</span>, <span class="refDoi"> DOI: 10.1586/era.13.47</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1586%2Fera.13.47" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=23773106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsFKiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=745-758&issue=6&author=P.+M.+Fordeauthor=D.+S.+Ettinger&title=Targeted+therapy+for+non-small-cell+lung+cancer%3A+past%2C+present+and+future&doi=10.1586%2Fera.13.47"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted therapy for non-small-cell lung cancer: past, present and future</span></div><div class="casAuthors">Forde, Patrick M.; Ettinger, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">745-758</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Therapy for advanced non-small-cell lung cancer has developed significantly with new awareness of histol. subtype as an important factor in guiding treatment and the development of targeted agents for mol. subgroups harboring crit. mutations that spur on cancer growth.  In this comprehensive review, we look back at developments in targeted therapy for advanced non-small-cell lung cancer, reviewing in detail efforts, both successful and in some cases less so, to target EGFR, VEGF and ALK.  This review provides an overview of where the field stands at present and the areas we feel are most likely to provide challenges and potential successes in the next 5 years including immune checkpoint inhibition, epigenetic therapy and driver mutation targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz1_lFCYvFNbVg90H21EOLACvtfcHk0lhIJu38AswQwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsFKiur8%253D&md5=fdd2c66ec4e6d506a28d0f57c6a4d012</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1586%2Fera.13.47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.13.47%26sid%3Dliteratum%253Aachs%26aulast%3DForde%26aufirst%3DP.%2BM.%26aulast%3DEttinger%26aufirst%3DD.%2BS.%26atitle%3DTargeted%2520therapy%2520for%2520non-small-cell%2520lung%2520cancer%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2013%26volume%3D13%26issue%3D6%26spage%3D745%26epage%3D758%26doi%3D10.1586%2Fera.13.47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, M. J.</span></span> <span> </span><span class="NLM_article-title">Pembrolizumab for the treatment of non-small cell lung cancer</span>. <i>Expert Opin. Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1517/14712598.2016.1145652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1517%2F14712598.2016.1145652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=26800463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVGms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=397-406&issue=3&author=S.+H.+Limauthor=J.+M.+Sunauthor=S.+H.+Leeauthor=J.+S.+Ahnauthor=K.+Parkauthor=M.+J.+Ahn&title=Pembrolizumab+for+the+treatment+of+non-small+cell+lung+cancer&doi=10.1517%2F14712598.2016.1145652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pembrolizumab for the treatment of non-small cell lung cancer</span></div><div class="casAuthors">Lim, Sung Hee; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-406</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Immune checkpoint inhibitors targeting programmed death protein 1 (PD-1) receptor and its ligand, PD-L1, have recently led to significant and durable improvements in the clin. outcomes of some types of cancers including lung cancer.  Pembrolizumab was approved by the US FDA for the treatment of advanced or metastatic NSCLC whose disease has progressed after other treatments and with tumors that express PD-L1.  In the phase I KEYNOTE-001 trial, the overall response rate (ORR) was 19.4%, the median progression-free survival (PFS) and overall survival (OS) were 3.7 mo and 12.0 mo for 495 unselected NSCLC patients.  Strong PD-L1 expression (≥ 50%) was assocd. with higher ORR, longer PFS, and longer OS.  The phase II/III randomized KEYNOTE-010 trial demonstrated that pembrolizumab improved OS vs. docetaxel in patients with previously treated NSCLC.  Pembrolizumab, demonstrated durable response and prolonged OS esp. in NSCLC patients with high expression of PD-1, thereby suggests a new treatment paradigm.  However, many issues remain to be explored, including the identification of other robust biomarkers that can accurately predict the immune-responsiveness of tumors.  Along with the identification of predictive biomarkers, further understanding of the tumor microenvironment is necessary to improve treatment outcomes through combinations of immunotherapy or combined with other targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJHo_7xR1oY7Vg90H21EOLACvtfcHk0lhIJu38AswQwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVGms7k%253D&md5=367f54f1013280406d627173644794b9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F14712598.2016.1145652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.2016.1145652%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DS.%2BH.%26aulast%3DSun%26aufirst%3DJ.%2BM.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DAhn%26aufirst%3DJ.%2BS.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DAhn%26aufirst%3DM.%2BJ.%26atitle%3DPembrolizumab%2520for%2520the%2520treatment%2520of%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2016%26volume%3D16%26issue%3D3%26spage%3D397%26epage%3D406%26doi%3D10.1517%2F14712598.2016.1145652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgensztern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, C.</span></span> <span> </span><span class="NLM_article-title">The biology and management of non-small cell lung cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>553</i></span> (<span class="NLM_issue">7689</span>),  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1038/nature25183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1038%2Fnature25183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=29364287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs12itbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=553&publication_year=2018&pages=446-454&issue=7689&author=R.+S.+Herbstauthor=D.+Morgenszternauthor=C.+Boshoff&title=The+biology+and+management+of+non-small+cell+lung+cancer&doi=10.1038%2Fnature25183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The biology and management of non-small cell lung cancer</span></div><div class="casAuthors">Herbst, Roy S.; Morgensztern, Daniel; Boshoff, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">553</span>
        (<span class="NLM_cas:issue">7689</span>),
    <span class="NLM_cas:pages">446-454</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Important advancements in the treatment of non-small cell lung cancer (NSCLC) have been achieved over the past two decades, increasing the understanding of the disease biol. and mechanisms of tumor progression, and advancing early detection and multimodal care.  The use of small mol. tyrosine kinase inhibitors and immunotherapy has led to unprecedented survival benefits in selected patients.  However, the overall cure and survival rates for NSCLC remain low, particularly in metastatic disease.  Therefore, continued research into new drugs and combination therapies is required to expand the clin. benefit to a broader patient population and to improve outcomes in NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4LzsacpsnpLVg90H21EOLACvtfcHk0ljJkW2H2Rj9iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs12itbo%253D&md5=9e7e092850f8707b96b6828e9a0d9585</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature25183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25183%26sid%3Dliteratum%253Aachs%26aulast%3DHerbst%26aufirst%3DR.%2BS.%26aulast%3DMorgensztern%26aufirst%3DD.%26aulast%3DBoshoff%26aufirst%3DC.%26atitle%3DThe%2520biology%2520and%2520management%2520of%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DNature%26date%3D2018%26volume%3D553%26issue%3D7689%26spage%3D446%26epage%3D454%26doi%3D10.1038%2Fnature25183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frantz, S.</span></span> <span> </span><span class="NLM_article-title">Drug approval triggers debate on future direction for cancer treatments</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1038/nrd1972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1038%2Fnrd1972" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=91-98&issue=2&author=S.+Frantz&title=Drug+approval+triggers+debate+on+future+direction+for+cancer+treatments&doi=10.1038%2Fnrd1972"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrd1972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1972%26sid%3Dliteratum%253Aachs%26aulast%3DFrantz%26aufirst%3DS.%26atitle%3DDrug%2520approval%2520triggers%2520debate%2520on%2520future%2520direction%2520for%2520cancer%2520treatments%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26issue%3D2%26spage%3D91%26epage%3D98%26doi%3D10.1038%2Fnrd1972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Melguizo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prados, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caba, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aranega, A.</span></span> <span> </span><span class="NLM_article-title">Modulation of MDR1 and MRP3 gene expression in lung cancer cells after paclitaxel and carboplatin exposure</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">16624</span>– <span class="NLM_lpage">16635</span>, <span class="refDoi"> DOI: 10.3390/ijms131216624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.3390%2Fijms131216624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=23443122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1emtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=16624-16635&issue=12&author=C.+Melguizoauthor=J.+Pradosauthor=R.+Luqueauthor=R.+Ortizauthor=O.+Cabaauthor=P.+J.+Alvarezauthor=B.+Gonzalezauthor=A.+Aranega&title=Modulation+of+MDR1+and+MRP3+gene+expression+in+lung+cancer+cells+after+paclitaxel+and+carboplatin+exposure&doi=10.3390%2Fijms131216624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of MDR1 and MRP3 gene expression in lung cancer cells after paclitaxel and carboplatin exposure</span></div><div class="casAuthors">Melguizo, Consolacion; Prados, Jose; Luque, Raquel; Ortiz, Raul; Caba, Octavio; Alvarez, Pablo J.; Gonzalez, Beatriz; Aranega, Antonia</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16624-16635</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Carboplatin-paclitaxel is a ref. regimen in the treatment of locally advanced or disseminated non-small cell lung cancer (NSCLC).  This paper discusses the multidrug resistance developed with this drug combination, which is one of the major obstacles to successful treatment.  In order to understand and overcome the drug resistance pattern of NSCLC after carboplatin plus paclitaxel exposure, levels of mRNA expression of multidrug resistance 1 (MDR1) and multidrug resistance-assocd. protein 3 (MRP3) were investigated in primary NSCLC cell lines (A-549 and A-427) and a metastasis-derived NSCLC cell line (NODO).  Our results showed that exposure of the three NSCLC lines to plasma concns. of paclitaxel (5 μM) produced an increase in MDR1 expression, while MRP3 showed no alteration in expression.  By contrast, the same cells exposed to carboplatin plasma concns. (30 μM) showed overexpression of MRP3.  In these cells, MDR1 showed no expression changes.  Interestingly, the combination of both paclitaxel and carboplatin caused increased expression of the MDR1 drug resistance gene rather than the individual treatments.  These results suggest that carboplatin and paclitaxel may induce drug resistance mediated by MDR1 and MRP3, which may be enhanced by the simultaneous use of both drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv3NpH6bpWg7Vg90H21EOLACvtfcHk0ljJkW2H2Rj9iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1emtA%253D%253D&md5=3a7ce5acb434fa5a4e2159ac9ae9cb87</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3390%2Fijms131216624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms131216624%26sid%3Dliteratum%253Aachs%26aulast%3DMelguizo%26aufirst%3DC.%26aulast%3DPrados%26aufirst%3DJ.%26aulast%3DLuque%26aufirst%3DR.%26aulast%3DOrtiz%26aufirst%3DR.%26aulast%3DCaba%26aufirst%3DO.%26aulast%3DAlvarez%26aufirst%3DP.%2BJ.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DAranega%26aufirst%3DA.%26atitle%3DModulation%2520of%2520MDR1%2520and%2520MRP3%2520gene%2520expression%2520in%2520lung%2520cancer%2520cells%2520after%2520paclitaxel%2520and%2520carboplatin%2520exposure%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2012%26volume%3D13%26issue%3D12%26spage%3D16624%26epage%3D16635%26doi%3D10.3390%2Fijms131216624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trachootham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span> <span> </span><span class="NLM_article-title">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.1038/nrd2803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1038%2Fnrd2803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=19478820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=579-591&issue=7&author=D.+Trachoothamauthor=J.+Alexandreauthor=P.+Huang&title=Targeting+cancer+cells+by+ROS-mediated+mechanisms%3A+a+radical+therapeutic+approach%3F&doi=10.1038%2Fnrd2803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span></div><div class="casAuthors">Trachootham, Dunyaporn; Alexandre, Jerome; Huang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">579-591</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Increased generation of reactive oxygen species (ROS) and an altered redox status have long been obsd. in cancer cells, and recent studies suggest that this biochem. property of cancer cells can be exploited for therapeutic benefits.  Cancer cells in advanced stage tumors frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially eliminate these cells by pharmacol. ROS insults.  However, the upregulation of antioxidant capacity in adaptation to intrinsic oxidative stress in cancer cells can confer drug resistance.  Abrogation of such drug-resistant mechanisms by redox modulation could have significant therapeutic implications.  We argue that modulating the unique redox regulatory mechanisms of cancer cells might be an effective strategy to eliminate these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgIa2fgBPBrVg90H21EOLACvtfcHk0lhniT1eksMLKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D&md5=d50931b8de8bcab62d376becc768a71c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrd2803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2803%26sid%3Dliteratum%253Aachs%26aulast%3DTrachootham%26aufirst%3DD.%26aulast%3DAlexandre%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DTargeting%2520cancer%2520cells%2520by%2520ROS-mediated%2520mechanisms%253A%2520a%2520radical%2520therapeutic%2520approach%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26issue%3D7%26spage%3D579%26epage%3D591%26doi%3D10.1038%2Fnrd2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W. S.</span></span> <span> </span><span class="NLM_article-title">The signaling mechanism of ROS in tumor progression</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1007/s10555-006-9037-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1007%2Fs10555-006-9037-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=695-705&issue=4&author=W.+S.+Wu&title=The+signaling+mechanism+of+ROS+in+tumor+progression&doi=10.1007%2Fs10555-006-9037-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10555-006-9037-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-006-9037-8%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%2BS.%26atitle%3DThe%2520signaling%2520mechanism%2520of%2520ROS%2520in%2520tumor%2520progression%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2007%26volume%3D25%26issue%3D4%26spage%3D695%26epage%3D705%26doi%3D10.1007%2Fs10555-006-9037-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. F.</span></span> <span> </span><span class="NLM_article-title">Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">19</span>, <span class="refDoi"> DOI: 10.1186/1756-8722-6-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1186%2F1756-8722-6-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=23442817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=19&author=X.+Liauthor=P.+Fangauthor=J.+Maiauthor=E.+T.+Choiauthor=H.+Wangauthor=X.+F.+Yang&title=Targeting+mitochondrial+reactive+oxygen+species+as+novel+therapy+for+inflammatory+diseases+and+cancers&doi=10.1186%2F1756-8722-6-19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</span></div><div class="casAuthors">Li, Xinyuan; Fang, Pu; Mai, Jietang; Choi, Eric T.; Wang, Hong; Yang, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  There are multiple sources of reactive oxygen species (ROS) in the cell.  As a major site of ROS prodn., mitochondria have drawn considerable interest because it was recently discovered that mitochondrial ROS (mtROS) directly stimulate the prodn. of proinflammatory cytokines and pathol. conditions as diverse as malignancies, autoimmune diseases, and cardiovascular diseases all share common phenotype of increased mtROS prodn. above basal levels.  Several excellent reviews on this topic have been published, but ever-changing new discoveries mandated a more up-to-date and comprehensive review on this topic.  Therefore, we update recent understanding of how mitochondria generate and regulate the prodn. of mtROS and the function of mtROS both in physiol. and pathol. conditions.  In addn., we describe newly developed methods to probe or scavenge mtROS and compare these methods in detail.  Thorough understanding of this topic and the application of mtROS-targeting drugs in the research is significant towards development of better therapies to combat inflammatory diseases and inflammatory malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdw7mjnRfUbVg90H21EOLACvtfcHk0lhniT1eksMLKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D&md5=d041a496a1ede846460023f0cc54885a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-6-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-6-19%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DP.%26aulast%3DMai%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DE.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DX.%2BF.%26atitle%3DTargeting%2520mitochondrial%2520reactive%2520oxygen%2520species%2520as%2520novel%2520therapy%2520for%2520inflammatory%2520diseases%2520and%2520cancers%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2013%26volume%3D6%26spage%3D19%26doi%3D10.1186%2F1756-8722-6-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gorrini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Modulation of oxidative stress as an anticancer strategy</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">931</span>– <span class="NLM_lpage">947</span>, <span class="refDoi"> DOI: 10.1038/nrd4002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1038%2Fnrd4002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=24287781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=931-947&issue=12&author=C.+Gorriniauthor=I.+S.+Harrisauthor=T.+W.+Mak&title=Modulation+of+oxidative+stress+as+an+anticancer+strategy&doi=10.1038%2Fnrd4002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of oxidative stress as an anticancer strategy</span></div><div class="casAuthors">Gorrini, Chiara; Harris, Isaac S.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">931-947</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The regulation of oxidative stress is an important factor in both tumor development and responses to anticancer therapies.  Many signalling pathways that are linked to tumorigenesis can also regulate the metab. of reactive oxygen species (ROS) through direct or indirect mechanisms.  High ROS levels are generally detrimental to cells, and the redox status of cancer cells usually differs from that of normal cells.  Because of metabolic and signalling aberrations, cancer cells exhibit elevated ROS levels.  The observation that this is balanced by an increased antioxidant capacity suggests that high ROS levels may constitute a barrier to tumorigenesis.  However, ROS can also promote tumor formation by inducing DNA mutations and pro-oncogenic signalling pathways.  These contradictory effects have important implications for potential anticancer strategies that aim to modulate levels of ROS.  In this Review, we address the controversial role of ROS in tumor development and in responses to anticancer therapies, and elaborate on the idea that targeting the antioxidant capacity of tumor cells can have a pos. therapeutic impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVKYMoILuOfbVg90H21EOLACvtfcHk0liicxC1WB08rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7%252FI&md5=7f135a1b32b1134a88cfa28b35c53de7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd4002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4002%26sid%3Dliteratum%253Aachs%26aulast%3DGorrini%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DI.%2BS.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DModulation%2520of%2520oxidative%2520stress%2520as%2520an%2520anticancer%2520strategy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D12%26spage%3D931%26epage%3D947%26doi%3D10.1038%2Fnrd4002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulesz-Martin, M.</span></span> <span> </span><span class="NLM_article-title">Destructive cycles: the role of genomic instability and adaptation in carcinogenesis</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2044</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgh204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1093%2Fcarcin%2Fbgh204" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=2033-2044&issue=11&author=B.+Schneiderauthor=M.+Kulesz-Martin&title=Destructive+cycles%3A+the+role+of+genomic+instability+and+adaptation+in+carcinogenesis&doi=10.1093%2Fcarcin%2Fbgh204"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgh204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgh204%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DB.%26aulast%3DKulesz-Martin%26aufirst%3DM.%26atitle%3DDestructive%2520cycles%253A%2520the%2520role%2520of%2520genomic%2520instability%2520and%2520adaptation%2520in%2520carcinogenesis%26jtitle%3DCarcinogenesis%26date%3D2004%26volume%3D25%26issue%3D11%26spage%3D2033%26epage%3D2044%26doi%3D10.1093%2Fcarcin%2Fbgh204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelicano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carney, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span> <span> </span><span class="NLM_article-title">ROS stress in cancer cells and therapeutic implications</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/j.drup.2004.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.drup.2004.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=15158766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1Wquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=97-110&issue=2&author=H.+Pelicanoauthor=D.+Carneyauthor=P.+Huang&title=ROS+stress+in+cancer+cells+and+therapeutic+implications&doi=10.1016%2Fj.drup.2004.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">ROS stress in cancer cells and therapeutic implications</span></div><div class="casAuthors">Pelicano, Helene; Carney, Dennis; Huang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-110</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are constantly generated and eliminated in the biol. system, and play important roles in a variety of normal biochem. functions and abnormal pathol. processes.  Growing evidence suggests that cancer cells exhibit increased intrinsic ROS stress, due in part to oncogenic stimulation, increased metabolic activity, and mitochondrial malfunction.  Since the mitochondrial respiratory chain (electron transport complexes) is a major source of ROS generation in the cells, the vulnerability of the mitochondrial DNA to ROS-mediated damage appears to be a mechanism to amplify ROS stress in cancer cells.  The escalated ROS generation in cancer cells serves as an endogenous source of DNA-damaging agents that promote genetic instability and development of drug resistance.  Malfunction of mitochondria also alters cellular apoptotic response to anticancer agents.  Despite the neg. impacts of increased ROS in cancer cells, it is possible to exploit this biochem. feature and develop novel therapeutic strategies to preferentially kill cancer cells through ROS-mediated mechanisms.  This article reviews ROS stress in cancer cells, its underlying mechanisms and relationship with mitochondrial malfunction and alteration in drug sensitivity, and suggests new therapeutic strategies that take advantage of increased ROS in cancer cells to enhance therapeutic activity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom2pkSeKlxObVg90H21EOLACvtfcHk0liicxC1WB08rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1Wquro%253D&md5=80f41fc45cd1e43971bb118a238e2196</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2004.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2004.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DPelicano%26aufirst%3DH.%26aulast%3DCarney%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DROS%2520stress%2520in%2520cancer%2520cells%2520and%2520therapeutic%2520implications%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2004%26volume%3D7%26issue%3D2%26spage%3D97%26epage%3D110%26doi%3D10.1016%2Fj.drup.2004.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deavall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, R.</span></span> <span> </span><span class="NLM_article-title">Drug-induced oxidative stress and toxicity</span>. <i>J. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">645460</span>, <span class="refDoi"> DOI: 10.1155/2012/645460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1155%2F2012%2F645460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=22919381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A280%3ADC%252BC38bgvFOitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=645460&author=D.+G.+Deavallauthor=E.+A.+Martinauthor=J.+M.+Hornerauthor=R.+Roberts&title=Drug-induced+oxidative+stress+and+toxicity&doi=10.1155%2F2012%2F645460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced oxidative stress and toxicity</span></div><div class="casAuthors">Deavall Damian G; Martin Elizabeth A; Horner Judith M; Roberts Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">645460</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Reactive oxygen species (ROS) are a byproduct of normal metabolism and have roles in cell signaling and homeostasis.  Species include oxygen radicals and reactive nonradicals.  Mechanisms exist that regulate cellular levels of ROS, as their reactive nature may otherwise cause damage to key cellular components including DNA, protein, and lipid.  When the cellular antioxidant capacity is exceeded, oxidative stress can result.  Pleiotropic deleterious effects of oxidative stress are observed in numerous disease states and are also implicated in a variety of drug-induced toxicities.  In this paper, we examine the nature of ROS-induced damage on key cellular targets of oxidative stress.  We also review evidence implicating ROS in clinically relevant, drug-related side effects including doxorubicin-induced cardiac damage, azidothymidine-induced myopathy, and cisplatin-induced ototoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9oQsBbs737BFwe7cAcrfPfW6udTcc2eb7Ljb42Phk17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bgvFOitQ%253D%253D&md5=e245205a37ccaf96754b69039a1e3358</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1155%2F2012%2F645460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F645460%26sid%3Dliteratum%253Aachs%26aulast%3DDeavall%26aufirst%3DD.%2BG.%26aulast%3DMartin%26aufirst%3DE.%2BA.%26aulast%3DHorner%26aufirst%3DJ.%2BM.%26aulast%3DRoberts%26aufirst%3DR.%26atitle%3DDrug-induced%2520oxidative%2520stress%2520and%2520toxicity%26jtitle%3DJ.%2520Toxicol.%26date%3D2012%26volume%3D2012%26spage%3D645460%26doi%3D10.1155%2F2012%2F645460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waris, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahsan, H.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species: role in the development of cancer and various chronic conditions</span>. <i>J. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">14</span>, <span class="refDoi"> DOI: 10.1186/1477-3163-5-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1186%2F1477-3163-5-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=16689993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A280%3ADC%252BD28zmsleisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=14&author=G.+Warisauthor=H.+Ahsan&title=Reactive+oxygen+species%3A+role+in+the+development+of+cancer+and+various+chronic+conditions&doi=10.1186%2F1477-3163-5-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species: role in the development of cancer and various chronic conditions</span></div><div class="casAuthors">Waris Gulam; Ahsan Haseeb</div><div class="citationInfo"><span class="NLM_cas:title">Journal of carcinogenesis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxygen derived species such as superoxide radical, hydrogen peroxide, singlet oxygen and hydroxyl radical are well known to be cytotoxic and have been implicated in the etiology of a wide array of human diseases, including cancer.  Various carcinogens may also partly exert their effect by generating reactive oxygen species (ROS) during their metabolism.  Oxidative damage to cellular DNA can lead to mutations and may, therefore, play an important role in the initiation and progression of multistage carcinogenesis.  The changes in DNA such as base modification, rearrangement of DNA sequence, miscoding of DNA lesion, gene duplication and the activation of oncogenes may be involved in the initiation of various cancers.  Elevated levels of ROS and down regulation of ROS scavengers and antioxidant enzymes are associated with various human diseases including various cancers.  ROS are also implicated in diabetes and neurodegenerative diseases.  ROS influences central cellular processes such as proliferation a, apoptosis, senescence which are implicated in the development of cancer.  Understanding the role of ROS as key mediators in signaling cascades may provide various opportunities for pharmacological intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRC2GZV0iYNvb5oR8RchjrrfW6udTcc2eb7Ljb42Phk17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zmsleisA%253D%253D&md5=14e0383e89dfc388283a052d575fbcfd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1186%2F1477-3163-5-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1477-3163-5-14%26sid%3Dliteratum%253Aachs%26aulast%3DWaris%26aufirst%3DG.%26aulast%3DAhsan%26aufirst%3DH.%26atitle%3DReactive%2520oxygen%2520species%253A%2520role%2520in%2520the%2520development%2520of%2520cancer%2520and%2520various%2520chronic%2520conditions%26jtitle%3DJ.%2520Carcinog.%26date%3D2006%26volume%3D5%26spage%3D14%26doi%3D10.1186%2F1477-3163-5-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Current development of ROS-modulating agents as novel antitumor therapy</span>. <i>Curr. Cancer Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.2174/1568009616666160216125833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.2174%2F1568009616666160216125833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=26881931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1eksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=122-136&issue=2&author=N.+Wangauthor=Y.+Wuauthor=J.+Bianauthor=X.+Qianauthor=H.+Linauthor=H.+Sunauthor=Q.+Youauthor=X.+Zhang&title=Current+development+of+ROS-modulating+agents+as+novel+antitumor+therapy&doi=10.2174%2F1568009616666160216125833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Current Development of ROS-Modulating Agents as Novel Antitumor Therapy</span></div><div class="casAuthors">Wang, Nan; Wu, Yue; Bian, Jinlei; Qian, Xue; Lin, Hongzhi; Sun, Haopeng; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">122-136</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Compared to normal cells, usually cancer cells are under higher oxidative stress.  Elevating intracellular levels of reactive oxygen species (ROS) by introducing excessive ROS or inhibiting antioxidant system may enhance selectively of cancer cell killing by ROS-modulating agents through stress sensitization or stress overload.  Meanwhile due to the adaptive response, normal cells may be capable of maintaining redox homeostasis under exogenous ROS.  Here we review ROS-modulating agents in different mechanisms and classify them into groups by various targets for illustrating more clearly.  At last, we discuss their side effects and the potential troubles of developing these agents and argue that might be an effective strategy for further exploring to modulate the unique redox regulatory mechanisms of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGiT3Tj48T9bVg90H21EOLACvtfcHk0lhtsC4uUB9GFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1eksbo%253D&md5=02ac2a93c914054fad81a62f98d6214f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1568009616666160216125833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009616666160216125833%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DCurrent%2520development%2520of%2520ROS-modulating%2520agents%2520as%2520novel%2520antitumor%2520therapy%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2017%26volume%3D17%26issue%3D2%26spage%3D122%26epage%3D136%26doi%3D10.2174%2F1568009616666160216125833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raj, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurkar, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolliday, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandinova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span> <span> </span><span class="NLM_article-title">Selective killing of cancer cells by a small molecule targeting the stress response to ROS</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>475</i></span> (<span class="NLM_issue">7355</span>),  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1038/nature10167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1038%2Fnature10167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=21753854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFegt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=231-234&issue=7355&author=L.+Rajauthor=T.+Ideauthor=A.+U.+Gurkarauthor=M.+Foleyauthor=M.+Schenoneauthor=X.+Liauthor=N.+J.+Tollidayauthor=T.+R.+Golubauthor=S.+A.+Carrauthor=A.+F.+Shamjiauthor=A.+M.+Sternauthor=A.+Mandinovaauthor=S.+L.+Schreiberauthor=S.+W.+Lee&title=Selective+killing+of+cancer+cells+by+a+small+molecule+targeting+the+stress+response+to+ROS&doi=10.1038%2Fnature10167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Selective killing of cancer cells by a small molecule targeting the stress response to ROS</span></div><div class="casAuthors">Raj, Lakshmi; Ide, Takao; Gurkar, Aditi U.; Foley, Michael; Schenone, Monica; Li, Xiaoyu; Tolliday, Nicola J.; Golub, Todd R.; Carr, Steven A.; Shamji, Alykhan F.; Stern, Andrew M.; Mandinova, Anna; Schreiber, Stuart L.; Lee, Sam W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7355</span>),
    <span class="NLM_cas:pages">231-234</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Malignant transformation, driven by gain-of-function mutations in oncogenes and loss-of-function mutations in tumor suppressor genes, results in cell deregulation that is frequently assocd. with enhanced cellular stress (for example, oxidative, replicative, metabolic and proteotoxic stress, and DNA damage).  Adaptation to this stress phenotype is required for cancer cells to survive, and consequently cancer cells may become dependent upon non-oncogenes that do not ordinarily perform such a vital function in normal cells.  Thus, targeting these non-oncogene dependencies in the context of a transformed genotype may result in a synthetic lethal interaction and the selective death of cancer cells.  Here we used a cell-based small-mol. screening and quant. proteomics approach that resulted in the unbiased identification of a small mol. that selectively kills cancer cells but not normal cells.  Piperlongumine increases the level of reactive oxygen species (ROS) and apoptotic cell death in both cancer cells and normal cells engineered to have a cancer genotype, irresp. of p53 status, but it has little effect on either rapidly or slowly dividing primary normal cells.  Significant antitumor effects are obsd. in piperlongumine-treated mouse xenograft tumor models, with no apparent toxicity in normal mice.  Moreover, piperlongumine potently inhibits the growth of spontaneously formed malignant breast tumors and their assocd. metastases in mice.  Our results demonstrate the ability of a small mol. to induce apoptosis selectively in cells that have a cancer genotype, by targeting a non-oncogene co-dependency acquired through the expression of the cancer genotype in response to transformation-induced oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm9UKP2p7HU7Vg90H21EOLACvtfcHk0lhtsC4uUB9GFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFegt7Y%253D&md5=06fae19f17d3894445399947e5838bc3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnature10167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10167%26sid%3Dliteratum%253Aachs%26aulast%3DRaj%26aufirst%3DL.%26aulast%3DIde%26aufirst%3DT.%26aulast%3DGurkar%26aufirst%3DA.%2BU.%26aulast%3DFoley%26aufirst%3DM.%26aulast%3DSchenone%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DTolliday%26aufirst%3DN.%2BJ.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26aulast%3DStern%26aufirst%3DA.%2BM.%26aulast%3DMandinova%26aufirst%3DA.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DS.%2BW.%26atitle%3DSelective%2520killing%2520of%2520cancer%2520cells%2520by%2520a%2520small%2520molecule%2520targeting%2520the%2520stress%2520response%2520to%2520ROS%26jtitle%3DNature%26date%3D2011%26volume%3D475%26issue%3D7355%26spage%3D231%26epage%3D234%26doi%3D10.1038%2Fnature10167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">2-Substituted 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-diones as specific L-shaped NQO1-mediated redox modulators for the treatment of non-small cell lung cancer</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">629</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.ejmech.2017.06.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=28710963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKrs77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=616-629&author=X.+Zhangauthor=J.+Bianauthor=X.+Liauthor=X.+Wuauthor=Y.+Dongauthor=Q.+You&title=2-Substituted+3%2C7%2C8-trimethylnaphtho%5B1%2C2-b%5Dfuran-4%2C5-diones+as+specific+L-shaped+NQO1-mediated+redox+modulators+for+the+treatment+of+non-small+cell+lung+cancer&doi=10.1016%2Fj.ejmech.2017.06.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">2-Substituted 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-diones as specific L-shaped NQO1-mediated redox modulators for the treatment of non-small cell lung cancer</span></div><div class="casAuthors">Zhang, Xiaojin; Bian, Jinlei; Li, Xiang; Wu, Xingsen; Dong, Yanan; You, Qidong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">616-629</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Based on the scaffold of 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-dione, a series of L-shaped derivs. with substituted side chains at the position of C2 were designed by analyzing the binding mode with NQO1.  The drug-like compd. I (named as DDO-7178) emerged as the most specific substrate of the two-electron oxidoreductase NQO1 and could hardly be reduced by one-electron oxidoreductases CPR (NQO1/CPR = 20.8).  In addn., compd. 6q showed much improved physicochem. properties such as water soly. than the control β-lap.  The follow-up studies indicated that I showed a NQO1-expressing cancer-cell-selective killing property.  Preliminary mechanism studies on the anticancer effect indicated that I induced ROS prodn. in an NQO1 dependent manner and activated Akt/MAPK pathways in a ROS-dependent fashion, thereby inducing apoptosis.  In addn., emphasized compd. I showed more significant antitumor efficacy than β-lap without producing obvious toxic effects in vivo, which gave us a new tool for further investigation of NQO1-mediated redox modulators as anticancer drugs for the treatment of NQO1-overexpressed NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHJLGgGWnp6bVg90H21EOLACvtfcHk0lhOIrVN9KlXWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKrs77L&md5=00c0fbd05ce4d28225430439dc820303</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3D2-Substituted%25203%252C7%252C8-trimethylnaphtho%255B1%252C2-b%255Dfuran-4%252C5-diones%2520as%2520specific%2520L-shaped%2520NQO1-mediated%2520redox%2520modulators%2520for%2520the%2520treatment%2520of%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D138%26spage%3D616%26epage%3D629%26doi%3D10.1016%2Fj.ejmech.2017.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of new monocarbonyl ligustrazine-curcumin hybrids for intervention of drug-sensitive and drug-resistant lung cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1747</span>– <span class="NLM_lpage">1760</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01203</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01203" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1747-1760&issue=5&author=Y.+Aiauthor=B.+Zhuauthor=C.+Renauthor=F.+Kangauthor=J.+Liauthor=Z.+Huangauthor=Y.+Laiauthor=S.+Pengauthor=K.+Dingauthor=J.+Tianauthor=Y.+Zhang&title=Discovery+of+new+monocarbonyl+ligustrazine-curcumin+hybrids+for+intervention+of+drug-sensitive+and+drug-resistant+lung+cancer&doi=10.1021%2Facs.jmedchem.5b01203"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01203%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DB.%26aulast%3DRen%26aufirst%3DC.%26aulast%3DKang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520new%2520monocarbonyl%2520ligustrazine-curcumin%2520hybrids%2520for%2520intervention%2520of%2520drug-sensitive%2520and%2520drug-resistant%2520lung%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D5%26spage%3D1747%26epage%3D1760%26doi%3D10.1021%2Facs.jmedchem.5b01203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handley, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span> <span> </span><span class="NLM_article-title">Is resistance useless? Multidrug resistance and collateral sensitivity</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2009.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.tips.2009.07.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=546-556&issue=10&author=M.+D.+Hallauthor=M.+D.+Handleyauthor=M.+M.+Gottesman&title=Is+resistance+useless%3F+Multidrug+resistance+and+collateral+sensitivity&doi=10.1016%2Fj.tips.2009.07.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2009.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2009.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DHandley%26aufirst%3DM.%2BD.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DIs%2520resistance%2520useless%253F%2520Multidrug%2520resistance%2520and%2520collateral%2520sensitivity%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26issue%3D10%26spage%3D546%26epage%3D556%26doi%3D10.1016%2Fj.tips.2009.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dharmaraja, A. T.</span></span> <span> </span><span class="NLM_article-title">Role of reactive oxygen species (ROS) in therapeutics and drug resistance in cancer and bacteria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3221</span>– <span class="NLM_lpage">3240</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01243</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3221-3240&issue=8&author=A.+T.+Dharmaraja&title=Role+of+reactive+oxygen+species+%28ROS%29+in+therapeutics+and+drug+resistance+in+cancer+and+bacteria&doi=10.1021%2Facs.jmedchem.6b01243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria</span></div><div class="casAuthors">Dharmaraja, Allimuthu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3221-3240</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Evading persistent drug resistance in cancer and bacteria to most of the com. used drugs is necessary to restore the human health settings.  A distinct property of cancer phenotype is enhanced glucose metab. and oxidative stress from normal cells.  Reactive oxygen species (ROS) are metabolic byproducts of aerobic respiration and are responsible for maintaining redox homeostasis in cells.  Maintaining the redox balance in cancerous cells are found to be crit. for their survival, which is modulated by reduced thiols and reducing cofactors NAD(P)H.  Thus altering the levels reducing equiv. were found to enhance intracellular ROS and sensitize cancer cells to therapeutics.  Similarly, Escherichia coli and life threatening infectious pathogens such as Staphylococcus aureus and Mycobacterium tuberculosis were found to be more sensitive to modulation of intracellular oxidative environment.  Combination drug strategies were successfully employed in attenuating the effects of drug resistant cancer and bacterial.  Here, a collection of some ROS modulation based cancer and bacterial therapeutics is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoshDBtCrwl5LVg90H21EOLACvtfcHk0lhOIrVN9KlXWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSjsrY%253D&md5=71bfb8f37ab75364fedcb07de262fc2c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01243%26sid%3Dliteratum%253Aachs%26aulast%3DDharmaraja%26aufirst%3DA.%2BT.%26atitle%3DRole%2520of%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%2520in%2520therapeutics%2520and%2520drug%2520resistance%2520in%2520cancer%2520and%2520bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D8%26spage%3D3221%26epage%3D3240%26doi%3D10.1021%2Facs.jmedchem.6b01243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bair, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palchaudhuri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">Chemistry and biology of deoxynyboquinone, a potent inducer of cancer cell death</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5469</span>– <span class="NLM_lpage">5478</span>, <span class="refDoi"> DOI: 10.1021/ja100610m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja100610m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=5469-5478&issue=15&author=J.+S.+Bairauthor=R.+Palchaudhuriauthor=P.+J.+Hergenrother&title=Chemistry+and+biology+of+deoxynyboquinone%2C+a+potent+inducer+of+cancer+cell+death&doi=10.1021%2Fja100610m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja100610m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja100610m%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DJ.%2BS.%26aulast%3DPalchaudhuri%26aufirst%3DR.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DChemistry%2520and%2520biology%2520of%2520deoxynyboquinone%252C%2520a%2520potent%2520inducer%2520of%2520cancer%2520cell%2520death%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26issue%3D15%26spage%3D5469%26epage%3D5478%26doi%3D10.1021%2Fja100610m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cismesia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">Efficient NQO1 substrates are potent and selective anticancer agents</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2173</span>– <span class="NLM_lpage">2183</span>, <span class="refDoi"> DOI: 10.1021/cb4005832</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb4005832" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=2173-2183&issue=10&author=E.+I.+Parkinsonauthor=J.+S.+Bairauthor=M.+Cismesiaauthor=P.+J.+Hergenrother&title=Efficient+NQO1+substrates+are+potent+and+selective+anticancer+agents&doi=10.1021%2Fcb4005832"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcb4005832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb4005832%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DE.%2BI.%26aulast%3DBair%26aufirst%3DJ.%2BS.%26aulast%3DCismesia%26aufirst%3DM.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DEfficient%2520NQO1%2520substrates%2520are%2520potent%2520and%2520selective%2520anticancer%2520agents%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26issue%3D10%26spage%3D2173%26epage%3D2183%26doi%3D10.1021%2Fcb4005832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Nanotechnology-enabled delivery of NQO1 bioactivatable drugs</span>. <i>J. Drug. Target</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">7–8</span>),  <span class="NLM_fpage">672</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.3109/1061186X.2015.1073296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.3109%2F1061186X.2015.1073296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=26453163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWgs7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=672-680&issue=7%E2%80%938&author=X.+Maauthor=Z.+R.+Mooreauthor=G.+Huangauthor=X.+Huangauthor=D.+A.+Boothmanauthor=J.+Gao&title=Nanotechnology-enabled+delivery+of+NQO1+bioactivatable+drugs&doi=10.3109%2F1061186X.2015.1073296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Nanotechnology-enabled delivery of NQO1 bioactivatable drugs</span></div><div class="casAuthors">Ma, Xinpeng; Moore, Zachary R.; Huang, Gang; Huang, Xiumei; Boothman, David A.; Gao, Jinming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">672-680</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1026-7158</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Current cancer chemotherapy lacks specificity and is limited by undesirable toxic side-effects, as well as a high rate of recurrence.  Nanotechnol. has the potential to offer paradigm-shifting solns. to improve the outcome of cancer diagnosis and therapy. β-Lapachone (β-lap) is a novel anticancer agent whose mechanism of action is highly dependent on NAD(P)H:quinone oxidoreductase 1 (NQO1), a phase II detoxifying enzyme overexpressed in solid tumors from a variety of cancer types.  However, the poor water soly. of β-lap limits its clin. potential.  A series of drug formulations were developed for systemic administration in preclin. evaluations.  Encapsulation of β-lap into polymeric micelles showed less side-effects and higher max. tolerated dose (MTD), prolonged blood circulation time and preferential accumulation in tumors with greatly improved safety and antitumor efficacy.  The prodrug strategy of β-lap further decreases the crystn. of β-lap by introducing esterase degradable side chains to the rigid fused ring structure. β-Lap prodrugs considerably increased the stability, drug-loading content and delivery efficiency of nanoparticles.  The optimized formulation of β-lap-dC3 prodrug micelles showed excellent antitumor efficacy in treating orthotopic non-small cell lung tumors that overexpress NQO1, with target validation using pharmacodynamic endpoints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQWALPeBqdHLVg90H21EOLACvtfcHk0lgh94Snu__40A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWgs7%252FJ&md5=29ef8202d9d76ad0c55136da17093ac9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3109%2F1061186X.2015.1073296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F1061186X.2015.1073296%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DMoore%26aufirst%3DZ.%2BR.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DNanotechnology-enabled%2520delivery%2520of%2520NQO1%2520bioactivatable%2520drugs%26jtitle%3DJ.%2520Drug.%2520Target%26date%3D2015%26volume%3D23%26issue%3D7%25E2%2580%25938%26spage%3D672%26epage%3D680%26doi%3D10.3109%2F1061186X.2015.1073296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>200</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2014.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.jconrel.2014.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=25542645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOnu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=2015&pages=201-211&author=X.+Maauthor=X.+Huangauthor=Z.+Mooreauthor=G.+Huangauthor=J.+A.+Kilgoreauthor=Y.+Wangauthor=S.+Hammerauthor=N.+S.+Williamsauthor=D.+A.+Boothmanauthor=J.+Gao&title=Esterase-activatable+%CE%B2-lapachone+prodrug+micelles+for+NQO1-targeted+lung+cancer+therapy&doi=10.1016%2Fj.jconrel.2014.12.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy</span></div><div class="casAuthors">Ma, Xinpeng; Huang, Xiumei; Moore, Zachary; Huang, Gang; Kilgore, Jessica A.; Wang, Yiguang; Hammer, Suntrea; Williams, Noelle S.; Boothman, David A.; Gao, Jinming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">200</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">201-211</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lung cancer is one of the most lethal forms of cancer and current chemotherapeutic strategies lack broad specificity and efficacy.  Recently, β-lapachone (β-lap) was shown to be highly efficacious in killing non-small cell lung cancer (NSCLC) cells regardless of their p53, cell cycle and caspase status.  Pre-clin. and clin. use of β-lap (clin. form, ARQ501 or 761) is hampered by poor pharmacokinetics and toxicity due to hemolytic anemia.  Here, we report the development and preclin. evaluation of β-lap prodrug nanotherapeutics consisting of diester derivs. of β-lap encapsulated in biocompatible and biodegradable poly(ethylene glycol)-b-poly(D,L-lactic acid) (PEG-b-PLA) micelles.  Compared to the parent drug, diester derivs. of β-lap showed higher drug loading densities inside PEG-b-PLA micelles.  After esterase treatment, micelle-delivered β-lap-dC3 and -dC6 prodrugs were converted to β-lap.  Cytotoxicity assays using A549 and H596 lung cancer cells showed that both micelle formulations maintained NAD(P)H:quinone oxidoreductase 1 (NQO1)-dependent cytotoxicity.  However, antitumor efficacy study of β-lap-dC3 micelles against orthotopic A549 NSCLC xenograft-bearing mice showed significantly greater long-term survival over β-lap-dC6 micelles or β-lap-HPβCD complexes.  Improved therapeutic efficacy of β-lap-dC3 micelles correlated with higher area under the concn.-time curves of β-lap in tumors, and enhanced pharmacodynamic endpoints (e.g., PARP1 hyperactivation, γH2AX, and ATP depletion). β-Lap-dC3 prodrug micelles provide a promising strategy for NQO1-targeted therapy of lung cancer with improved safety and antitumor efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO2FerlWGgMLVg90H21EOLACvtfcHk0lgh94Snu__40A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOnu7%252FP&md5=71e06637c89831a56dc76bf94562bac7</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2014.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2014.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DMoore%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DKilgore%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHammer%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DEsterase-activatable%2520%25CE%25B2-lapachone%2520prodrug%2520micelles%2520for%2520NQO1-targeted%2520lung%2520cancer%2520therapy%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2015%26volume%3D200%26spage%3D201%26epage%3D211%26doi%3D10.1016%2Fj.jconrel.2014.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span> <span> </span><span class="NLM_article-title">An NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of tanshinone IIA against non-small cell lung cancer</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">7</span>), <span class="NLM_elocation-id">e42138</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0042138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1371%2Fjournal.pone.0042138" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&issue=7&author=F.+Liuauthor=G.+Yuauthor=G.+Wangauthor=H.+Liuauthor=X.+Wuauthor=Q.+Wangauthor=M.+Liuauthor=K.+Liaoauthor=M.+Wuauthor=X.+Chengauthor=H.+Hao&title=An+NQO1-initiated+and+p53-independent+apoptotic+pathway+determines+the+anti-tumor+effect+of+tanshinone+IIA+against+non-small+cell+lung+cancer&doi=10.1371%2Fjournal.pone.0042138"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0042138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0042138%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLiao%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DHao%26aufirst%3DH.%26atitle%3DAn%2520NQO1-initiated%2520and%2520p53-independent%2520apoptotic%2520pathway%2520determines%2520the%2520anti-tumor%2520effect%2520of%2520tanshinone%2520IIA%2520against%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D7%26doi%3D10.1371%2Fjournal.pone.0042138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of (±)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1244</span>– <span class="NLM_lpage">1248</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.01.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.bmcl.2015.01.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1244-1248&issue=6&author=J.+Bianauthor=L.+Xuauthor=B.+Dengauthor=X.+Qianauthor=J.+Fanauthor=X.+Yangauthor=F.+Liuauthor=X.+Xuauthor=X.+Guoauthor=X.+Liauthor=H.+Sunauthor=Q.+Youauthor=X.+Zhang&title=Synthesis+and+evaluation+of+%28%C2%B1%29-dunnione+and+its+ortho-quinone+analogues+as+substrates+for+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29&doi=10.1016%2Fj.bmcl.2015.01.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.01.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.01.057%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%2528%25C2%25B1%2529-dunnione%2520and%2520its%2520ortho-quinone%2520analogues%2520as%2520substrates%2520for%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D6%26spage%3D1244%26epage%3D1248%26doi%3D10.1016%2Fj.bmcl.2015.01.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sung, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gayam, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diau, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S. P.</span></span> <span> </span><span class="NLM_article-title">Quinone-modified Mn-doped ZnS quantum dots for room-temperature phosphorescence sensing of human cancer cells that overexpress NQO1</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">25961</span>– <span class="NLM_lpage">25969</span>, <span class="refDoi"> DOI: 10.1021/acsami.5b09244</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.5b09244" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=25961-25969&issue=46&author=Y.+M.+Sungauthor=S.+R.+Gayamauthor=P.+Y.+Hsiehauthor=H.+Y.+Hsuauthor=E.+W.+Diauauthor=S.+P.+Wu&title=Quinone-modified+Mn-doped+ZnS+quantum+dots+for+room-temperature+phosphorescence+sensing+of+human+cancer+cells+that+overexpress+NQO1&doi=10.1021%2Facsami.5b09244"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsami.5b09244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.5b09244%26sid%3Dliteratum%253Aachs%26aulast%3DSung%26aufirst%3DY.%2BM.%26aulast%3DGayam%26aufirst%3DS.%2BR.%26aulast%3DHsieh%26aufirst%3DP.%2BY.%26aulast%3DHsu%26aufirst%3DH.%2BY.%26aulast%3DDiau%26aufirst%3DE.%2BW.%26aulast%3DWu%26aufirst%3DS.%2BP.%26atitle%3DQuinone-modified%2520Mn-doped%2520ZnS%2520quantum%2520dots%2520for%2520room-temperature%2520phosphorescence%2520sensing%2520of%2520human%2520cancer%2520cells%2520that%2520overexpress%2520NQO1%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2015%26volume%3D7%26issue%3D46%26spage%3D25961%26epage%3D25969%26doi%3D10.1021%2Facsami.5b09244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">11832</span>– <span class="NLM_lpage">11837</span>, <span class="refDoi"> DOI: 10.1073/pnas.0702176104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1073%2Fpnas.0702176104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=11832-11837&issue=28&author=E.+A.+Beyauthor=M.+S.+Bentleauthor=K.+E.+Reinickeauthor=Y.+Dongauthor=C.+R.+Yangauthor=L.+Girardauthor=J.+D.+Minnaauthor=W.+G.+Bornmannauthor=J.+Gaoauthor=D.+A.+Boothman&title=An+NQO1-+and+PARP-1-mediated+cell+death+pathway+induced+in+non-small-cell+lung+cancer+cells+by+%CE%B2-lapachone&doi=10.1073%2Fpnas.0702176104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0702176104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0702176104%26sid%3Dliteratum%253Aachs%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DBentle%26aufirst%3DM.%2BS.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%2BR.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DAn%2520NQO1-%2520and%2520PARP-1-mediated%2520cell%2520death%2520pathway%2520induced%2520in%2520non-small-cell%2520lung%2520cancer%2520cells%2520by%2520%25CE%25B2-lapachone%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26issue%3D28%26spage%3D11832%26epage%3D11837%26doi%3D10.1073%2Fpnas.0702176104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">Deoxynyboquinones as NQO1-activated cancer therapeutics</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2715</span>– <span class="NLM_lpage">2723</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.5b00365</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.5b00365" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=2715-2723&issue=10&author=E.+I.+Parkinsonauthor=P.+J.+Hergenrother&title=Deoxynyboquinones+as+NQO1-activated+cancer+therapeutics&doi=10.1021%2Facs.accounts.5b00365"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.5b00365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.5b00365%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DE.%2BI.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DDeoxynyboquinones%2520as%2520NQO1-activated%2520cancer%2520therapeutics%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2015%26volume%3D48%26issue%3D10%26spage%3D2715%26epage%3D2723%26doi%3D10.1021%2Facs.accounts.5b00365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holley, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineswala, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maharjan, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebrahimian, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seradj, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocksdale, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammadi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marvin, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerdes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behforouz, M.</span></span> <span> </span><span class="NLM_article-title">Novel lavendamycin analogues as antitumor agents: synthesis, in vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H:quinone oxidoreductase 1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7733</span>– <span class="NLM_lpage">7749</span>, <span class="refDoi"> DOI: 10.1021/jm050758z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050758z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7733-7749&issue=24&author=M.+Hassaniauthor=W.+Caiauthor=D.+C.+Holleyauthor=J.+P.+Lineswalaauthor=B.+R.+Maharjanauthor=G.+R.+Ebrahimianauthor=H.+Seradjauthor=M.+G.+Stocksdaleauthor=F.+Mohammadiauthor=C.+C.+Marvinauthor=J.+M.+Gerdesauthor=H.+D.+Beallauthor=M.+Behforouz&title=Novel+lavendamycin+analogues+as+antitumor+agents%3A+synthesis%2C+in+vitro+cytotoxicity%2C+structure-metabolism%2C+and+computational+molecular+modeling+studies+with+NAD%28P%29H%3Aquinone+oxidoreductase+1&doi=10.1021%2Fjm050758z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm050758z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050758z%26sid%3Dliteratum%253Aachs%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DHolley%26aufirst%3DD.%2BC.%26aulast%3DLineswala%26aufirst%3DJ.%2BP.%26aulast%3DMaharjan%26aufirst%3DB.%2BR.%26aulast%3DEbrahimian%26aufirst%3DG.%2BR.%26aulast%3DSeradj%26aufirst%3DH.%26aulast%3DStocksdale%26aufirst%3DM.%2BG.%26aulast%3DMohammadi%26aufirst%3DF.%26aulast%3DMarvin%26aufirst%3DC.%2BC.%26aulast%3DGerdes%26aufirst%3DJ.%2BM.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DBehforouz%26aufirst%3DM.%26atitle%3DNovel%2520lavendamycin%2520analogues%2520as%2520antitumor%2520agents%253A%2520synthesis%252C%2520in%2520vitro%2520cytotoxicity%252C%2520structure-metabolism%252C%2520and%2520computational%2520molecular%2520modeling%2520studies%2520with%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D24%26spage%3D7733%26epage%3D7749%26doi%3D10.1021%2Fjm050758z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koelsch, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holley, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineswala, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerdes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behforouz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span> <span> </span><span class="NLM_article-title">Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3104</span>– <span class="NLM_lpage">3115</span>, <span class="refDoi"> DOI: 10.1021/jm701066a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701066a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3104-3115&issue=11&author=M.+Hassaniauthor=W.+Caiauthor=K.+H.+Koelschauthor=D.+C.+Holleyauthor=A.+S.+Roseauthor=F.+Olangauthor=J.+P.+Lineswalaauthor=W.+G.+Hollowayauthor=J.+M.+Gerdesauthor=M.+Behforouzauthor=H.+D.+Beall&title=Lavendamycin+antitumor+agents%3A+structure-based+design%2C+synthesis%2C+and+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29+model+validation+with+molecular+docking+and+biological+studies&doi=10.1021%2Fjm701066a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm701066a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701066a%26sid%3Dliteratum%253Aachs%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DKoelsch%26aufirst%3DK.%2BH.%26aulast%3DHolley%26aufirst%3DD.%2BC.%26aulast%3DRose%26aufirst%3DA.%2BS.%26aulast%3DOlang%26aufirst%3DF.%26aulast%3DLineswala%26aufirst%3DJ.%2BP.%26aulast%3DHolloway%26aufirst%3DW.%2BG.%26aulast%3DGerdes%26aufirst%3DJ.%2BM.%26aulast%3DBehforouz%26aufirst%3DM.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26atitle%3DLavendamycin%2520antitumor%2520agents%253A%2520structure-based%2520design%252C%2520synthesis%252C%2520and%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520model%2520validation%2520with%2520molecular%2520docking%2520and%2520biological%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D11%26spage%3D3104%26epage%3D3115%26doi%3D10.1021%2Fjm701066a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newsome, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colucci, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span> <span> </span><span class="NLM_article-title">Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3665</span>– <span class="NLM_lpage">3673</span>, <span class="refDoi"> DOI: 10.1039/b713044a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1039%2Fb713044a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=17971996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1GjurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=3665-3673&author=J.+J.+Newsomeauthor=M.+A.+Colucciauthor=M.+Hassaniauthor=H.+D.+Beallauthor=C.+J.+Moody&title=Benzimidazole-+and+benzothiazole-quinones%3A+excellent+substrates+for+NAD%28P%29H%3Aquinone+oxidoreductase+1&doi=10.1039%2Fb713044a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1</span></div><div class="casAuthors">Newsome, Jeffery J.; Colucci, Marie A.; Hassani, Mary; Beall, Howard D.; Moody, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3665-3673</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of benzimidazole- and benzothiazole-quinones has been synthesized.  The ability of these heterocyclic quinones to act as substrates for recombinant human NAD(P)H:quinone oxidoreductase (NQO1), a two-electron reductase upregulated in tumor cells, was detd.  Overall, the quinones were excellent substrates for NQO1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVt2vO8k19V7Vg90H21EOLACvtfcHk0ljhKvqHUCdIUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1GjurzF&md5=6ff94b0fe217f9ea3ff50dd1db4574ee</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2Fb713044a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb713044a%26sid%3Dliteratum%253Aachs%26aulast%3DNewsome%26aufirst%3DJ.%2BJ.%26aulast%3DColucci%26aufirst%3DM.%2BA.%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DBenzimidazole-%2520and%2520benzothiazole-quinones%253A%2520excellent%2520substrates%2520for%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2007%26volume%3D5%26spage%3D3665%26epage%3D3673%26doi%3D10.1039%2Fb713044a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&issue=7&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0ljhKvqHUCdIUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D7%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sechi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel reactive oxygen species inducers for the treatment of pancreatic ductal adenocarcinoma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1576</span>– <span class="NLM_lpage">1594</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1576-1594&issue=4&author=Y.+Kuangauthor=M.+Sechiauthor=S.+Nurraauthor=M.+Ljungmanauthor=N.+Neamati&title=Design+and+synthesis+of+novel+reactive+oxygen+species+inducers+for+the+treatment+of+pancreatic+ductal+adenocarcinoma&doi=10.1021%2Facs.jmedchem.7b01463"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01463%26sid%3Dliteratum%253Aachs%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DNurra%26aufirst%3DS.%26aulast%3DLjungman%26aufirst%3DM.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520reactive%2520oxygen%2520species%2520inducers%2520for%2520the%2520treatment%2520of%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D4%26spage%3D1576%26epage%3D1594%26doi%3D10.1021%2Facs.jmedchem.7b01463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Novel naphtha[2,1-d]oxazole-4,5-diones as NQO1 substrates with improved aqueous solubility: design, synthesis, and in vivo antitumor evaluation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1006</span>– <span class="NLM_lpage">1013</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.bmc.2016.01.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1006-1013&issue=5&author=X.+Liauthor=J.+Bianauthor=N.+Wangauthor=X.+Qianauthor=J.+Guauthor=T.+Muauthor=J.+Fanauthor=X.+Yangauthor=S.+Liauthor=T.+Yangauthor=H.+Sunauthor=Q.+Youauthor=X.+Zhang&title=Novel+naphtha%5B2%2C1-d%5Doxazole-4%2C5-diones+as+NQO1+substrates+with+improved+aqueous+solubility%3A+design%2C+synthesis%2C+and+in+vivo+antitumor+evaluation&doi=10.1016%2Fj.bmc.2016.01.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DMu%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DNovel%2520naphtha%255B2%252C1-d%255Doxazole-4%252C5-diones%2520as%2520NQO1%2520substrates%2520with%2520improved%2520aqueous%2520solubility%253A%2520design%252C%2520synthesis%252C%2520and%2520in%2520vivo%2520antitumor%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26issue%3D5%26spage%3D1006%26epage%3D1013%26doi%3D10.1016%2Fj.bmc.2016.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fryatt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardipee, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slawin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span> <span> </span><span class="NLM_article-title">Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase 1 (NQO1)</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1667</span>– <span class="NLM_lpage">1687</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.bmc.2004.01.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1667-1687&issue=7&author=T.+Fryattauthor=H.+I.+Petterssonauthor=W.+T.+Gardipeeauthor=K.+C.+Brayauthor=S.+J.+Greenauthor=A.+M.+Slawinauthor=H.+D.+Beallauthor=C.+J.+Moody&title=Novel+quinolinequinone+antitumor+agents%3A+structure-metabolism+studies+with+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29&doi=10.1016%2Fj.bmc.2004.01.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DFryatt%26aufirst%3DT.%26aulast%3DPettersson%26aufirst%3DH.%2BI.%26aulast%3DGardipee%26aufirst%3DW.%2BT.%26aulast%3DBray%26aufirst%3DK.%2BC.%26aulast%3DGreen%26aufirst%3DS.%2BJ.%26aulast%3DSlawin%26aufirst%3DA.%2BM.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DNovel%2520quinolinequinone%2520antitumor%2520agents%253A%2520structure-metabolism%2520studies%2520with%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26issue%3D7%26spage%3D1667%26epage%3D1687%26doi%3D10.1016%2Fj.bmc.2004.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">da
Cruz, E. H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussene, C. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diogo, E. B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Melo, I. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigus, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenca, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camara, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Paiva, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulart, M. O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalcanti, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pessoa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva Junior, E. N.</span></span> <span> </span><span class="NLM_article-title">1,2,3-Triazole-, arylamino- and thio-substituted 1,4-naphthoquinones: potent antitumor activity, electrochemical aspects, and bioisosteric replacement of C-ring-modified lapachones</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1608</span>– <span class="NLM_lpage">1619</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.bmc.2014.01.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1608-1619&issue=5&author=E.+H.+G.+da%0ACruzauthor=C.+M.+B.+Husseneauthor=G.+G.+Diasauthor=E.+B.+T.+Diogoauthor=I.+M.+M.+de+Meloauthor=B.+L.+Rodrigusauthor=M.+G.+da+Silvaauthor=W.+O.+Valencaauthor=C.+A.+Camaraauthor=R.+N.+de+Oliveiraauthor=Y.+G.+de+Paivaauthor=M.+O.+F.+Goulartauthor=B.+C.+Cavalcantiauthor=C.+Pessoaauthor=E.+N.+da+Silva+Junior&title=1%2C2%2C3-Triazole-%2C+arylamino-+and+thio-substituted+1%2C4-naphthoquinones%3A+potent+antitumor+activity%2C+electrochemical+aspects%2C+and+bioisosteric+replacement+of+C-ring-modified+lapachones&doi=10.1016%2Fj.bmc.2014.01.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.01.033%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BCruz%26aufirst%3DE.%2BH.%2BG.%26aulast%3DHussene%26aufirst%3DC.%2BM.%2BB.%26aulast%3DDias%26aufirst%3DG.%2BG.%26aulast%3DDiogo%26aufirst%3DE.%2BB.%2BT.%26aulast%3Dde%2BMelo%26aufirst%3DI.%2BM.%2BM.%26aulast%3DRodrigus%26aufirst%3DB.%2BL.%26aulast%3Dda%2BSilva%26aufirst%3DM.%2BG.%26aulast%3DValenca%26aufirst%3DW.%2BO.%26aulast%3DCamara%26aufirst%3DC.%2BA.%26aulast%3Dde%2BOliveira%26aufirst%3DR.%2BN.%26aulast%3Dde%2BPaiva%26aufirst%3DY.%2BG.%26aulast%3DGoulart%26aufirst%3DM.%2BO.%2BF.%26aulast%3DCavalcanti%26aufirst%3DB.%2BC.%26aulast%3DPessoa%26aufirst%3DC.%26aulast%3Dda%2BSilva%2BJunior%26aufirst%3DE.%2BN.%26atitle%3D1%252C2%252C3-Triazole-%252C%2520arylamino-%2520and%2520thio-substituted%25201%252C4-naphthoquinones%253A%2520potent%2520antitumor%2520activity%252C%2520electrochemical%2520aspects%252C%2520and%2520bioisosteric%2520replacement%2520of%2520C-ring-modified%2520lapachones%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26issue%3D5%26spage%3D1608%26epage%3D1619%26doi%3D10.1016%2Fj.bmc.2014.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profile</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.ejmech.2017.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=28214631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVehu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2017&pages=27-40&author=J.+Bianauthor=X.+Liauthor=N.+Wangauthor=X.+Wuauthor=Q.+Youauthor=X.+Zhang&title=Discovery+of+quinone-directed+antitumor+agents+selectively+bioactivated+by+NQO1+over+CPR+with+improved+safety+profile&doi=10.1016%2Fj.ejmech.2017.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profile</span></div><div class="casAuthors">Bian, Jinlei; Li, Xiang; Wang, Nan; Wu, Xingsen; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-40</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The authors mainly focused on discovering compds. with good selectivity for NQO1 over CPR.  The NQO1-mediated two-electron redn. of compds. would kill cancer cells selectively, while CPR-mediated one-electron redn. would induce potential hepatotoxicity.  Several novel quinone-directed antitumor agents were discovered as specific NQO1 substrates through structure-activity relationship studies.  Among them, compd. 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-dione (12b) emerged as the most specific substrate of the two-electron oxidoreductase NQO1 and could hardly be reduced by CPR.  It afforded the highest selectivity between NQO1/CPR (selectivity ratio = 6.37), much higher than the control β-lapachone (selectivity ratio = 1.36), indicated 12b may possess superior safety profile.  The electrochem. studies provided a reasonable explanation to the good selectivity toward NQO1.  Mol. docking studies supported that 12b was capable of forming addnl. C-H... π interactions with Trp 105 and Phe 178 residues compared to the control β-lap.  In addn., compd. 12b was shown to kill cancer cells efficiently both in vitro and in vivo model.  This work gave the authors a promising and novel scaffold for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqRMIKxcCSGLVg90H21EOLACvtfcHk0lgrBKqz-GeB8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVehu70%253D&md5=18c03007ddfea2f3165662912048ff3b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520quinone-directed%2520antitumor%2520agents%2520selectively%2520bioactivated%2520by%2520NQO1%2520over%2520CPR%2520with%2520improved%2520safety%2520profile%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D129%26spage%3D27%26epage%3D40%26doi%3D10.1016%2Fj.ejmech.2017.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hillard, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Abreu, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaouen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulart, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amatore, C.</span></span> <span> </span><span class="NLM_article-title">Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2612</span>– <span class="NLM_lpage">2628</span>, <span class="refDoi"> DOI: 10.1039/b718116g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1039%2Fb718116g" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=2612-2628&author=E.+A.+Hillardauthor=F.+C.+de+Abreuauthor=D.+C.+Ferreiraauthor=G.+Jaouenauthor=M.+O.+Goulartauthor=C.+Amatore&title=Electrochemical+parameters+and+techniques+in+drug+development%2C+with+an+emphasis+on+quinones+and+related+compounds&doi=10.1039%2Fb718116g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1039%2Fb718116g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb718116g%26sid%3Dliteratum%253Aachs%26aulast%3DHillard%26aufirst%3DE.%2BA.%26aulast%3Dde%2BAbreu%26aufirst%3DF.%2BC.%26aulast%3DFerreira%26aufirst%3DD.%2BC.%26aulast%3DJaouen%26aufirst%3DG.%26aulast%3DGoulart%26aufirst%3DM.%2BO.%26aulast%3DAmatore%26aufirst%3DC.%26atitle%3DElectrochemical%2520parameters%2520and%2520techniques%2520in%2520drug%2520development%252C%2520with%2520an%2520emphasis%2520on%2520quinones%2520and%2520related%2520compounds%26jtitle%3DChem.%2520Commun.%26date%3D2008%26volume%3D23%26spage%3D2612%26epage%3D2628%26doi%3D10.1039%2Fb718116g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudnott, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span> <span> </span><span class="NLM_article-title">Structure-based development of anticancer drugs: complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1016/S0969-2126(01)00636-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2FS0969-2126%2801%2900636-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=659-667&author=M.+Faigauthor=M.+A.+Bianchetauthor=S.+Winskiauthor=R.+Hargreavesauthor=C.+J.+Moodyauthor=A.+R.+Hudnottauthor=D.+Rossauthor=L.+M.+Amzel&title=Structure-based+development+of+anticancer+drugs%3A+complexes+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+with+chemotherapeutic+quinones&doi=10.1016%2FS0969-2126%2801%2900636-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2801%2900636-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252801%252900636-0%26sid%3Dliteratum%253Aachs%26aulast%3DFaig%26aufirst%3DM.%26aulast%3DBianchet%26aufirst%3DM.%2BA.%26aulast%3DWinski%26aufirst%3DS.%26aulast%3DHargreaves%26aufirst%3DR.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DHudnott%26aufirst%3DA.%2BR.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DStructure-based%2520development%2520of%2520anticancer%2520drugs%253A%2520complexes%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520with%2520chemotherapeutic%2520quinones%26jtitle%3DStructure%26date%3D2001%26volume%3D9%26spage%3D659%26epage%3D667%26doi%3D10.1016%2FS0969-2126%2801%2900636-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.ejmech.2014.05.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=56-67&author=J.+Bianauthor=B.+Dengauthor=L.+Xuauthor=X.+Xuauthor=N.+Wangauthor=T.+Huauthor=Z.+Yaoauthor=J.+Duauthor=L.+Yangauthor=Y.+Leiauthor=X.+Liauthor=H.+Sunauthor=X.+Zhangauthor=Q.+You&title=2-Substituted+3-methylnaphtho%5B1%2C2-b%5Dfuran-4%2C5-diones+as+novel+L-shaped+ortho-quinone+substrates+for+NAD%28P%29H%3Aquinone+oxidoreductase+%28NQO1%29&doi=10.1016%2Fj.ejmech.2014.05.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.041%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DYao%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3D2-Substituted%25203-methylnaphtho%255B1%252C2-b%255Dfuran-4%252C5-diones%2520as%2520novel%2520L-shaped%2520ortho-quinone%2520substrates%2520for%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520%2528NQO1%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D82%26spage%3D56%26epage%3D67%26doi%3D10.1016%2Fj.ejmech.2014.05.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doncaster, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunstan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leys, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryce, R. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">7142</span>– <span class="NLM_lpage">7156</span>, <span class="refDoi"> DOI: 10.1021/jm9011609</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9011609" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7142-7156&issue=22&author=K.+A.+Nolanauthor=J.+R.+Doncasterauthor=M.+S.+Dunstanauthor=K.+A.+Scottauthor=A.+D.+Frenkelauthor=D.+Siegelauthor=D.+Rossauthor=J.+Barnesauthor=C.+Levyauthor=D.+Leysauthor=R.+C.+Whiteheadauthor=I.+J.+Stratfordauthor=R.+A.+Bryce&title=Synthesis+and+biological+evaluation+of+coumarin-based+inhibitors+of+NAD%28P%29H%3A+quinone+oxidoreductase-1+%28NQO1%29&doi=10.1021%2Fjm9011609"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm9011609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9011609%26sid%3Dliteratum%253Aachs%26aulast%3DNolan%26aufirst%3DK.%2BA.%26aulast%3DDoncaster%26aufirst%3DJ.%2BR.%26aulast%3DDunstan%26aufirst%3DM.%2BS.%26aulast%3DScott%26aufirst%3DK.%2BA.%26aulast%3DFrenkel%26aufirst%3DA.%2BD.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DBarnes%26aufirst%3DJ.%26aulast%3DLevy%26aufirst%3DC.%26aulast%3DLeys%26aufirst%3DD.%26aulast%3DWhitehead%26aufirst%3DR.%2BC.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DBryce%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520coumarin-based%2520inhibitors%2520of%2520NAD%2528P%2529H%253A%2520quinone%2520oxidoreductase-1%2520%2528NQO1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D22%26spage%3D7142%26epage%3D7156%26doi%3D10.1021%2Fjm9011609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollabaugh, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hettiarachchi, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">Human NAD(P)H:quinone oxidoreductase type I (hNQO1) activation of quinone propionic acid trigger groups</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">40</span>),  <span class="NLM_fpage">8014</span>– <span class="NLM_lpage">8026</span>, <span class="refDoi"> DOI: 10.1021/bi300760u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi300760u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=8014-8026&issue=40&author=M.+F.+Mendozaauthor=N.+M.+Hollabaughauthor=S.+H.+Hettiarachchiauthor=R.+L.+McCarley&title=Human+NAD%28P%29H%3Aquinone+oxidoreductase+type+I+%28hNQO1%29+activation+of+quinone+propionic+acid+trigger+groups&doi=10.1021%2Fbi300760u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fbi300760u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi300760u%26sid%3Dliteratum%253Aachs%26aulast%3DMendoza%26aufirst%3DM.%2BF.%26aulast%3DHollabaugh%26aufirst%3DN.%2BM.%26aulast%3DHettiarachchi%26aufirst%3DS.%2BH.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3DHuman%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520type%2520I%2520%2528hNQO1%2529%2520activation%2520of%2520quinone%2520propionic%2520acid%2520trigger%2520groups%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26issue%3D40%26spage%3D8014%26epage%3D8026%26doi%3D10.1021%2Fbi300760u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fales, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokoloski, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasquez-Vivar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, B.</span></span> <span> </span><span class="NLM_article-title">Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">5727</span>– <span class="NLM_lpage">5732</span>, <span class="refDoi"> DOI: 10.1073/pnas.0501719102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1073%2Fpnas.0501719102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=5727-5732&issue=16&author=H.+Zhaoauthor=J.+Josephauthor=H.+M.+Falesauthor=E.+A.+Sokoloskiauthor=R.+L.+Levineauthor=J.+Vasquez-Vivarauthor=B.+Kalyanaraman&title=Detection+and+characterization+of+the+product+of+hydroethidine+and+intracellular+superoxide+by+HPLC+and+limitations+of+fluorescence&doi=10.1073%2Fpnas.0501719102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0501719102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0501719102%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DJoseph%26aufirst%3DJ.%26aulast%3DFales%26aufirst%3DH.%2BM.%26aulast%3DSokoloski%26aufirst%3DE.%2BA.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DVasquez-Vivar%26aufirst%3DJ.%26aulast%3DKalyanaraman%26aufirst%3DB.%26atitle%3DDetection%2520and%2520characterization%2520of%2520the%2520product%2520of%2520hydroethidine%2520and%2520intracellular%2520superoxide%2520by%2520HPLC%2520and%2520limitations%2520of%2520fluorescence%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26issue%3D16%26spage%3D5727%26epage%3D5732%26doi%3D10.1073%2Fpnas.0501719102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dharmaraja, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrapani, H.</span></span> <span> </span><span class="NLM_article-title">A small molecule for controlled generation of reactive oxygen species (ROS)</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">398</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1021/ol403300a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol403300a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=398-401&issue=2&author=A.+T.+Dharmarajaauthor=H.+Chakrapani&title=A+small+molecule+for+controlled+generation+of+reactive+oxygen+species+%28ROS%29&doi=10.1021%2Fol403300a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fol403300a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol403300a%26sid%3Dliteratum%253Aachs%26aulast%3DDharmaraja%26aufirst%3DA.%2BT.%26aulast%3DChakrapani%26aufirst%3DH.%26atitle%3DA%2520small%2520molecule%2520for%2520controlled%2520generation%2520of%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26issue%3D2%26spage%3D398%26epage%3D401%26doi%3D10.1021%2Fol403300a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bentle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitz, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Calcium-dependent modulation of poly(ADP-ribose) polymerase-1 alters cellular metabolism and DNA repair</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">33684</span>– <span class="NLM_lpage">33696</span>, <span class="refDoi"> DOI: 10.1074/jbc.M603678200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1074%2Fjbc.M603678200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=33684-33696&issue=44&author=M.+S.+Bentleauthor=K.+E.+Reinickeauthor=E.+A.+Beyauthor=D.+R.+Spitzauthor=D.+A.+Boothman&title=Calcium-dependent+modulation+of+poly%28ADP-ribose%29+polymerase-1+alters+cellular+metabolism+and+DNA+repair&doi=10.1074%2Fjbc.M603678200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M603678200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M603678200%26sid%3Dliteratum%253Aachs%26aulast%3DBentle%26aufirst%3DM.%2BS.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DSpitz%26aufirst%3DD.%2BR.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DCalcium-dependent%2520modulation%2520of%2520poly%2528ADP-ribose%2529%2520polymerase-1%2520alters%2520cellular%2520metabolism%2520and%2520DNA%2520repair%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D44%26spage%3D33684%26epage%3D33696%26doi%3D10.1074%2Fjbc.M603678200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Pengfei Wang, Qijie Gong, Jiabao Hu, Xiang Li, <span class="NLM_string-name hlFld-ContribAuthor">Xiaojin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 298-325. <a href="https://doi.org/10.1021/acs.jmedchem.0c01704" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01704%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DReactive%252BOxygen%252BSpecies%252B%252528ROS%252529-Responsive%252BProdrugs%25252C%252BProbes%25252C%252Band%252BTheranostic%252BProdrugs%25253A%252BApplications%252Bin%252Bthe%252BROS-Related%252BDiseases%26aulast%3DWang%26aufirst%3DPengfei%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D28092020%26date%3D23122020%26volume%3D64%26issue%3D1%26spage%3D298%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vladislava V. Matveevskaya, Dmitry I. Pavlov, Taisiya S. Sukhikh, Artem L. Gushchin, Alexander Yu. Ivanov, Tatiana B. Tennikova, Vladimir V. Sharoyko, Sergey V. Baykov, Enrico Benassi, <span class="NLM_string-name hlFld-ContribAuthor">Andrei S. Potapov</span>. </span><span class="cited-content_cbyCitation_article-title">Arene–Ruthenium(II) Complexes Containing 11H-Indeno[1,2-b]quinoxalin-11-one Derivatives and Tryptanthrin-6-oxime: Synthesis, Characterization, Cytotoxicity, and Catalytic Transfer Hydrogenation of Aryl Ketones. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (19)
                                     , 11167-11179. <a href="https://doi.org/10.1021/acsomega.0c01204" title="DOI URL">https://doi.org/10.1021/acsomega.0c01204</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c01204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c01204%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DArene%2525E2%252580%252593Ruthenium%252528II%252529%252BComplexes%252BContaining%252B11H-Indeno%25255B1%25252C2-b%25255Dquinoxalin-11-one%252BDerivatives%252Band%252BTryptanthrin-6-oxime%25253A%252BSynthesis%25252C%252BCharacterization%25252C%252BCytotoxicity%25252C%252Band%252BCatalytic%252BTransfer%252BHydrogenation%252Bof%252BAryl%252BKetones%26aulast%3DMatveevskaya%26aufirst%3DVladislava%2BV.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18032020%26date%3D28042020%26date%3D07052020%26volume%3D5%26issue%3D19%26spage%3D11167%26epage%3D11179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">In-Cheol Sun, Hong Yeol Yoon, Dong-Kwon Lim, <span class="NLM_string-name hlFld-ContribAuthor">Kwangmeyung Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Trends in In Situ Enzyme-Activatable Prodrugs for Targeted Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2020,</strong> <em>31 </em>
                                    (4)
                                     , 1012-1024. <a href="https://doi.org/10.1021/acs.bioconjchem.0c00082" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.0c00082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.0c00082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.0c00082%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DRecent%252BTrends%252Bin%252BIn%252BSitu%252BEnzyme-Activatable%252BProdrugs%252Bfor%252BTargeted%252BCancer%252BTherapy%26aulast%3DSun%26aufirst%3DIn-Cheol%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D13022020%26date%3D07032020%26date%3D19032020%26date%3D12032020%26volume%3D31%26issue%3D4%26spage%3D1012%26epage%3D1024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wen-Juan Yang, Hui-Lin Fang, Jing Sun, <span class="NLM_string-name hlFld-ContribAuthor">Chao-Guo Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of Dispiro-Indenone Scaffolds via Domino Cycloaddition Reactions of α,β-Unsaturated Aldimines with 2-Arylidene-1,3-indenediones and 2,2′-(Arylmethylene)bis(1,3-indenediones). </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (8)
                                     , 13553-13569. <a href="https://doi.org/10.1021/acsomega.9b01960" title="DOI URL">https://doi.org/10.1021/acsomega.9b01960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b01960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b01960%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DConstruction%252Bof%252BDispiro-Indenone%252BScaffolds%252Bvia%252BDomino%252BCycloaddition%252BReactions%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252BAldimines%252Bwith%252B2-Arylidene-1%25252C3-indenediones%252Band%252B2%25252C2%2525E2%252580%2525B2-%252528Arylmethylene%252529bis%2525281%25252C3-indenediones%252529%26aulast%3DYang%26aufirst%3DWen-Juan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D29062019%26date%3D25072019%26date%3D07082019%26volume%3D4%26issue%3D8%26spage%3D13553%26epage%3D13569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qijie  Gong</span>, <span class="hlFld-ContribAuthor ">Fulai  Yang</span>, <span class="hlFld-ContribAuthor ">Jiabao  Hu</span>, <span class="hlFld-ContribAuthor ">Tian  Li</span>, <span class="hlFld-ContribAuthor ">Pengfei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Rational designed highly sensitive NQO1-activated near-infrared fluorescent probe combined with NQO1 substrates in vivo: An innovative strategy for NQO1-overexpressing cancer theranostics. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113707. <a href="https://doi.org/10.1016/j.ejmech.2021.113707" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113707</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113707%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bdesigned%252Bhighly%252Bsensitive%252BNQO1-activated%252Bnear-infrared%252Bfluorescent%252Bprobe%252Bcombined%252Bwith%252BNQO1%252Bsubstrates%252Bin%2525C2%2525A0vivo%25253A%252BAn%252Binnovative%252Bstrategy%252Bfor%252BNQO1-overexpressing%252Bcancer%252Btheranostics%26aulast%3DGong%26aufirst%3DQijie%26date%3D2021%26volume%3D224%26spage%3D113707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qijie  Gong</span>, <span class="hlFld-ContribAuthor ">Quanwei  Yu</span>, <span class="hlFld-ContribAuthor ">Nan  Wang</span>, <span class="hlFld-ContribAuthor ">Jiabao  Hu</span>, <span class="hlFld-ContribAuthor ">Pengfei  Wang</span>, <span class="hlFld-ContribAuthor ">Fulai  Yang</span>, <span class="hlFld-ContribAuthor ">Tian  Li</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Application of cation-π interactions in enzyme-substrate binding: Design, synthesis, biological evaluation, and molecular dynamics insights of novel hydrophilic substrates for NQO1. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113515. <a href="https://doi.org/10.1016/j.ejmech.2021.113515" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113515%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplication%252Bof%252Bcation-%2525CF%252580%252Binteractions%252Bin%252Benzyme-substrate%252Bbinding%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bmolecular%252Bdynamics%252Binsights%252Bof%252Bnovel%252Bhydrophilic%252Bsubstrates%252Bfor%252BNQO1%26aulast%3DGong%26aufirst%3DQijie%26date%3D2021%26volume%3D221%26spage%3D113515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-ying  Gao</span>, <span class="hlFld-ContribAuthor ">Hua  Guo</span>, <span class="hlFld-ContribAuthor ">Gui-zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Yi-qing  Yang</span>, <span class="hlFld-ContribAuthor ">Qian  Hu</span>, <span class="hlFld-ContribAuthor ">Li-jun  Liang</span>, <span class="hlFld-ContribAuthor ">Qun  Zhao</span>, <span class="hlFld-ContribAuthor ">Da-wei  Xie</span>, <span class="hlFld-ContribAuthor ">Yu  Rao</span>, <span class="hlFld-ContribAuthor ">Guang-biao  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2021,</strong> <em>71 </em><a href="https://doi.org/10.1038/s41401-021-00691-8" title="DOI URL">https://doi.org/10.1038/s41401-021-00691-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-021-00691-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-021-00691-8%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DUpregulation%252Bof%252Bwild-type%252Bp53%252Bby%252Bsmall%252Bmolecule-induced%252Belevation%252Bof%252BNQO1%252Bin%252Bnon-small%252Bcell%252Blung%252Bcancer%252Bcells%26aulast%3DYu%26aufirst%3DHong%26date%3D2021%26date%3D2021%26volume%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qijie  Gong</span>, <span class="hlFld-ContribAuthor ">Jiabao  Hu</span>, <span class="hlFld-ContribAuthor ">Pengfei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive review on β-lapachone: Mechanisms, structural modifications, and therapeutic potentials. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112962. <a href="https://doi.org/10.1016/j.ejmech.2020.112962" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112962</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112962%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bcomprehensive%252Breview%252Bon%252B%2525CE%2525B2-lapachone%25253A%252BMechanisms%25252C%252Bstructural%252Bmodifications%25252C%252Band%252Btherapeutic%252Bpotentials%26aulast%3DGong%26aufirst%3DQijie%26date%3D2021%26volume%3D210%26spage%3D112962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mianli  Bian</span>, <span class="hlFld-ContribAuthor ">Ying  Sun</span>, <span class="hlFld-ContribAuthor ">Yuanhao  Liu</span>, <span class="hlFld-ContribAuthor ">Zhongren  Xu</span>, <span class="hlFld-ContribAuthor ">Rong  Fan</span>, <span class="hlFld-ContribAuthor ">Ziwen  Liu</span>, <span class="hlFld-ContribAuthor ">Wukun  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A Gold(I) Complex Containing an Oleanolic Acid Derivative as a Potential Anti‐Ovarian‐Cancer Agent by Inhibiting TrxR and Activating ROS‐Mediated ERS. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (31)
                                     , 7092-7108. <a href="https://doi.org/10.1002/chem.202000045" title="DOI URL">https://doi.org/10.1002/chem.202000045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202000045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202000045%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DA%252BGold%252528I%252529%252BComplex%252BContaining%252Ban%252BOleanolic%252BAcid%252BDerivative%252Bas%252Ba%252BPotential%252BAnti%2525E2%252580%252590Ovarian%2525E2%252580%252590Cancer%252BAgent%252Bby%252BInhibiting%252BTrxR%252Band%252BActivating%252BROS%2525E2%252580%252590Mediated%252BERS%26aulast%3DBian%26aufirst%3DMianli%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D31%26spage%3D7092%26epage%3D7108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunhui  Cheng</span>, <span class="hlFld-ContribAuthor ">Fan  Yun</span>, <span class="hlFld-ContribAuthor ">Sadeeq  Ullah</span>, <span class="hlFld-ContribAuthor ">Qipeng  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel cyclin-dependent kinase (CDK) and histone deacetylase (HDAC) dual inhibitors with potent in vitro and in vivo anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>189 </em>, 112073. <a href="https://doi.org/10.1016/j.ejmech.2020.112073" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112073%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bcyclin-dependent%252Bkinase%252B%252528CDK%252529%252Band%252Bhistone%252Bdeacetylase%252B%252528HDAC%252529%252Bdual%252Binhibitors%252Bwith%252Bpotent%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252Banticancer%252Bactivity%26aulast%3DCheng%26aufirst%3DChunhui%26date%3D2020%26volume%3D189%26spage%3D112073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Redox cycling of quinone substrates for NQO1, and the principle of NADPH-based NQO1 assay for screening new redox cycling NQO1 substrates; (B) representative NQO1-mediated redox cycling quinones as antitumor ROS generators; and (C) structure of hit compound <b>1</b> as nonquinone redox cycling substrate for NQO1 in this work.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) <i>N</i> (cycles), representing the the number of equivalents of NADPH consumed, relative to the number of equivalents of substrates (10 μM) over the course of the NADPH-based NQO1 assay (in 5 min) monitored at 340 nm. (B) The initial reduction rates of nonquinone compound <b>1</b> and β-lap (10 μM) by NQO1. (C) Michaelis–Menten curves for <b>1</b> and β-lap with NQO1. (D) Rate of ROS production of <b>1</b> and β-lap in the presence and absence of the NQO1 inhibitor (DIC, 25 μM) with NQO1. (E) Cell death of NQO1-rich A549 cancer cells with <b>1</b> and β-lap for 72 h by MTT assay. (F) Cell death of NQO1-rich A549/Taxol drug-resistant cancer cells with <b>1</b> and β-lap for 72 h by MTT assay. (G) Cell death of NQO1-deficient L02 normal hepatic cells with <b>1</b> and β-lap for 72 h by MTT assay. (H) The selectivity ratio (SR) toward NQO1-rich A549/Taxol cancer cells over NQO1-deficient L02 normal hepatic cells; SR = IC<sub>50</sub> (L02)/IC<sub>50</sub> (A549/Taxol).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design of the target compounds <b>2</b>–<b>10</b>, focusing on the rings C and D of <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design of the target compounds <b>11</b>–<b>19</b> focusing on the rings B and C of <b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Michaelis–Menten curves for <b>1</b>, <b>10</b>, <b>20i</b>, <b>20k</b>, and β-lap with NQO1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes for the Target Compounds <b>2</b>–<b>8</b>, and <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) AcOH, EtOH, rt, 2 h, 73%–86%; (b) AcOH, EtOH, 40 °C, 4 h, 28%–30%; and (c) AcOH, EtOH, 70 °C, 4 h, 66%.</p></p></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes for the Target Compounds <b>11</b>–<b>19</b>, and <b>20a</b>–<b>20m</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>27</b> (1 equiv), isopropanol, rt, 2 h, 82%; (b) corresponding sodium alkoxides (1 equiv) or amines (1–3 equiv), THF, rt, 2 h, 37%–87%; (c) <i>tert</i>-butyl nitrite (5 equiv), CuCl<sub>2</sub> (5 equiv), CH<sub>3</sub>CN, 65 °C, 4 h, 58%; (d) corresponding alkynes (1.5 equiv), Pd(dppf)<sub>2</sub>Cl<sub>2</sub> (0.1 equiv), CuI (0.1 equiv), Et<sub>3</sub>N (1.1 equiv), CH<sub>3</sub>CN, 80 °C, 3 h, 24%–36%; (e) <b>27</b> (1 equiv), EtOH, rt, 6 h; (f) K<sub>2</sub>Cr<sub>2</sub>O<sub>7</sub> (0.6 equiv), AcOH, H<sub>2</sub>O, 100 °C, 1 h, 42%–66% over two steps. The detailed R groups for <b>20a</b>–<b>20m</b> are shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</p></p></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <i>E</i><sub>redox</sub> values and NQO1 rates for representative target compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Docked poses of (A) compound <b>1</b> and (B) compound <b>20k</b> into the catalytic sites of NQO1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H69">1H69</a>). (C) Proposed redox cycling process for <b>20k</b> by NQO1 reduction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Cytotoxicity of <b>20k</b> toward NQO1-rich A549/Taxol, A549/VCR, MCF-7, and MIA PaCa-2 cancer cells and NQO1-deficient H596 lung cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Cytotoxicity of <b>20k</b> toward A549/Taxol cancer cells in the presence and absence of the NQO1 inhibitor (DIC, 50 μM) and ROS Scavenger (NAC, 10 mM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Rate of ROS production of representative compounds (<b>1</b>, <b>10</b>, and <b>20k</b>), <b>20k</b> + NQO1 inhibitor DIC (25 μM), <b>9</b>, and <b>11</b> were used as negative controls. β-Lap was used as a positive control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) Compound <b>20k</b> generated high levels of ROS in A549/Taxol cancer cells. Fluorescence was detected using a fluorescence microscope. (B) Similar experiments were done in A549 cells using three different ROS probes (DCFH-DA, DHE, APF) with pretreatment with 50 μM DIC or 10 mM NAC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Compound <b>20k</b> induced DNA damage in A549/Taxol cells in a NQO1, ROS-dependent manner. Cells were also exposed to 2 mM H<sub>2</sub>O<sub>2</sub> for 2 h as positive controls. Comet tail lengths of A549/Taxol cells were measured by using ImageJ software (a.u., arbitrary unit).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Compound <b>20k</b> induced PARP-1 hyperactivation causing NQO1-dependent nucleotide depletion. Cells were exposed to 10 μM <b>20k</b>, with or without 50 μM DIC and 10 mM NAC, and harvested at the indicated times. (A) Western blot analyses of PAR formation in A549/Taxol cells exposed to compound <b>20k</b> (10 μM) (left) with or without 50 μM DIC and 10 mM NAC (right) and harvested at the indicated times. (B) Changes of intracellular ATP level (left) and NAD<sup>+</sup> level (right) in the presence and absence of the NQO1 inhibitor (DIC, 50 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Inhibition of PARP-1 hyperactivation delays NQO1-dependent nucleotide pool depletion in A549/Taxol cells after <b>20k</b> treatment. (A) Western blot analyses of PAR formation in A549/Taxol cells exposed to compound <b>20k</b> (10 μM) (left) with or without 25 mM 3-AB and harvested at the indicated times. (B) Changes of intracellular ATP level (left) and NAD<sup>+</sup> level (right) in the presence and absence of the PARP-1 inhibitor (3-AB, 25 mM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Compound <b>20k</b> induced NQO1-dependent apoptosis in A549/Taxol cells. Cells were exposed to 10 μM compound <b>20k</b>, with or without 50 μM DIC and 10 mM NAC, and harvested at the indicated times. (A) FACS analysis showed apoptosis in A549/Taxol cells after treatment of <b>20k</b> for 24 h. (B) Percentage of apoptosis cells after treatment with indicated concentration of <b>20k</b>. (C) <b>20k</b> blocked the generation of PARP cleavage and p53 in A549/Taxol cells in an NQO1- and ROS-dependent manner. The arrows indicate cleaved PARP and P53, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Compound <b>20k</b> suppressed the tumor growth in vivo in A549/Taxol tumor xenografts nude model. A549/Taxol tumor-bearing mice were treated with vehicle and <b>20k</b> (15 mg/kg and 30 mg/kg). Taxol (2 mg/kg) was selected as the reference. (A) Changes in tumor volume of A549/Taxol tumor-bearing mice after treatment for 3 weeks. (B) Tumor weight after treatment. (C) Mice body weight of the treated mice. (D) H&E stained tissue sections from A549/Taxol tumor-bearing mice after treatment. Scale bars = 400 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Evaluation of <b>20k</b>-induced systemic toxicities in vivo. (A) H&E staining of major organs from nude mice after treatment of saline, <b>20k</b> (15 mg/kg and 30 mg/kg) and Taxol (2 mg/kg). (B) Blood biochemistry analysis of the indicators of TP, ALB, GLB, AST, BUN, and LDH in mice. Scale bars = 400 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/medium/jm-2018-014243_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Measurement of ROS and GSH levels in tumor tissues isolated from A549/Taxol tumor-bearing mice: (A) ROS generation and (B) GSH depletion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01424/20181226/images/large/jm-2018-014243_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01424&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i89">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 49 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oser, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederst, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sequist, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span> <span> </span><span class="NLM_article-title">Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">e165</span>– <span class="NLM_lpage">e172</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(14)71180-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2FS1470-2045%2814%2971180-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=25846096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1Gntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=e165-e172&issue=4&author=M.+G.+Oserauthor=M.+J.+Niederstauthor=L.+V.+Sequistauthor=J.+A.+Engelman&title=Transformation+from+non-small-cell+lung+cancer+to+small-cell+lung+cancer%3A+molecular+drivers+and+cells+of+origin&doi=10.1016%2FS1470-2045%2814%2971180-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin</span></div><div class="casAuthors">Oser, Matthew G.; Niederst, Matthew J.; Sequist, Lecia V.; Engelman, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e165-e172</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Lung cancer is the most common cause of cancer deaths worldwide.  The two broad histol. subtypes of lung cancer are small-cell lung cancer (SCLC), which is the cause of 15% of cases, and non-small-cell lung cancer (NSCLC), which accounts for 85% of cases and includes adenocarcinoma, squamous-cell carcinoma, and large-cell carcinoma.  Although NSCLC and SCLC are commonly thought to be different diseases owing to their distinct biol. and genomic abnormalities, the idea that these malignant disorders might share common cells of origin has been gaining support.  This idea has been supported by the unexpected findings that a subset of NSCLCs with mutated EGFR return as SCLC when resistance to EGFR tyrosine kinase inhibitors develops.  Addnl., other case reports have described the coexistence of NSCLC and SCLC, further challenging the commonly accepted view of their distinct lineages.  Here, we summarize the published clin. observations and biol. underlying tumors with combined SCLC and NSCLC histol. and cancers that transform from adenocarcinoma to SCLC.  We also discuss pre-clin. studies pointing to common potential cells of origin, and speculate how the distinct paths of differentiation are detd. by the genomics of each disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxTYO7xdPsabVg90H21EOLACvtfcHk0lgywj8jVcJD0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1Gntbw%253D&md5=9b28f389a12e304fda76a53730136783</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2814%2971180-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252814%252971180-5%26sid%3Dliteratum%253Aachs%26aulast%3DOser%26aufirst%3DM.%2BG.%26aulast%3DNiederst%26aufirst%3DM.%2BJ.%26aulast%3DSequist%26aufirst%3DL.%2BV.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26atitle%3DTransformation%2520from%2520non-small-cell%2520lung%2520cancer%2520to%2520small-cell%2520lung%2520cancer%253A%2520molecular%2520drivers%2520and%2520cells%2520of%2520origin%26jtitle%3DLancet%2520Oncol.%26date%3D2015%26volume%3D16%26issue%3D4%26spage%3De165%26epage%3De172%26doi%3D10.1016%2FS1470-2045%2814%2971180-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span> <span> </span><span class="NLM_article-title">miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">756</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-12-2651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1158%2F0008-5472.CAN-12-2651" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=756-766&issue=2&author=J.+Caiauthor=J.+Wuauthor=H.+Zhangauthor=L.+Fangauthor=Y.+Huangauthor=Y.+Yangauthor=X.+Zhuauthor=R.+Liauthor=M.+Li&title=miR-186+downregulation+correlates+with+poor+survival+in+lung+adenocarcinoma%2C+where+it+interferes+with+cell-cycle+regulation&doi=10.1158%2F0008-5472.CAN-12-2651"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-2651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-2651%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DM.%26atitle%3DmiR-186%2520downregulation%2520correlates%2520with%2520poor%2520survival%2520in%2520lung%2520adenocarcinoma%252C%2520where%2520it%2520interferes%2520with%2520cell-cycle%2520regulation%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26issue%3D2%26spage%3D756%26epage%3D766%26doi%3D10.1158%2F0008-5472.CAN-12-2651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shum, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Soler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span> <span> </span><span class="NLM_article-title">Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">701</span>– <span class="NLM_lpage">716</span>, <span class="refDoi"> DOI: 10.1080/14656566.2017.1316374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1080%2F14656566.2017.1316374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=28388240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtlOgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=701-716&issue=7&author=C.+Hardinauthor=E.+Shumauthor=A.+P.+Singhauthor=R.+Perez-Solerauthor=H.+Cheng&title=Emerging+treatment+using+tubulin+inhibitors+in+advanced+non-small+cell+lung+cancer&doi=10.1080%2F14656566.2017.1316374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer</span></div><div class="casAuthors">Hardin, C.; Shum, E.; Singh, A. P.; Perez-Soler, R.; Cheng, H.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">701-716</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Tubulin inhibitors including taxanes and vinca alkaloids are important components of chemotherapy regimens used in advanced non-small cell lung cancer (NSCLC).  Despite a treatment paradigm shift due to molecularly-targeted therapies and immunotherapy, a majority of patients will receive chemotherapy during their treatment course.  Either used alone or in combination, tubulin inhibitors have demonstrated clin. benefits in different settings of lung cancer management.  This review first discusses FDA-approved tubulin inhibitors for NSCLC, such as paclitaxel, docetaxel, vinorelbine, and nab-paclitaxel.  The article then provides a summary of novel tubulin inhibitors, including cabazitaxel, eribulin, ixabepilone, patupilone, plinabulin, new colchicine analogs and others.  It also discusses new tubulin inhibitor combinations with immunotherapy (PD-1/PD-L1 inhibitors) and molecularly-targeted therapies (e.g. anti-angiogenic agents, mTOR inhibitors, heat shock protein 90 inhibitors, MEK inhibitors, and anti-HER3 agents).  Lastly, emerging data on potential resistance mechanisms and predictive biomarkers for tubulin inhibitors are explored.  Tubulin inhibitors will likely continue to play important roles in NSCLC management due to the advent of novel agents and combinations.  Through further understanding of tumor biol., investigation of drug resistance, and development of predictive biomarkers, we will be better positioned to incorporate microtubule inhibition into patient specific treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK-YrHuRCjlbVg90H21EOLACvtfcHk0lgywj8jVcJD0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtlOgs7g%253D&md5=93b5c6a7083682bb9efd8c274490a8ff</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F14656566.2017.1316374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14656566.2017.1316374%26sid%3Dliteratum%253Aachs%26aulast%3DHardin%26aufirst%3DC.%26aulast%3DShum%26aufirst%3DE.%26aulast%3DSingh%26aufirst%3DA.%2BP.%26aulast%3DPerez-Soler%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DH.%26atitle%3DEmerging%2520treatment%2520using%2520tubulin%2520inhibitors%2520in%2520advanced%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2017%26volume%3D18%26issue%3D7%26spage%3D701%26epage%3D716%26doi%3D10.1080%2F14656566.2017.1316374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gridelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sgambato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casaluce, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adjei, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciardiello, F.</span></span> <span> </span><span class="NLM_article-title">ALK inhibitors in the treatment of advanced NSCLC</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2013.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.ctrv.2013.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=23931927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1elu7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2014&pages=300-306&issue=2&author=C.+Gridelliauthor=S.+Petersauthor=A.+Sgambatoauthor=F.+Casaluceauthor=A.+A.+Adjeiauthor=F.+Ciardiello&title=ALK+inhibitors+in+the+treatment+of+advanced+NSCLC&doi=10.1016%2Fj.ctrv.2013.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">ALK inhibitors in the treatment of advanced NSCLC</span></div><div class="casAuthors">Gridelli, Cesare; Peters, Solange; Sgambato, Assunta; Casaluce, Francesca; Adjei, Alex A.; Ciardiello, Fortunato</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-306</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Pharmacol. agents that target protein products of oncogenes in tumors are playing an increasing clin. role in the treatment of cancer.  Currently, the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) represent the std. of care for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring activating EGFR mutations.  Subsequently other genetic abnormalities with "driver" characteristics - implying transforming and tumor maintenance capabilities have been extensively reported in several small distinct subsets of NSCLC.  Among these rare genetic changes, anaplastic lymphoma kinase (ALK) gene rearrangements, most often consisting in a chromosome 2 inversion leading to a fusion with the echinoderm microtubule-assocd. protein like 4 (EML4) gene, results in the abnormal expression and activation of this tyrosine kinase in the cytoplasm of cancer cells.  This rearrangement occurs in 2-5% of NSCLC, predominantly in young (50 years or younger), never- or former-smokers with adenocarcinoma.  This aberration most commonly occurs a independently of EGFR and KRAS gene mutations.  A fluorescent in situ hybridization assay was approved by the US Food and Drug Administration (FDA) as the std. method for the detection of ALK gene rearrangement in clin. practice and is considered the gold std.  Crizotinib, a first-in-class dual ALK and c-MET inhibitor, has been shown to be particularly effective against ALK pos. NSCLC, showing dramatic and prolonged responses with low toxicity, predominantly restricted to the gastro-intestinal and visual systems, and generally self-limiting or easily managed.  However, resistance to crizotinib inevitably emerges.  The mol. mechanisms of resistance are currently under investigation, as are therapeutic approaches including crizotinib-based combination therapy and novel agents such as Hsp90 inhibitors.  This review aims to present the current knowledge on this fusion gene, the clinic-pathol. profile of ALK rearranged NSCLC, and to review the existing literature on ALK inhibitors, focusing on their role in the treatment of NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdYKLtYrF29bVg90H21EOLACvtfcHk0lg6STzahhW9ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1elu7zF&md5=25ac98f22906223641088f231c3e5702</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2013.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2013.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DGridelli%26aufirst%3DC.%26aulast%3DPeters%26aufirst%3DS.%26aulast%3DSgambato%26aufirst%3DA.%26aulast%3DCasaluce%26aufirst%3DF.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26aulast%3DCiardiello%26aufirst%3DF.%26atitle%3DALK%2520inhibitors%2520in%2520the%2520treatment%2520of%2520advanced%2520NSCLC%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2014%26volume%3D40%26issue%3D2%26spage%3D300%26epage%3D306%26doi%3D10.1016%2Fj.ctrv.2013.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forde, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ettinger, D. S.</span></span> <span> </span><span class="NLM_article-title">Targeted therapy for non-small-cell lung cancer: past, present and future</span>. <i>Expert Rev. Anticancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">758</span>, <span class="refDoi"> DOI: 10.1586/era.13.47</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1586%2Fera.13.47" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=23773106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsFKiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=745-758&issue=6&author=P.+M.+Fordeauthor=D.+S.+Ettinger&title=Targeted+therapy+for+non-small-cell+lung+cancer%3A+past%2C+present+and+future&doi=10.1586%2Fera.13.47"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted therapy for non-small-cell lung cancer: past, present and future</span></div><div class="casAuthors">Forde, Patrick M.; Ettinger, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">745-758</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Therapy for advanced non-small-cell lung cancer has developed significantly with new awareness of histol. subtype as an important factor in guiding treatment and the development of targeted agents for mol. subgroups harboring crit. mutations that spur on cancer growth.  In this comprehensive review, we look back at developments in targeted therapy for advanced non-small-cell lung cancer, reviewing in detail efforts, both successful and in some cases less so, to target EGFR, VEGF and ALK.  This review provides an overview of where the field stands at present and the areas we feel are most likely to provide challenges and potential successes in the next 5 years including immune checkpoint inhibition, epigenetic therapy and driver mutation targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz1_lFCYvFNbVg90H21EOLACvtfcHk0lg6STzahhW9ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsFKiur8%253D&md5=fdd2c66ec4e6d506a28d0f57c6a4d012</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1586%2Fera.13.47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.13.47%26sid%3Dliteratum%253Aachs%26aulast%3DForde%26aufirst%3DP.%2BM.%26aulast%3DEttinger%26aufirst%3DD.%2BS.%26atitle%3DTargeted%2520therapy%2520for%2520non-small-cell%2520lung%2520cancer%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2013%26volume%3D13%26issue%3D6%26spage%3D745%26epage%3D758%26doi%3D10.1586%2Fera.13.47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, M. J.</span></span> <span> </span><span class="NLM_article-title">Pembrolizumab for the treatment of non-small cell lung cancer</span>. <i>Expert Opin. Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1517/14712598.2016.1145652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1517%2F14712598.2016.1145652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=26800463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVGms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=397-406&issue=3&author=S.+H.+Limauthor=J.+M.+Sunauthor=S.+H.+Leeauthor=J.+S.+Ahnauthor=K.+Parkauthor=M.+J.+Ahn&title=Pembrolizumab+for+the+treatment+of+non-small+cell+lung+cancer&doi=10.1517%2F14712598.2016.1145652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pembrolizumab for the treatment of non-small cell lung cancer</span></div><div class="casAuthors">Lim, Sung Hee; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-406</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Immune checkpoint inhibitors targeting programmed death protein 1 (PD-1) receptor and its ligand, PD-L1, have recently led to significant and durable improvements in the clin. outcomes of some types of cancers including lung cancer.  Pembrolizumab was approved by the US FDA for the treatment of advanced or metastatic NSCLC whose disease has progressed after other treatments and with tumors that express PD-L1.  In the phase I KEYNOTE-001 trial, the overall response rate (ORR) was 19.4%, the median progression-free survival (PFS) and overall survival (OS) were 3.7 mo and 12.0 mo for 495 unselected NSCLC patients.  Strong PD-L1 expression (≥ 50%) was assocd. with higher ORR, longer PFS, and longer OS.  The phase II/III randomized KEYNOTE-010 trial demonstrated that pembrolizumab improved OS vs. docetaxel in patients with previously treated NSCLC.  Pembrolizumab, demonstrated durable response and prolonged OS esp. in NSCLC patients with high expression of PD-1, thereby suggests a new treatment paradigm.  However, many issues remain to be explored, including the identification of other robust biomarkers that can accurately predict the immune-responsiveness of tumors.  Along with the identification of predictive biomarkers, further understanding of the tumor microenvironment is necessary to improve treatment outcomes through combinations of immunotherapy or combined with other targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJHo_7xR1oY7Vg90H21EOLACvtfcHk0lg6STzahhW9ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVGms7k%253D&md5=367f54f1013280406d627173644794b9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F14712598.2016.1145652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.2016.1145652%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DS.%2BH.%26aulast%3DSun%26aufirst%3DJ.%2BM.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DAhn%26aufirst%3DJ.%2BS.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DAhn%26aufirst%3DM.%2BJ.%26atitle%3DPembrolizumab%2520for%2520the%2520treatment%2520of%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2016%26volume%3D16%26issue%3D3%26spage%3D397%26epage%3D406%26doi%3D10.1517%2F14712598.2016.1145652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgensztern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, C.</span></span> <span> </span><span class="NLM_article-title">The biology and management of non-small cell lung cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>553</i></span> (<span class="NLM_issue">7689</span>),  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1038/nature25183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1038%2Fnature25183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=29364287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs12itbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=553&publication_year=2018&pages=446-454&issue=7689&author=R.+S.+Herbstauthor=D.+Morgenszternauthor=C.+Boshoff&title=The+biology+and+management+of+non-small+cell+lung+cancer&doi=10.1038%2Fnature25183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The biology and management of non-small cell lung cancer</span></div><div class="casAuthors">Herbst, Roy S.; Morgensztern, Daniel; Boshoff, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">553</span>
        (<span class="NLM_cas:issue">7689</span>),
    <span class="NLM_cas:pages">446-454</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Important advancements in the treatment of non-small cell lung cancer (NSCLC) have been achieved over the past two decades, increasing the understanding of the disease biol. and mechanisms of tumor progression, and advancing early detection and multimodal care.  The use of small mol. tyrosine kinase inhibitors and immunotherapy has led to unprecedented survival benefits in selected patients.  However, the overall cure and survival rates for NSCLC remain low, particularly in metastatic disease.  Therefore, continued research into new drugs and combination therapies is required to expand the clin. benefit to a broader patient population and to improve outcomes in NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4LzsacpsnpLVg90H21EOLACvtfcHk0lg6STzahhW9ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs12itbo%253D&md5=9e7e092850f8707b96b6828e9a0d9585</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature25183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25183%26sid%3Dliteratum%253Aachs%26aulast%3DHerbst%26aufirst%3DR.%2BS.%26aulast%3DMorgensztern%26aufirst%3DD.%26aulast%3DBoshoff%26aufirst%3DC.%26atitle%3DThe%2520biology%2520and%2520management%2520of%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DNature%26date%3D2018%26volume%3D553%26issue%3D7689%26spage%3D446%26epage%3D454%26doi%3D10.1038%2Fnature25183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frantz, S.</span></span> <span> </span><span class="NLM_article-title">Drug approval triggers debate on future direction for cancer treatments</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1038/nrd1972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1038%2Fnrd1972" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=91-98&issue=2&author=S.+Frantz&title=Drug+approval+triggers+debate+on+future+direction+for+cancer+treatments&doi=10.1038%2Fnrd1972"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrd1972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1972%26sid%3Dliteratum%253Aachs%26aulast%3DFrantz%26aufirst%3DS.%26atitle%3DDrug%2520approval%2520triggers%2520debate%2520on%2520future%2520direction%2520for%2520cancer%2520treatments%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26issue%3D2%26spage%3D91%26epage%3D98%26doi%3D10.1038%2Fnrd1972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Melguizo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prados, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caba, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aranega, A.</span></span> <span> </span><span class="NLM_article-title">Modulation of MDR1 and MRP3 gene expression in lung cancer cells after paclitaxel and carboplatin exposure</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">16624</span>– <span class="NLM_lpage">16635</span>, <span class="refDoi"> DOI: 10.3390/ijms131216624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.3390%2Fijms131216624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=23443122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1emtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=16624-16635&issue=12&author=C.+Melguizoauthor=J.+Pradosauthor=R.+Luqueauthor=R.+Ortizauthor=O.+Cabaauthor=P.+J.+Alvarezauthor=B.+Gonzalezauthor=A.+Aranega&title=Modulation+of+MDR1+and+MRP3+gene+expression+in+lung+cancer+cells+after+paclitaxel+and+carboplatin+exposure&doi=10.3390%2Fijms131216624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of MDR1 and MRP3 gene expression in lung cancer cells after paclitaxel and carboplatin exposure</span></div><div class="casAuthors">Melguizo, Consolacion; Prados, Jose; Luque, Raquel; Ortiz, Raul; Caba, Octavio; Alvarez, Pablo J.; Gonzalez, Beatriz; Aranega, Antonia</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16624-16635</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Carboplatin-paclitaxel is a ref. regimen in the treatment of locally advanced or disseminated non-small cell lung cancer (NSCLC).  This paper discusses the multidrug resistance developed with this drug combination, which is one of the major obstacles to successful treatment.  In order to understand and overcome the drug resistance pattern of NSCLC after carboplatin plus paclitaxel exposure, levels of mRNA expression of multidrug resistance 1 (MDR1) and multidrug resistance-assocd. protein 3 (MRP3) were investigated in primary NSCLC cell lines (A-549 and A-427) and a metastasis-derived NSCLC cell line (NODO).  Our results showed that exposure of the three NSCLC lines to plasma concns. of paclitaxel (5 μM) produced an increase in MDR1 expression, while MRP3 showed no alteration in expression.  By contrast, the same cells exposed to carboplatin plasma concns. (30 μM) showed overexpression of MRP3.  In these cells, MDR1 showed no expression changes.  Interestingly, the combination of both paclitaxel and carboplatin caused increased expression of the MDR1 drug resistance gene rather than the individual treatments.  These results suggest that carboplatin and paclitaxel may induce drug resistance mediated by MDR1 and MRP3, which may be enhanced by the simultaneous use of both drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv3NpH6bpWg7Vg90H21EOLACvtfcHk0lj1h_ZmE-L69g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1emtA%253D%253D&md5=3a7ce5acb434fa5a4e2159ac9ae9cb87</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3390%2Fijms131216624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms131216624%26sid%3Dliteratum%253Aachs%26aulast%3DMelguizo%26aufirst%3DC.%26aulast%3DPrados%26aufirst%3DJ.%26aulast%3DLuque%26aufirst%3DR.%26aulast%3DOrtiz%26aufirst%3DR.%26aulast%3DCaba%26aufirst%3DO.%26aulast%3DAlvarez%26aufirst%3DP.%2BJ.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DAranega%26aufirst%3DA.%26atitle%3DModulation%2520of%2520MDR1%2520and%2520MRP3%2520gene%2520expression%2520in%2520lung%2520cancer%2520cells%2520after%2520paclitaxel%2520and%2520carboplatin%2520exposure%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2012%26volume%3D13%26issue%3D12%26spage%3D16624%26epage%3D16635%26doi%3D10.3390%2Fijms131216624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trachootham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span> <span> </span><span class="NLM_article-title">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.1038/nrd2803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1038%2Fnrd2803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=19478820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=579-591&issue=7&author=D.+Trachoothamauthor=J.+Alexandreauthor=P.+Huang&title=Targeting+cancer+cells+by+ROS-mediated+mechanisms%3A+a+radical+therapeutic+approach%3F&doi=10.1038%2Fnrd2803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span></div><div class="casAuthors">Trachootham, Dunyaporn; Alexandre, Jerome; Huang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">579-591</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Increased generation of reactive oxygen species (ROS) and an altered redox status have long been obsd. in cancer cells, and recent studies suggest that this biochem. property of cancer cells can be exploited for therapeutic benefits.  Cancer cells in advanced stage tumors frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially eliminate these cells by pharmacol. ROS insults.  However, the upregulation of antioxidant capacity in adaptation to intrinsic oxidative stress in cancer cells can confer drug resistance.  Abrogation of such drug-resistant mechanisms by redox modulation could have significant therapeutic implications.  We argue that modulating the unique redox regulatory mechanisms of cancer cells might be an effective strategy to eliminate these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgIa2fgBPBrVg90H21EOLACvtfcHk0lj1h_ZmE-L69g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D&md5=d50931b8de8bcab62d376becc768a71c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrd2803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2803%26sid%3Dliteratum%253Aachs%26aulast%3DTrachootham%26aufirst%3DD.%26aulast%3DAlexandre%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DTargeting%2520cancer%2520cells%2520by%2520ROS-mediated%2520mechanisms%253A%2520a%2520radical%2520therapeutic%2520approach%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26issue%3D7%26spage%3D579%26epage%3D591%26doi%3D10.1038%2Fnrd2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W. S.</span></span> <span> </span><span class="NLM_article-title">The signaling mechanism of ROS in tumor progression</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1007/s10555-006-9037-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1007%2Fs10555-006-9037-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=695-705&issue=4&author=W.+S.+Wu&title=The+signaling+mechanism+of+ROS+in+tumor+progression&doi=10.1007%2Fs10555-006-9037-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10555-006-9037-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-006-9037-8%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%2BS.%26atitle%3DThe%2520signaling%2520mechanism%2520of%2520ROS%2520in%2520tumor%2520progression%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2007%26volume%3D25%26issue%3D4%26spage%3D695%26epage%3D705%26doi%3D10.1007%2Fs10555-006-9037-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. F.</span></span> <span> </span><span class="NLM_article-title">Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">19</span>, <span class="refDoi"> DOI: 10.1186/1756-8722-6-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1186%2F1756-8722-6-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=23442817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=19&author=X.+Liauthor=P.+Fangauthor=J.+Maiauthor=E.+T.+Choiauthor=H.+Wangauthor=X.+F.+Yang&title=Targeting+mitochondrial+reactive+oxygen+species+as+novel+therapy+for+inflammatory+diseases+and+cancers&doi=10.1186%2F1756-8722-6-19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</span></div><div class="casAuthors">Li, Xinyuan; Fang, Pu; Mai, Jietang; Choi, Eric T.; Wang, Hong; Yang, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  There are multiple sources of reactive oxygen species (ROS) in the cell.  As a major site of ROS prodn., mitochondria have drawn considerable interest because it was recently discovered that mitochondrial ROS (mtROS) directly stimulate the prodn. of proinflammatory cytokines and pathol. conditions as diverse as malignancies, autoimmune diseases, and cardiovascular diseases all share common phenotype of increased mtROS prodn. above basal levels.  Several excellent reviews on this topic have been published, but ever-changing new discoveries mandated a more up-to-date and comprehensive review on this topic.  Therefore, we update recent understanding of how mitochondria generate and regulate the prodn. of mtROS and the function of mtROS both in physiol. and pathol. conditions.  In addn., we describe newly developed methods to probe or scavenge mtROS and compare these methods in detail.  Thorough understanding of this topic and the application of mtROS-targeting drugs in the research is significant towards development of better therapies to combat inflammatory diseases and inflammatory malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdw7mjnRfUbVg90H21EOLACvtfcHk0liyi4cBwzqtnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D&md5=d041a496a1ede846460023f0cc54885a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-6-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-6-19%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DP.%26aulast%3DMai%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DE.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DX.%2BF.%26atitle%3DTargeting%2520mitochondrial%2520reactive%2520oxygen%2520species%2520as%2520novel%2520therapy%2520for%2520inflammatory%2520diseases%2520and%2520cancers%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2013%26volume%3D6%26spage%3D19%26doi%3D10.1186%2F1756-8722-6-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gorrini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Modulation of oxidative stress as an anticancer strategy</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">931</span>– <span class="NLM_lpage">947</span>, <span class="refDoi"> DOI: 10.1038/nrd4002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1038%2Fnrd4002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=24287781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=931-947&issue=12&author=C.+Gorriniauthor=I.+S.+Harrisauthor=T.+W.+Mak&title=Modulation+of+oxidative+stress+as+an+anticancer+strategy&doi=10.1038%2Fnrd4002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of oxidative stress as an anticancer strategy</span></div><div class="casAuthors">Gorrini, Chiara; Harris, Isaac S.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">931-947</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The regulation of oxidative stress is an important factor in both tumor development and responses to anticancer therapies.  Many signalling pathways that are linked to tumorigenesis can also regulate the metab. of reactive oxygen species (ROS) through direct or indirect mechanisms.  High ROS levels are generally detrimental to cells, and the redox status of cancer cells usually differs from that of normal cells.  Because of metabolic and signalling aberrations, cancer cells exhibit elevated ROS levels.  The observation that this is balanced by an increased antioxidant capacity suggests that high ROS levels may constitute a barrier to tumorigenesis.  However, ROS can also promote tumor formation by inducing DNA mutations and pro-oncogenic signalling pathways.  These contradictory effects have important implications for potential anticancer strategies that aim to modulate levels of ROS.  In this Review, we address the controversial role of ROS in tumor development and in responses to anticancer therapies, and elaborate on the idea that targeting the antioxidant capacity of tumor cells can have a pos. therapeutic impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVKYMoILuOfbVg90H21EOLACvtfcHk0liyi4cBwzqtnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7%252FI&md5=7f135a1b32b1134a88cfa28b35c53de7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd4002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4002%26sid%3Dliteratum%253Aachs%26aulast%3DGorrini%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DI.%2BS.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DModulation%2520of%2520oxidative%2520stress%2520as%2520an%2520anticancer%2520strategy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D12%26spage%3D931%26epage%3D947%26doi%3D10.1038%2Fnrd4002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulesz-Martin, M.</span></span> <span> </span><span class="NLM_article-title">Destructive cycles: the role of genomic instability and adaptation in carcinogenesis</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2044</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgh204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1093%2Fcarcin%2Fbgh204" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=2033-2044&issue=11&author=B.+Schneiderauthor=M.+Kulesz-Martin&title=Destructive+cycles%3A+the+role+of+genomic+instability+and+adaptation+in+carcinogenesis&doi=10.1093%2Fcarcin%2Fbgh204"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgh204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgh204%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DB.%26aulast%3DKulesz-Martin%26aufirst%3DM.%26atitle%3DDestructive%2520cycles%253A%2520the%2520role%2520of%2520genomic%2520instability%2520and%2520adaptation%2520in%2520carcinogenesis%26jtitle%3DCarcinogenesis%26date%3D2004%26volume%3D25%26issue%3D11%26spage%3D2033%26epage%3D2044%26doi%3D10.1093%2Fcarcin%2Fbgh204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelicano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carney, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span> <span> </span><span class="NLM_article-title">ROS stress in cancer cells and therapeutic implications</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/j.drup.2004.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.drup.2004.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=15158766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1Wquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=97-110&issue=2&author=H.+Pelicanoauthor=D.+Carneyauthor=P.+Huang&title=ROS+stress+in+cancer+cells+and+therapeutic+implications&doi=10.1016%2Fj.drup.2004.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">ROS stress in cancer cells and therapeutic implications</span></div><div class="casAuthors">Pelicano, Helene; Carney, Dennis; Huang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-110</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are constantly generated and eliminated in the biol. system, and play important roles in a variety of normal biochem. functions and abnormal pathol. processes.  Growing evidence suggests that cancer cells exhibit increased intrinsic ROS stress, due in part to oncogenic stimulation, increased metabolic activity, and mitochondrial malfunction.  Since the mitochondrial respiratory chain (electron transport complexes) is a major source of ROS generation in the cells, the vulnerability of the mitochondrial DNA to ROS-mediated damage appears to be a mechanism to amplify ROS stress in cancer cells.  The escalated ROS generation in cancer cells serves as an endogenous source of DNA-damaging agents that promote genetic instability and development of drug resistance.  Malfunction of mitochondria also alters cellular apoptotic response to anticancer agents.  Despite the neg. impacts of increased ROS in cancer cells, it is possible to exploit this biochem. feature and develop novel therapeutic strategies to preferentially kill cancer cells through ROS-mediated mechanisms.  This article reviews ROS stress in cancer cells, its underlying mechanisms and relationship with mitochondrial malfunction and alteration in drug sensitivity, and suggests new therapeutic strategies that take advantage of increased ROS in cancer cells to enhance therapeutic activity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom2pkSeKlxObVg90H21EOLACvtfcHk0liyi4cBwzqtnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1Wquro%253D&md5=80f41fc45cd1e43971bb118a238e2196</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2004.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2004.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DPelicano%26aufirst%3DH.%26aulast%3DCarney%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DROS%2520stress%2520in%2520cancer%2520cells%2520and%2520therapeutic%2520implications%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2004%26volume%3D7%26issue%3D2%26spage%3D97%26epage%3D110%26doi%3D10.1016%2Fj.drup.2004.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deavall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, R.</span></span> <span> </span><span class="NLM_article-title">Drug-induced oxidative stress and toxicity</span>. <i>J. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">645460</span>, <span class="refDoi"> DOI: 10.1155/2012/645460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1155%2F2012%2F645460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=22919381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A280%3ADC%252BC38bgvFOitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=645460&author=D.+G.+Deavallauthor=E.+A.+Martinauthor=J.+M.+Hornerauthor=R.+Roberts&title=Drug-induced+oxidative+stress+and+toxicity&doi=10.1155%2F2012%2F645460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced oxidative stress and toxicity</span></div><div class="casAuthors">Deavall Damian G; Martin Elizabeth A; Horner Judith M; Roberts Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">645460</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Reactive oxygen species (ROS) are a byproduct of normal metabolism and have roles in cell signaling and homeostasis.  Species include oxygen radicals and reactive nonradicals.  Mechanisms exist that regulate cellular levels of ROS, as their reactive nature may otherwise cause damage to key cellular components including DNA, protein, and lipid.  When the cellular antioxidant capacity is exceeded, oxidative stress can result.  Pleiotropic deleterious effects of oxidative stress are observed in numerous disease states and are also implicated in a variety of drug-induced toxicities.  In this paper, we examine the nature of ROS-induced damage on key cellular targets of oxidative stress.  We also review evidence implicating ROS in clinically relevant, drug-related side effects including doxorubicin-induced cardiac damage, azidothymidine-induced myopathy, and cisplatin-induced ototoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9oQsBbs737BFwe7cAcrfPfW6udTcc2ea558Ar5PM_07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bgvFOitQ%253D%253D&md5=e245205a37ccaf96754b69039a1e3358</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1155%2F2012%2F645460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F645460%26sid%3Dliteratum%253Aachs%26aulast%3DDeavall%26aufirst%3DD.%2BG.%26aulast%3DMartin%26aufirst%3DE.%2BA.%26aulast%3DHorner%26aufirst%3DJ.%2BM.%26aulast%3DRoberts%26aufirst%3DR.%26atitle%3DDrug-induced%2520oxidative%2520stress%2520and%2520toxicity%26jtitle%3DJ.%2520Toxicol.%26date%3D2012%26volume%3D2012%26spage%3D645460%26doi%3D10.1155%2F2012%2F645460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waris, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahsan, H.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species: role in the development of cancer and various chronic conditions</span>. <i>J. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">14</span>, <span class="refDoi"> DOI: 10.1186/1477-3163-5-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1186%2F1477-3163-5-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=16689993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A280%3ADC%252BD28zmsleisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=14&author=G.+Warisauthor=H.+Ahsan&title=Reactive+oxygen+species%3A+role+in+the+development+of+cancer+and+various+chronic+conditions&doi=10.1186%2F1477-3163-5-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species: role in the development of cancer and various chronic conditions</span></div><div class="casAuthors">Waris Gulam; Ahsan Haseeb</div><div class="citationInfo"><span class="NLM_cas:title">Journal of carcinogenesis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxygen derived species such as superoxide radical, hydrogen peroxide, singlet oxygen and hydroxyl radical are well known to be cytotoxic and have been implicated in the etiology of a wide array of human diseases, including cancer.  Various carcinogens may also partly exert their effect by generating reactive oxygen species (ROS) during their metabolism.  Oxidative damage to cellular DNA can lead to mutations and may, therefore, play an important role in the initiation and progression of multistage carcinogenesis.  The changes in DNA such as base modification, rearrangement of DNA sequence, miscoding of DNA lesion, gene duplication and the activation of oncogenes may be involved in the initiation of various cancers.  Elevated levels of ROS and down regulation of ROS scavengers and antioxidant enzymes are associated with various human diseases including various cancers.  ROS are also implicated in diabetes and neurodegenerative diseases.  ROS influences central cellular processes such as proliferation a, apoptosis, senescence which are implicated in the development of cancer.  Understanding the role of ROS as key mediators in signaling cascades may provide various opportunities for pharmacological intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRC2GZV0iYNvb5oR8RchjrrfW6udTcc2ea558Ar5PM_07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zmsleisA%253D%253D&md5=14e0383e89dfc388283a052d575fbcfd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1186%2F1477-3163-5-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1477-3163-5-14%26sid%3Dliteratum%253Aachs%26aulast%3DWaris%26aufirst%3DG.%26aulast%3DAhsan%26aufirst%3DH.%26atitle%3DReactive%2520oxygen%2520species%253A%2520role%2520in%2520the%2520development%2520of%2520cancer%2520and%2520various%2520chronic%2520conditions%26jtitle%3DJ.%2520Carcinog.%26date%3D2006%26volume%3D5%26spage%3D14%26doi%3D10.1186%2F1477-3163-5-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Current development of ROS-modulating agents as novel antitumor therapy</span>. <i>Curr. Cancer Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.2174/1568009616666160216125833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.2174%2F1568009616666160216125833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=26881931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1eksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=122-136&issue=2&author=N.+Wangauthor=Y.+Wuauthor=J.+Bianauthor=X.+Qianauthor=H.+Linauthor=H.+Sunauthor=Q.+Youauthor=X.+Zhang&title=Current+development+of+ROS-modulating+agents+as+novel+antitumor+therapy&doi=10.2174%2F1568009616666160216125833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Current Development of ROS-Modulating Agents as Novel Antitumor Therapy</span></div><div class="casAuthors">Wang, Nan; Wu, Yue; Bian, Jinlei; Qian, Xue; Lin, Hongzhi; Sun, Haopeng; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">122-136</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Compared to normal cells, usually cancer cells are under higher oxidative stress.  Elevating intracellular levels of reactive oxygen species (ROS) by introducing excessive ROS or inhibiting antioxidant system may enhance selectively of cancer cell killing by ROS-modulating agents through stress sensitization or stress overload.  Meanwhile due to the adaptive response, normal cells may be capable of maintaining redox homeostasis under exogenous ROS.  Here we review ROS-modulating agents in different mechanisms and classify them into groups by various targets for illustrating more clearly.  At last, we discuss their side effects and the potential troubles of developing these agents and argue that might be an effective strategy for further exploring to modulate the unique redox regulatory mechanisms of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGiT3Tj48T9bVg90H21EOLACvtfcHk0li1x-7QXJBzHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1eksbo%253D&md5=02ac2a93c914054fad81a62f98d6214f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1568009616666160216125833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009616666160216125833%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DCurrent%2520development%2520of%2520ROS-modulating%2520agents%2520as%2520novel%2520antitumor%2520therapy%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2017%26volume%3D17%26issue%3D2%26spage%3D122%26epage%3D136%26doi%3D10.2174%2F1568009616666160216125833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raj, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurkar, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolliday, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandinova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span> <span> </span><span class="NLM_article-title">Selective killing of cancer cells by a small molecule targeting the stress response to ROS</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>475</i></span> (<span class="NLM_issue">7355</span>),  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1038/nature10167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1038%2Fnature10167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=21753854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFegt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=231-234&issue=7355&author=L.+Rajauthor=T.+Ideauthor=A.+U.+Gurkarauthor=M.+Foleyauthor=M.+Schenoneauthor=X.+Liauthor=N.+J.+Tollidayauthor=T.+R.+Golubauthor=S.+A.+Carrauthor=A.+F.+Shamjiauthor=A.+M.+Sternauthor=A.+Mandinovaauthor=S.+L.+Schreiberauthor=S.+W.+Lee&title=Selective+killing+of+cancer+cells+by+a+small+molecule+targeting+the+stress+response+to+ROS&doi=10.1038%2Fnature10167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Selective killing of cancer cells by a small molecule targeting the stress response to ROS</span></div><div class="casAuthors">Raj, Lakshmi; Ide, Takao; Gurkar, Aditi U.; Foley, Michael; Schenone, Monica; Li, Xiaoyu; Tolliday, Nicola J.; Golub, Todd R.; Carr, Steven A.; Shamji, Alykhan F.; Stern, Andrew M.; Mandinova, Anna; Schreiber, Stuart L.; Lee, Sam W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7355</span>),
    <span class="NLM_cas:pages">231-234</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Malignant transformation, driven by gain-of-function mutations in oncogenes and loss-of-function mutations in tumor suppressor genes, results in cell deregulation that is frequently assocd. with enhanced cellular stress (for example, oxidative, replicative, metabolic and proteotoxic stress, and DNA damage).  Adaptation to this stress phenotype is required for cancer cells to survive, and consequently cancer cells may become dependent upon non-oncogenes that do not ordinarily perform such a vital function in normal cells.  Thus, targeting these non-oncogene dependencies in the context of a transformed genotype may result in a synthetic lethal interaction and the selective death of cancer cells.  Here we used a cell-based small-mol. screening and quant. proteomics approach that resulted in the unbiased identification of a small mol. that selectively kills cancer cells but not normal cells.  Piperlongumine increases the level of reactive oxygen species (ROS) and apoptotic cell death in both cancer cells and normal cells engineered to have a cancer genotype, irresp. of p53 status, but it has little effect on either rapidly or slowly dividing primary normal cells.  Significant antitumor effects are obsd. in piperlongumine-treated mouse xenograft tumor models, with no apparent toxicity in normal mice.  Moreover, piperlongumine potently inhibits the growth of spontaneously formed malignant breast tumors and their assocd. metastases in mice.  Our results demonstrate the ability of a small mol. to induce apoptosis selectively in cells that have a cancer genotype, by targeting a non-oncogene co-dependency acquired through the expression of the cancer genotype in response to transformation-induced oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm9UKP2p7HU7Vg90H21EOLACvtfcHk0li1x-7QXJBzHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFegt7Y%253D&md5=06fae19f17d3894445399947e5838bc3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnature10167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10167%26sid%3Dliteratum%253Aachs%26aulast%3DRaj%26aufirst%3DL.%26aulast%3DIde%26aufirst%3DT.%26aulast%3DGurkar%26aufirst%3DA.%2BU.%26aulast%3DFoley%26aufirst%3DM.%26aulast%3DSchenone%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DTolliday%26aufirst%3DN.%2BJ.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26aulast%3DStern%26aufirst%3DA.%2BM.%26aulast%3DMandinova%26aufirst%3DA.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DS.%2BW.%26atitle%3DSelective%2520killing%2520of%2520cancer%2520cells%2520by%2520a%2520small%2520molecule%2520targeting%2520the%2520stress%2520response%2520to%2520ROS%26jtitle%3DNature%26date%3D2011%26volume%3D475%26issue%3D7355%26spage%3D231%26epage%3D234%26doi%3D10.1038%2Fnature10167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">2-Substituted 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-diones as specific L-shaped NQO1-mediated redox modulators for the treatment of non-small cell lung cancer</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">629</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.ejmech.2017.06.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=28710963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKrs77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=616-629&author=X.+Zhangauthor=J.+Bianauthor=X.+Liauthor=X.+Wuauthor=Y.+Dongauthor=Q.+You&title=2-Substituted+3%2C7%2C8-trimethylnaphtho%5B1%2C2-b%5Dfuran-4%2C5-diones+as+specific+L-shaped+NQO1-mediated+redox+modulators+for+the+treatment+of+non-small+cell+lung+cancer&doi=10.1016%2Fj.ejmech.2017.06.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">2-Substituted 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-diones as specific L-shaped NQO1-mediated redox modulators for the treatment of non-small cell lung cancer</span></div><div class="casAuthors">Zhang, Xiaojin; Bian, Jinlei; Li, Xiang; Wu, Xingsen; Dong, Yanan; You, Qidong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">616-629</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Based on the scaffold of 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-dione, a series of L-shaped derivs. with substituted side chains at the position of C2 were designed by analyzing the binding mode with NQO1.  The drug-like compd. I (named as DDO-7178) emerged as the most specific substrate of the two-electron oxidoreductase NQO1 and could hardly be reduced by one-electron oxidoreductases CPR (NQO1/CPR = 20.8).  In addn., compd. 6q showed much improved physicochem. properties such as water soly. than the control β-lap.  The follow-up studies indicated that I showed a NQO1-expressing cancer-cell-selective killing property.  Preliminary mechanism studies on the anticancer effect indicated that I induced ROS prodn. in an NQO1 dependent manner and activated Akt/MAPK pathways in a ROS-dependent fashion, thereby inducing apoptosis.  In addn., emphasized compd. I showed more significant antitumor efficacy than β-lap without producing obvious toxic effects in vivo, which gave us a new tool for further investigation of NQO1-mediated redox modulators as anticancer drugs for the treatment of NQO1-overexpressed NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHJLGgGWnp6bVg90H21EOLACvtfcHk0lhSGdcnzgQ3WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKrs77L&md5=00c0fbd05ce4d28225430439dc820303</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3D2-Substituted%25203%252C7%252C8-trimethylnaphtho%255B1%252C2-b%255Dfuran-4%252C5-diones%2520as%2520specific%2520L-shaped%2520NQO1-mediated%2520redox%2520modulators%2520for%2520the%2520treatment%2520of%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D138%26spage%3D616%26epage%3D629%26doi%3D10.1016%2Fj.ejmech.2017.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of new monocarbonyl ligustrazine-curcumin hybrids for intervention of drug-sensitive and drug-resistant lung cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1747</span>– <span class="NLM_lpage">1760</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01203</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01203" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1747-1760&issue=5&author=Y.+Aiauthor=B.+Zhuauthor=C.+Renauthor=F.+Kangauthor=J.+Liauthor=Z.+Huangauthor=Y.+Laiauthor=S.+Pengauthor=K.+Dingauthor=J.+Tianauthor=Y.+Zhang&title=Discovery+of+new+monocarbonyl+ligustrazine-curcumin+hybrids+for+intervention+of+drug-sensitive+and+drug-resistant+lung+cancer&doi=10.1021%2Facs.jmedchem.5b01203"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01203%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DB.%26aulast%3DRen%26aufirst%3DC.%26aulast%3DKang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520new%2520monocarbonyl%2520ligustrazine-curcumin%2520hybrids%2520for%2520intervention%2520of%2520drug-sensitive%2520and%2520drug-resistant%2520lung%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D5%26spage%3D1747%26epage%3D1760%26doi%3D10.1021%2Facs.jmedchem.5b01203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handley, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span> <span> </span><span class="NLM_article-title">Is resistance useless? Multidrug resistance and collateral sensitivity</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2009.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.tips.2009.07.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=546-556&issue=10&author=M.+D.+Hallauthor=M.+D.+Handleyauthor=M.+M.+Gottesman&title=Is+resistance+useless%3F+Multidrug+resistance+and+collateral+sensitivity&doi=10.1016%2Fj.tips.2009.07.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2009.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2009.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DHandley%26aufirst%3DM.%2BD.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DIs%2520resistance%2520useless%253F%2520Multidrug%2520resistance%2520and%2520collateral%2520sensitivity%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26issue%3D10%26spage%3D546%26epage%3D556%26doi%3D10.1016%2Fj.tips.2009.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dharmaraja, A. T.</span></span> <span> </span><span class="NLM_article-title">Role of reactive oxygen species (ROS) in therapeutics and drug resistance in cancer and bacteria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3221</span>– <span class="NLM_lpage">3240</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01243</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3221-3240&issue=8&author=A.+T.+Dharmaraja&title=Role+of+reactive+oxygen+species+%28ROS%29+in+therapeutics+and+drug+resistance+in+cancer+and+bacteria&doi=10.1021%2Facs.jmedchem.6b01243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria</span></div><div class="casAuthors">Dharmaraja, Allimuthu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3221-3240</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Evading persistent drug resistance in cancer and bacteria to most of the com. used drugs is necessary to restore the human health settings.  A distinct property of cancer phenotype is enhanced glucose metab. and oxidative stress from normal cells.  Reactive oxygen species (ROS) are metabolic byproducts of aerobic respiration and are responsible for maintaining redox homeostasis in cells.  Maintaining the redox balance in cancerous cells are found to be crit. for their survival, which is modulated by reduced thiols and reducing cofactors NAD(P)H.  Thus altering the levels reducing equiv. were found to enhance intracellular ROS and sensitize cancer cells to therapeutics.  Similarly, Escherichia coli and life threatening infectious pathogens such as Staphylococcus aureus and Mycobacterium tuberculosis were found to be more sensitive to modulation of intracellular oxidative environment.  Combination drug strategies were successfully employed in attenuating the effects of drug resistant cancer and bacterial.  Here, a collection of some ROS modulation based cancer and bacterial therapeutics is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoshDBtCrwl5LVg90H21EOLACvtfcHk0ljznt7Jdw0aEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSjsrY%253D&md5=71bfb8f37ab75364fedcb07de262fc2c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01243%26sid%3Dliteratum%253Aachs%26aulast%3DDharmaraja%26aufirst%3DA.%2BT.%26atitle%3DRole%2520of%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%2520in%2520therapeutics%2520and%2520drug%2520resistance%2520in%2520cancer%2520and%2520bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D8%26spage%3D3221%26epage%3D3240%26doi%3D10.1021%2Facs.jmedchem.6b01243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bair, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palchaudhuri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">Chemistry and biology of deoxynyboquinone, a potent inducer of cancer cell death</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5469</span>– <span class="NLM_lpage">5478</span>, <span class="refDoi"> DOI: 10.1021/ja100610m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja100610m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=5469-5478&issue=15&author=J.+S.+Bairauthor=R.+Palchaudhuriauthor=P.+J.+Hergenrother&title=Chemistry+and+biology+of+deoxynyboquinone%2C+a+potent+inducer+of+cancer+cell+death&doi=10.1021%2Fja100610m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja100610m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja100610m%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DJ.%2BS.%26aulast%3DPalchaudhuri%26aufirst%3DR.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DChemistry%2520and%2520biology%2520of%2520deoxynyboquinone%252C%2520a%2520potent%2520inducer%2520of%2520cancer%2520cell%2520death%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26issue%3D15%26spage%3D5469%26epage%3D5478%26doi%3D10.1021%2Fja100610m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cismesia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">Efficient NQO1 substrates are potent and selective anticancer agents</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2173</span>– <span class="NLM_lpage">2183</span>, <span class="refDoi"> DOI: 10.1021/cb4005832</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb4005832" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=2173-2183&issue=10&author=E.+I.+Parkinsonauthor=J.+S.+Bairauthor=M.+Cismesiaauthor=P.+J.+Hergenrother&title=Efficient+NQO1+substrates+are+potent+and+selective+anticancer+agents&doi=10.1021%2Fcb4005832"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcb4005832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb4005832%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DE.%2BI.%26aulast%3DBair%26aufirst%3DJ.%2BS.%26aulast%3DCismesia%26aufirst%3DM.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DEfficient%2520NQO1%2520substrates%2520are%2520potent%2520and%2520selective%2520anticancer%2520agents%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26issue%3D10%26spage%3D2173%26epage%3D2183%26doi%3D10.1021%2Fcb4005832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Nanotechnology-enabled delivery of NQO1 bioactivatable drugs</span>. <i>J. Drug. Target</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">7–8</span>),  <span class="NLM_fpage">672</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.3109/1061186X.2015.1073296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.3109%2F1061186X.2015.1073296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=26453163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWgs7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=672-680&issue=7%E2%80%938&author=X.+Maauthor=Z.+R.+Mooreauthor=G.+Huangauthor=X.+Huangauthor=D.+A.+Boothmanauthor=J.+Gao&title=Nanotechnology-enabled+delivery+of+NQO1+bioactivatable+drugs&doi=10.3109%2F1061186X.2015.1073296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Nanotechnology-enabled delivery of NQO1 bioactivatable drugs</span></div><div class="casAuthors">Ma, Xinpeng; Moore, Zachary R.; Huang, Gang; Huang, Xiumei; Boothman, David A.; Gao, Jinming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">672-680</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1026-7158</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Current cancer chemotherapy lacks specificity and is limited by undesirable toxic side-effects, as well as a high rate of recurrence.  Nanotechnol. has the potential to offer paradigm-shifting solns. to improve the outcome of cancer diagnosis and therapy. β-Lapachone (β-lap) is a novel anticancer agent whose mechanism of action is highly dependent on NAD(P)H:quinone oxidoreductase 1 (NQO1), a phase II detoxifying enzyme overexpressed in solid tumors from a variety of cancer types.  However, the poor water soly. of β-lap limits its clin. potential.  A series of drug formulations were developed for systemic administration in preclin. evaluations.  Encapsulation of β-lap into polymeric micelles showed less side-effects and higher max. tolerated dose (MTD), prolonged blood circulation time and preferential accumulation in tumors with greatly improved safety and antitumor efficacy.  The prodrug strategy of β-lap further decreases the crystn. of β-lap by introducing esterase degradable side chains to the rigid fused ring structure. β-Lap prodrugs considerably increased the stability, drug-loading content and delivery efficiency of nanoparticles.  The optimized formulation of β-lap-dC3 prodrug micelles showed excellent antitumor efficacy in treating orthotopic non-small cell lung tumors that overexpress NQO1, with target validation using pharmacodynamic endpoints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQWALPeBqdHLVg90H21EOLACvtfcHk0ljznt7Jdw0aEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWgs7%252FJ&md5=29ef8202d9d76ad0c55136da17093ac9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3109%2F1061186X.2015.1073296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F1061186X.2015.1073296%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DMoore%26aufirst%3DZ.%2BR.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DNanotechnology-enabled%2520delivery%2520of%2520NQO1%2520bioactivatable%2520drugs%26jtitle%3DJ.%2520Drug.%2520Target%26date%3D2015%26volume%3D23%26issue%3D7%25E2%2580%25938%26spage%3D672%26epage%3D680%26doi%3D10.3109%2F1061186X.2015.1073296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>200</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2014.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.jconrel.2014.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=25542645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOnu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=2015&pages=201-211&author=X.+Maauthor=X.+Huangauthor=Z.+Mooreauthor=G.+Huangauthor=J.+A.+Kilgoreauthor=Y.+Wangauthor=S.+Hammerauthor=N.+S.+Williamsauthor=D.+A.+Boothmanauthor=J.+Gao&title=Esterase-activatable+%CE%B2-lapachone+prodrug+micelles+for+NQO1-targeted+lung+cancer+therapy&doi=10.1016%2Fj.jconrel.2014.12.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy</span></div><div class="casAuthors">Ma, Xinpeng; Huang, Xiumei; Moore, Zachary; Huang, Gang; Kilgore, Jessica A.; Wang, Yiguang; Hammer, Suntrea; Williams, Noelle S.; Boothman, David A.; Gao, Jinming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">200</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">201-211</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lung cancer is one of the most lethal forms of cancer and current chemotherapeutic strategies lack broad specificity and efficacy.  Recently, β-lapachone (β-lap) was shown to be highly efficacious in killing non-small cell lung cancer (NSCLC) cells regardless of their p53, cell cycle and caspase status.  Pre-clin. and clin. use of β-lap (clin. form, ARQ501 or 761) is hampered by poor pharmacokinetics and toxicity due to hemolytic anemia.  Here, we report the development and preclin. evaluation of β-lap prodrug nanotherapeutics consisting of diester derivs. of β-lap encapsulated in biocompatible and biodegradable poly(ethylene glycol)-b-poly(D,L-lactic acid) (PEG-b-PLA) micelles.  Compared to the parent drug, diester derivs. of β-lap showed higher drug loading densities inside PEG-b-PLA micelles.  After esterase treatment, micelle-delivered β-lap-dC3 and -dC6 prodrugs were converted to β-lap.  Cytotoxicity assays using A549 and H596 lung cancer cells showed that both micelle formulations maintained NAD(P)H:quinone oxidoreductase 1 (NQO1)-dependent cytotoxicity.  However, antitumor efficacy study of β-lap-dC3 micelles against orthotopic A549 NSCLC xenograft-bearing mice showed significantly greater long-term survival over β-lap-dC6 micelles or β-lap-HPβCD complexes.  Improved therapeutic efficacy of β-lap-dC3 micelles correlated with higher area under the concn.-time curves of β-lap in tumors, and enhanced pharmacodynamic endpoints (e.g., PARP1 hyperactivation, γH2AX, and ATP depletion). β-Lap-dC3 prodrug micelles provide a promising strategy for NQO1-targeted therapy of lung cancer with improved safety and antitumor efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO2FerlWGgMLVg90H21EOLACvtfcHk0lijh-q5uPHn6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOnu7%252FP&md5=71e06637c89831a56dc76bf94562bac7</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2014.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2014.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DMoore%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DKilgore%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHammer%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DEsterase-activatable%2520%25CE%25B2-lapachone%2520prodrug%2520micelles%2520for%2520NQO1-targeted%2520lung%2520cancer%2520therapy%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2015%26volume%3D200%26spage%3D201%26epage%3D211%26doi%3D10.1016%2Fj.jconrel.2014.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span> <span> </span><span class="NLM_article-title">An NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of tanshinone IIA against non-small cell lung cancer</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">7</span>), <span class="NLM_elocation-id">e42138</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0042138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1371%2Fjournal.pone.0042138" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&issue=7&author=F.+Liuauthor=G.+Yuauthor=G.+Wangauthor=H.+Liuauthor=X.+Wuauthor=Q.+Wangauthor=M.+Liuauthor=K.+Liaoauthor=M.+Wuauthor=X.+Chengauthor=H.+Hao&title=An+NQO1-initiated+and+p53-independent+apoptotic+pathway+determines+the+anti-tumor+effect+of+tanshinone+IIA+against+non-small+cell+lung+cancer&doi=10.1371%2Fjournal.pone.0042138"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0042138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0042138%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLiao%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DHao%26aufirst%3DH.%26atitle%3DAn%2520NQO1-initiated%2520and%2520p53-independent%2520apoptotic%2520pathway%2520determines%2520the%2520anti-tumor%2520effect%2520of%2520tanshinone%2520IIA%2520against%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D7%26doi%3D10.1371%2Fjournal.pone.0042138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of (±)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1244</span>– <span class="NLM_lpage">1248</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.01.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.bmcl.2015.01.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1244-1248&issue=6&author=J.+Bianauthor=L.+Xuauthor=B.+Dengauthor=X.+Qianauthor=J.+Fanauthor=X.+Yangauthor=F.+Liuauthor=X.+Xuauthor=X.+Guoauthor=X.+Liauthor=H.+Sunauthor=Q.+Youauthor=X.+Zhang&title=Synthesis+and+evaluation+of+%28%C2%B1%29-dunnione+and+its+ortho-quinone+analogues+as+substrates+for+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29&doi=10.1016%2Fj.bmcl.2015.01.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.01.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.01.057%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%2528%25C2%25B1%2529-dunnione%2520and%2520its%2520ortho-quinone%2520analogues%2520as%2520substrates%2520for%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D6%26spage%3D1244%26epage%3D1248%26doi%3D10.1016%2Fj.bmcl.2015.01.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sung, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gayam, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diau, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S. P.</span></span> <span> </span><span class="NLM_article-title">Quinone-modified Mn-doped ZnS quantum dots for room-temperature phosphorescence sensing of human cancer cells that overexpress NQO1</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">25961</span>– <span class="NLM_lpage">25969</span>, <span class="refDoi"> DOI: 10.1021/acsami.5b09244</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.5b09244" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=25961-25969&issue=46&author=Y.+M.+Sungauthor=S.+R.+Gayamauthor=P.+Y.+Hsiehauthor=H.+Y.+Hsuauthor=E.+W.+Diauauthor=S.+P.+Wu&title=Quinone-modified+Mn-doped+ZnS+quantum+dots+for+room-temperature+phosphorescence+sensing+of+human+cancer+cells+that+overexpress+NQO1&doi=10.1021%2Facsami.5b09244"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsami.5b09244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.5b09244%26sid%3Dliteratum%253Aachs%26aulast%3DSung%26aufirst%3DY.%2BM.%26aulast%3DGayam%26aufirst%3DS.%2BR.%26aulast%3DHsieh%26aufirst%3DP.%2BY.%26aulast%3DHsu%26aufirst%3DH.%2BY.%26aulast%3DDiau%26aufirst%3DE.%2BW.%26aulast%3DWu%26aufirst%3DS.%2BP.%26atitle%3DQuinone-modified%2520Mn-doped%2520ZnS%2520quantum%2520dots%2520for%2520room-temperature%2520phosphorescence%2520sensing%2520of%2520human%2520cancer%2520cells%2520that%2520overexpress%2520NQO1%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2015%26volume%3D7%26issue%3D46%26spage%3D25961%26epage%3D25969%26doi%3D10.1021%2Facsami.5b09244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">11832</span>– <span class="NLM_lpage">11837</span>, <span class="refDoi"> DOI: 10.1073/pnas.0702176104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1073%2Fpnas.0702176104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=11832-11837&issue=28&author=E.+A.+Beyauthor=M.+S.+Bentleauthor=K.+E.+Reinickeauthor=Y.+Dongauthor=C.+R.+Yangauthor=L.+Girardauthor=J.+D.+Minnaauthor=W.+G.+Bornmannauthor=J.+Gaoauthor=D.+A.+Boothman&title=An+NQO1-+and+PARP-1-mediated+cell+death+pathway+induced+in+non-small-cell+lung+cancer+cells+by+%CE%B2-lapachone&doi=10.1073%2Fpnas.0702176104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0702176104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0702176104%26sid%3Dliteratum%253Aachs%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DBentle%26aufirst%3DM.%2BS.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%2BR.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DAn%2520NQO1-%2520and%2520PARP-1-mediated%2520cell%2520death%2520pathway%2520induced%2520in%2520non-small-cell%2520lung%2520cancer%2520cells%2520by%2520%25CE%25B2-lapachone%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26issue%3D28%26spage%3D11832%26epage%3D11837%26doi%3D10.1073%2Fpnas.0702176104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">Deoxynyboquinones as NQO1-activated cancer therapeutics</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2715</span>– <span class="NLM_lpage">2723</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.5b00365</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.5b00365" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=2715-2723&issue=10&author=E.+I.+Parkinsonauthor=P.+J.+Hergenrother&title=Deoxynyboquinones+as+NQO1-activated+cancer+therapeutics&doi=10.1021%2Facs.accounts.5b00365"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.5b00365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.5b00365%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DE.%2BI.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DDeoxynyboquinones%2520as%2520NQO1-activated%2520cancer%2520therapeutics%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2015%26volume%3D48%26issue%3D10%26spage%3D2715%26epage%3D2723%26doi%3D10.1021%2Facs.accounts.5b00365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holley, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineswala, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maharjan, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebrahimian, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seradj, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocksdale, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammadi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marvin, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerdes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behforouz, M.</span></span> <span> </span><span class="NLM_article-title">Novel lavendamycin analogues as antitumor agents: synthesis, in vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H:quinone oxidoreductase 1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7733</span>– <span class="NLM_lpage">7749</span>, <span class="refDoi"> DOI: 10.1021/jm050758z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050758z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7733-7749&issue=24&author=M.+Hassaniauthor=W.+Caiauthor=D.+C.+Holleyauthor=J.+P.+Lineswalaauthor=B.+R.+Maharjanauthor=G.+R.+Ebrahimianauthor=H.+Seradjauthor=M.+G.+Stocksdaleauthor=F.+Mohammadiauthor=C.+C.+Marvinauthor=J.+M.+Gerdesauthor=H.+D.+Beallauthor=M.+Behforouz&title=Novel+lavendamycin+analogues+as+antitumor+agents%3A+synthesis%2C+in+vitro+cytotoxicity%2C+structure-metabolism%2C+and+computational+molecular+modeling+studies+with+NAD%28P%29H%3Aquinone+oxidoreductase+1&doi=10.1021%2Fjm050758z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm050758z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050758z%26sid%3Dliteratum%253Aachs%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DHolley%26aufirst%3DD.%2BC.%26aulast%3DLineswala%26aufirst%3DJ.%2BP.%26aulast%3DMaharjan%26aufirst%3DB.%2BR.%26aulast%3DEbrahimian%26aufirst%3DG.%2BR.%26aulast%3DSeradj%26aufirst%3DH.%26aulast%3DStocksdale%26aufirst%3DM.%2BG.%26aulast%3DMohammadi%26aufirst%3DF.%26aulast%3DMarvin%26aufirst%3DC.%2BC.%26aulast%3DGerdes%26aufirst%3DJ.%2BM.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DBehforouz%26aufirst%3DM.%26atitle%3DNovel%2520lavendamycin%2520analogues%2520as%2520antitumor%2520agents%253A%2520synthesis%252C%2520in%2520vitro%2520cytotoxicity%252C%2520structure-metabolism%252C%2520and%2520computational%2520molecular%2520modeling%2520studies%2520with%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D24%26spage%3D7733%26epage%3D7749%26doi%3D10.1021%2Fjm050758z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koelsch, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holley, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineswala, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerdes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behforouz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span> <span> </span><span class="NLM_article-title">Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3104</span>– <span class="NLM_lpage">3115</span>, <span class="refDoi"> DOI: 10.1021/jm701066a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701066a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3104-3115&issue=11&author=M.+Hassaniauthor=W.+Caiauthor=K.+H.+Koelschauthor=D.+C.+Holleyauthor=A.+S.+Roseauthor=F.+Olangauthor=J.+P.+Lineswalaauthor=W.+G.+Hollowayauthor=J.+M.+Gerdesauthor=M.+Behforouzauthor=H.+D.+Beall&title=Lavendamycin+antitumor+agents%3A+structure-based+design%2C+synthesis%2C+and+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29+model+validation+with+molecular+docking+and+biological+studies&doi=10.1021%2Fjm701066a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm701066a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701066a%26sid%3Dliteratum%253Aachs%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DKoelsch%26aufirst%3DK.%2BH.%26aulast%3DHolley%26aufirst%3DD.%2BC.%26aulast%3DRose%26aufirst%3DA.%2BS.%26aulast%3DOlang%26aufirst%3DF.%26aulast%3DLineswala%26aufirst%3DJ.%2BP.%26aulast%3DHolloway%26aufirst%3DW.%2BG.%26aulast%3DGerdes%26aufirst%3DJ.%2BM.%26aulast%3DBehforouz%26aufirst%3DM.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26atitle%3DLavendamycin%2520antitumor%2520agents%253A%2520structure-based%2520design%252C%2520synthesis%252C%2520and%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520model%2520validation%2520with%2520molecular%2520docking%2520and%2520biological%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D11%26spage%3D3104%26epage%3D3115%26doi%3D10.1021%2Fjm701066a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newsome, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colucci, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span> <span> </span><span class="NLM_article-title">Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3665</span>– <span class="NLM_lpage">3673</span>, <span class="refDoi"> DOI: 10.1039/b713044a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1039%2Fb713044a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=17971996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1GjurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=3665-3673&author=J.+J.+Newsomeauthor=M.+A.+Colucciauthor=M.+Hassaniauthor=H.+D.+Beallauthor=C.+J.+Moody&title=Benzimidazole-+and+benzothiazole-quinones%3A+excellent+substrates+for+NAD%28P%29H%3Aquinone+oxidoreductase+1&doi=10.1039%2Fb713044a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1</span></div><div class="casAuthors">Newsome, Jeffery J.; Colucci, Marie A.; Hassani, Mary; Beall, Howard D.; Moody, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3665-3673</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of benzimidazole- and benzothiazole-quinones has been synthesized.  The ability of these heterocyclic quinones to act as substrates for recombinant human NAD(P)H:quinone oxidoreductase (NQO1), a two-electron reductase upregulated in tumor cells, was detd.  Overall, the quinones were excellent substrates for NQO1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVt2vO8k19V7Vg90H21EOLACvtfcHk0lgxwr1bNj5hMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1GjurzF&md5=6ff94b0fe217f9ea3ff50dd1db4574ee</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2Fb713044a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb713044a%26sid%3Dliteratum%253Aachs%26aulast%3DNewsome%26aufirst%3DJ.%2BJ.%26aulast%3DColucci%26aufirst%3DM.%2BA.%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DBenzimidazole-%2520and%2520benzothiazole-quinones%253A%2520excellent%2520substrates%2520for%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2007%26volume%3D5%26spage%3D3665%26epage%3D3673%26doi%3D10.1039%2Fb713044a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&issue=7&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lhfD47moOjgnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D7%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sechi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel reactive oxygen species inducers for the treatment of pancreatic ductal adenocarcinoma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1576</span>– <span class="NLM_lpage">1594</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1576-1594&issue=4&author=Y.+Kuangauthor=M.+Sechiauthor=S.+Nurraauthor=M.+Ljungmanauthor=N.+Neamati&title=Design+and+synthesis+of+novel+reactive+oxygen+species+inducers+for+the+treatment+of+pancreatic+ductal+adenocarcinoma&doi=10.1021%2Facs.jmedchem.7b01463"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01463%26sid%3Dliteratum%253Aachs%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DNurra%26aufirst%3DS.%26aulast%3DLjungman%26aufirst%3DM.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520reactive%2520oxygen%2520species%2520inducers%2520for%2520the%2520treatment%2520of%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D4%26spage%3D1576%26epage%3D1594%26doi%3D10.1021%2Facs.jmedchem.7b01463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Novel naphtha[2,1-d]oxazole-4,5-diones as NQO1 substrates with improved aqueous solubility: design, synthesis, and in vivo antitumor evaluation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1006</span>– <span class="NLM_lpage">1013</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.bmc.2016.01.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1006-1013&issue=5&author=X.+Liauthor=J.+Bianauthor=N.+Wangauthor=X.+Qianauthor=J.+Guauthor=T.+Muauthor=J.+Fanauthor=X.+Yangauthor=S.+Liauthor=T.+Yangauthor=H.+Sunauthor=Q.+Youauthor=X.+Zhang&title=Novel+naphtha%5B2%2C1-d%5Doxazole-4%2C5-diones+as+NQO1+substrates+with+improved+aqueous+solubility%3A+design%2C+synthesis%2C+and+in+vivo+antitumor+evaluation&doi=10.1016%2Fj.bmc.2016.01.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DMu%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DNovel%2520naphtha%255B2%252C1-d%255Doxazole-4%252C5-diones%2520as%2520NQO1%2520substrates%2520with%2520improved%2520aqueous%2520solubility%253A%2520design%252C%2520synthesis%252C%2520and%2520in%2520vivo%2520antitumor%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26issue%3D5%26spage%3D1006%26epage%3D1013%26doi%3D10.1016%2Fj.bmc.2016.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fryatt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardipee, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slawin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span> <span> </span><span class="NLM_article-title">Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase 1 (NQO1)</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1667</span>– <span class="NLM_lpage">1687</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.bmc.2004.01.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1667-1687&issue=7&author=T.+Fryattauthor=H.+I.+Petterssonauthor=W.+T.+Gardipeeauthor=K.+C.+Brayauthor=S.+J.+Greenauthor=A.+M.+Slawinauthor=H.+D.+Beallauthor=C.+J.+Moody&title=Novel+quinolinequinone+antitumor+agents%3A+structure-metabolism+studies+with+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29&doi=10.1016%2Fj.bmc.2004.01.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DFryatt%26aufirst%3DT.%26aulast%3DPettersson%26aufirst%3DH.%2BI.%26aulast%3DGardipee%26aufirst%3DW.%2BT.%26aulast%3DBray%26aufirst%3DK.%2BC.%26aulast%3DGreen%26aufirst%3DS.%2BJ.%26aulast%3DSlawin%26aufirst%3DA.%2BM.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DNovel%2520quinolinequinone%2520antitumor%2520agents%253A%2520structure-metabolism%2520studies%2520with%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26issue%3D7%26spage%3D1667%26epage%3D1687%26doi%3D10.1016%2Fj.bmc.2004.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">da
Cruz, E. H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussene, C. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diogo, E. B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Melo, I. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigus, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenca, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camara, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Paiva, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulart, M. O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalcanti, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pessoa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva Junior, E. N.</span></span> <span> </span><span class="NLM_article-title">1,2,3-Triazole-, arylamino- and thio-substituted 1,4-naphthoquinones: potent antitumor activity, electrochemical aspects, and bioisosteric replacement of C-ring-modified lapachones</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1608</span>– <span class="NLM_lpage">1619</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.bmc.2014.01.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1608-1619&issue=5&author=E.+H.+G.+da%0ACruzauthor=C.+M.+B.+Husseneauthor=G.+G.+Diasauthor=E.+B.+T.+Diogoauthor=I.+M.+M.+de+Meloauthor=B.+L.+Rodrigusauthor=M.+G.+da+Silvaauthor=W.+O.+Valencaauthor=C.+A.+Camaraauthor=R.+N.+de+Oliveiraauthor=Y.+G.+de+Paivaauthor=M.+O.+F.+Goulartauthor=B.+C.+Cavalcantiauthor=C.+Pessoaauthor=E.+N.+da+Silva+Junior&title=1%2C2%2C3-Triazole-%2C+arylamino-+and+thio-substituted+1%2C4-naphthoquinones%3A+potent+antitumor+activity%2C+electrochemical+aspects%2C+and+bioisosteric+replacement+of+C-ring-modified+lapachones&doi=10.1016%2Fj.bmc.2014.01.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.01.033%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BCruz%26aufirst%3DE.%2BH.%2BG.%26aulast%3DHussene%26aufirst%3DC.%2BM.%2BB.%26aulast%3DDias%26aufirst%3DG.%2BG.%26aulast%3DDiogo%26aufirst%3DE.%2BB.%2BT.%26aulast%3Dde%2BMelo%26aufirst%3DI.%2BM.%2BM.%26aulast%3DRodrigus%26aufirst%3DB.%2BL.%26aulast%3Dda%2BSilva%26aufirst%3DM.%2BG.%26aulast%3DValenca%26aufirst%3DW.%2BO.%26aulast%3DCamara%26aufirst%3DC.%2BA.%26aulast%3Dde%2BOliveira%26aufirst%3DR.%2BN.%26aulast%3Dde%2BPaiva%26aufirst%3DY.%2BG.%26aulast%3DGoulart%26aufirst%3DM.%2BO.%2BF.%26aulast%3DCavalcanti%26aufirst%3DB.%2BC.%26aulast%3DPessoa%26aufirst%3DC.%26aulast%3Dda%2BSilva%2BJunior%26aufirst%3DE.%2BN.%26atitle%3D1%252C2%252C3-Triazole-%252C%2520arylamino-%2520and%2520thio-substituted%25201%252C4-naphthoquinones%253A%2520potent%2520antitumor%2520activity%252C%2520electrochemical%2520aspects%252C%2520and%2520bioisosteric%2520replacement%2520of%2520C-ring-modified%2520lapachones%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26issue%3D5%26spage%3D1608%26epage%3D1619%26doi%3D10.1016%2Fj.bmc.2014.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profile</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.ejmech.2017.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=28214631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVehu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2017&pages=27-40&author=J.+Bianauthor=X.+Liauthor=N.+Wangauthor=X.+Wuauthor=Q.+Youauthor=X.+Zhang&title=Discovery+of+quinone-directed+antitumor+agents+selectively+bioactivated+by+NQO1+over+CPR+with+improved+safety+profile&doi=10.1016%2Fj.ejmech.2017.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profile</span></div><div class="casAuthors">Bian, Jinlei; Li, Xiang; Wang, Nan; Wu, Xingsen; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-40</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The authors mainly focused on discovering compds. with good selectivity for NQO1 over CPR.  The NQO1-mediated two-electron redn. of compds. would kill cancer cells selectively, while CPR-mediated one-electron redn. would induce potential hepatotoxicity.  Several novel quinone-directed antitumor agents were discovered as specific NQO1 substrates through structure-activity relationship studies.  Among them, compd. 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-dione (12b) emerged as the most specific substrate of the two-electron oxidoreductase NQO1 and could hardly be reduced by CPR.  It afforded the highest selectivity between NQO1/CPR (selectivity ratio = 6.37), much higher than the control β-lapachone (selectivity ratio = 1.36), indicated 12b may possess superior safety profile.  The electrochem. studies provided a reasonable explanation to the good selectivity toward NQO1.  Mol. docking studies supported that 12b was capable of forming addnl. C-H... π interactions with Trp 105 and Phe 178 residues compared to the control β-lap.  In addn., compd. 12b was shown to kill cancer cells efficiently both in vitro and in vivo model.  This work gave the authors a promising and novel scaffold for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqRMIKxcCSGLVg90H21EOLACvtfcHk0lhxwhhZo4IEJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVehu70%253D&md5=18c03007ddfea2f3165662912048ff3b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520quinone-directed%2520antitumor%2520agents%2520selectively%2520bioactivated%2520by%2520NQO1%2520over%2520CPR%2520with%2520improved%2520safety%2520profile%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D129%26spage%3D27%26epage%3D40%26doi%3D10.1016%2Fj.ejmech.2017.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hillard, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Abreu, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaouen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulart, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amatore, C.</span></span> <span> </span><span class="NLM_article-title">Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2612</span>– <span class="NLM_lpage">2628</span>, <span class="refDoi"> DOI: 10.1039/b718116g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1039%2Fb718116g" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=2612-2628&author=E.+A.+Hillardauthor=F.+C.+de+Abreuauthor=D.+C.+Ferreiraauthor=G.+Jaouenauthor=M.+O.+Goulartauthor=C.+Amatore&title=Electrochemical+parameters+and+techniques+in+drug+development%2C+with+an+emphasis+on+quinones+and+related+compounds&doi=10.1039%2Fb718116g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1039%2Fb718116g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb718116g%26sid%3Dliteratum%253Aachs%26aulast%3DHillard%26aufirst%3DE.%2BA.%26aulast%3Dde%2BAbreu%26aufirst%3DF.%2BC.%26aulast%3DFerreira%26aufirst%3DD.%2BC.%26aulast%3DJaouen%26aufirst%3DG.%26aulast%3DGoulart%26aufirst%3DM.%2BO.%26aulast%3DAmatore%26aufirst%3DC.%26atitle%3DElectrochemical%2520parameters%2520and%2520techniques%2520in%2520drug%2520development%252C%2520with%2520an%2520emphasis%2520on%2520quinones%2520and%2520related%2520compounds%26jtitle%3DChem.%2520Commun.%26date%3D2008%26volume%3D23%26spage%3D2612%26epage%3D2628%26doi%3D10.1039%2Fb718116g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudnott, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span> <span> </span><span class="NLM_article-title">Structure-based development of anticancer drugs: complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1016/S0969-2126(01)00636-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2FS0969-2126%2801%2900636-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=659-667&author=M.+Faigauthor=M.+A.+Bianchetauthor=S.+Winskiauthor=R.+Hargreavesauthor=C.+J.+Moodyauthor=A.+R.+Hudnottauthor=D.+Rossauthor=L.+M.+Amzel&title=Structure-based+development+of+anticancer+drugs%3A+complexes+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+with+chemotherapeutic+quinones&doi=10.1016%2FS0969-2126%2801%2900636-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2801%2900636-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252801%252900636-0%26sid%3Dliteratum%253Aachs%26aulast%3DFaig%26aufirst%3DM.%26aulast%3DBianchet%26aufirst%3DM.%2BA.%26aulast%3DWinski%26aufirst%3DS.%26aulast%3DHargreaves%26aufirst%3DR.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DHudnott%26aufirst%3DA.%2BR.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DStructure-based%2520development%2520of%2520anticancer%2520drugs%253A%2520complexes%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520with%2520chemotherapeutic%2520quinones%26jtitle%3DStructure%26date%3D2001%26volume%3D9%26spage%3D659%26epage%3D667%26doi%3D10.1016%2FS0969-2126%2801%2900636-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1016%2Fj.ejmech.2014.05.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=56-67&author=J.+Bianauthor=B.+Dengauthor=L.+Xuauthor=X.+Xuauthor=N.+Wangauthor=T.+Huauthor=Z.+Yaoauthor=J.+Duauthor=L.+Yangauthor=Y.+Leiauthor=X.+Liauthor=H.+Sunauthor=X.+Zhangauthor=Q.+You&title=2-Substituted+3-methylnaphtho%5B1%2C2-b%5Dfuran-4%2C5-diones+as+novel+L-shaped+ortho-quinone+substrates+for+NAD%28P%29H%3Aquinone+oxidoreductase+%28NQO1%29&doi=10.1016%2Fj.ejmech.2014.05.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.041%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DYao%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3D2-Substituted%25203-methylnaphtho%255B1%252C2-b%255Dfuran-4%252C5-diones%2520as%2520novel%2520L-shaped%2520ortho-quinone%2520substrates%2520for%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520%2528NQO1%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D82%26spage%3D56%26epage%3D67%26doi%3D10.1016%2Fj.ejmech.2014.05.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doncaster, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunstan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leys, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryce, R. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">7142</span>– <span class="NLM_lpage">7156</span>, <span class="refDoi"> DOI: 10.1021/jm9011609</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9011609" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7142-7156&issue=22&author=K.+A.+Nolanauthor=J.+R.+Doncasterauthor=M.+S.+Dunstanauthor=K.+A.+Scottauthor=A.+D.+Frenkelauthor=D.+Siegelauthor=D.+Rossauthor=J.+Barnesauthor=C.+Levyauthor=D.+Leysauthor=R.+C.+Whiteheadauthor=I.+J.+Stratfordauthor=R.+A.+Bryce&title=Synthesis+and+biological+evaluation+of+coumarin-based+inhibitors+of+NAD%28P%29H%3A+quinone+oxidoreductase-1+%28NQO1%29&doi=10.1021%2Fjm9011609"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm9011609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9011609%26sid%3Dliteratum%253Aachs%26aulast%3DNolan%26aufirst%3DK.%2BA.%26aulast%3DDoncaster%26aufirst%3DJ.%2BR.%26aulast%3DDunstan%26aufirst%3DM.%2BS.%26aulast%3DScott%26aufirst%3DK.%2BA.%26aulast%3DFrenkel%26aufirst%3DA.%2BD.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DBarnes%26aufirst%3DJ.%26aulast%3DLevy%26aufirst%3DC.%26aulast%3DLeys%26aufirst%3DD.%26aulast%3DWhitehead%26aufirst%3DR.%2BC.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DBryce%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520coumarin-based%2520inhibitors%2520of%2520NAD%2528P%2529H%253A%2520quinone%2520oxidoreductase-1%2520%2528NQO1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D22%26spage%3D7142%26epage%3D7156%26doi%3D10.1021%2Fjm9011609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollabaugh, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hettiarachchi, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">Human NAD(P)H:quinone oxidoreductase type I (hNQO1) activation of quinone propionic acid trigger groups</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">40</span>),  <span class="NLM_fpage">8014</span>– <span class="NLM_lpage">8026</span>, <span class="refDoi"> DOI: 10.1021/bi300760u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi300760u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=8014-8026&issue=40&author=M.+F.+Mendozaauthor=N.+M.+Hollabaughauthor=S.+H.+Hettiarachchiauthor=R.+L.+McCarley&title=Human+NAD%28P%29H%3Aquinone+oxidoreductase+type+I+%28hNQO1%29+activation+of+quinone+propionic+acid+trigger+groups&doi=10.1021%2Fbi300760u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fbi300760u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi300760u%26sid%3Dliteratum%253Aachs%26aulast%3DMendoza%26aufirst%3DM.%2BF.%26aulast%3DHollabaugh%26aufirst%3DN.%2BM.%26aulast%3DHettiarachchi%26aufirst%3DS.%2BH.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3DHuman%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520type%2520I%2520%2528hNQO1%2529%2520activation%2520of%2520quinone%2520propionic%2520acid%2520trigger%2520groups%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26issue%3D40%26spage%3D8014%26epage%3D8026%26doi%3D10.1021%2Fbi300760u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fales, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokoloski, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasquez-Vivar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, B.</span></span> <span> </span><span class="NLM_article-title">Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">5727</span>– <span class="NLM_lpage">5732</span>, <span class="refDoi"> DOI: 10.1073/pnas.0501719102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1073%2Fpnas.0501719102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=5727-5732&issue=16&author=H.+Zhaoauthor=J.+Josephauthor=H.+M.+Falesauthor=E.+A.+Sokoloskiauthor=R.+L.+Levineauthor=J.+Vasquez-Vivarauthor=B.+Kalyanaraman&title=Detection+and+characterization+of+the+product+of+hydroethidine+and+intracellular+superoxide+by+HPLC+and+limitations+of+fluorescence&doi=10.1073%2Fpnas.0501719102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0501719102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0501719102%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DJoseph%26aufirst%3DJ.%26aulast%3DFales%26aufirst%3DH.%2BM.%26aulast%3DSokoloski%26aufirst%3DE.%2BA.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DVasquez-Vivar%26aufirst%3DJ.%26aulast%3DKalyanaraman%26aufirst%3DB.%26atitle%3DDetection%2520and%2520characterization%2520of%2520the%2520product%2520of%2520hydroethidine%2520and%2520intracellular%2520superoxide%2520by%2520HPLC%2520and%2520limitations%2520of%2520fluorescence%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26issue%3D16%26spage%3D5727%26epage%3D5732%26doi%3D10.1073%2Fpnas.0501719102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dharmaraja, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrapani, H.</span></span> <span> </span><span class="NLM_article-title">A small molecule for controlled generation of reactive oxygen species (ROS)</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">398</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1021/ol403300a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol403300a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=398-401&issue=2&author=A.+T.+Dharmarajaauthor=H.+Chakrapani&title=A+small+molecule+for+controlled+generation+of+reactive+oxygen+species+%28ROS%29&doi=10.1021%2Fol403300a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fol403300a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol403300a%26sid%3Dliteratum%253Aachs%26aulast%3DDharmaraja%26aufirst%3DA.%2BT.%26aulast%3DChakrapani%26aufirst%3DH.%26atitle%3DA%2520small%2520molecule%2520for%2520controlled%2520generation%2520of%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26issue%3D2%26spage%3D398%26epage%3D401%26doi%3D10.1021%2Fol403300a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bentle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitz, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Calcium-dependent modulation of poly(ADP-ribose) polymerase-1 alters cellular metabolism and DNA repair</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">33684</span>– <span class="NLM_lpage">33696</span>, <span class="refDoi"> DOI: 10.1074/jbc.M603678200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;key=10.1074%2Fjbc.M603678200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=33684-33696&issue=44&author=M.+S.+Bentleauthor=K.+E.+Reinickeauthor=E.+A.+Beyauthor=D.+R.+Spitzauthor=D.+A.+Boothman&title=Calcium-dependent+modulation+of+poly%28ADP-ribose%29+polymerase-1+alters+cellular+metabolism+and+DNA+repair&doi=10.1074%2Fjbc.M603678200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M603678200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M603678200%26sid%3Dliteratum%253Aachs%26aulast%3DBentle%26aufirst%3DM.%2BS.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DSpitz%26aufirst%3DD.%2BR.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DCalcium-dependent%2520modulation%2520of%2520poly%2528ADP-ribose%2529%2520polymerase-1%2520alters%2520cellular%2520metabolism%2520and%2520DNA%2520repair%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D44%26spage%3D33684%26epage%3D33696%26doi%3D10.1074%2Fjbc.M603678200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H69" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H69','PDB','1H69'); return false;">PDB: 1H69</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i86"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01424">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_13362"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01424">10.1021/acs.jmedchem.8b01424</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Determination of the NQO1 activity in corresponding cancer cells, and normal hepatic L02 cells, cyclic voltammograms of the representive compounds, β-lap, and the control Ferrocene, doking poses for the representive compounds, possible reduction process for quinone substrate β-lap by NQO1, HPLC spectra for compound recovery after NQO1 assay, <sup>1</sup>H NMR and HRMS spectra for all of the target compounds, and <sup>13</sup>C NMR spectra for representative target compounds, HPLC assessment of purity for target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01424/suppl_file/jm8b01424_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01424/suppl_file/jm8b01424_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01424/suppl_file/jm8b01424_si_001.pdf">jm8b01424_si_001.pdf (6.53 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01424/suppl_file/jm8b01424_si_002.csv">jm8b01424_si_002.csv (1.74 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01424%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-24%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01424" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996f218ae4d1db","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
